40391-99-9 | Pamidronic acid

Packsize	Purity	Availability	Price	Discounted Price
1mg	95%	in stock	$16.00	$11.00
10mg	95%	in stock	$20.00	$14.00
50mg	95%	in stock	$25.00	$17.00
250mg	95%	in stock	$39.00	$27.00
1g	95%	in stock	$63.00	$44.00
5g	95%	in stock	$219.00	$153.00
10g	95%	in stock	$387.00	$271.00

Description

• Catalog Number: AD30468
• Chemical Name: Pamidronic acid
• CAS Number: 40391-99-9
• Molecular Formula: C3H11NO7P2
• Molecular Weight: 235.0695
• MDL Number: MFCD00168777
• SMILES: NCCC(P(=O)(O)O)(P(=O)(O)O)O

Computed Properties

• Complexity: 243
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 13
• Hydrogen Bond Acceptor Count: 8
• Hydrogen Bond Donor Count: 6
• Rotatable Bond Count: 4
• XLogP3: -6.9

Literature

• Modulation of paraoxonase 1 (PON1) activity and protein N-homocysteinylation by bisphosphonates in rats.

  Chemico-biological interactions 20161125

• Treatment with pamidronate for osteoporosis complicating long-term intestinal failure.

  Journal of pediatric gastroenterology and nutrition 20121101

• Prospective study of histomorphometry, biochemical bone markers and bone densitometric response to pamidronate in β-thalassaemia presenting with osteopenia-osteoporosis syndrome.

  British journal of haematology 20121101

• Incidence of maxillary sinusitis and oro-antral fistulae in bisphosphonate-related osteonecrosis of the jaw.

  Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery 20121001

• Incidence of serious side effects with intravenous bisphosphonate: a clinical audit.

  QJM : monthly journal of the Association of Physicians 20121001

• Diffuse sclerosing osteomyelitis of the mandible successfully treated with pamidronate: a long-term follow-up report.

  Oral surgery, oral medicine, oral pathology and oral radiology 20121001

• Methylenebisphosphonate and triphosphate derivatives of the mevalonate pathway are substrates of yeast UTP:glucose-1-phosphate uridylyltransferase.

  Biochimie 20120901

• Renal complications from bisphosphonate treatment.

  Current opinion in supportive and palliative care 20120901

• Resorptive hypercalcemia in post-essential thrombocythemia myelofibrosis: treatment with denosumab.

  The Journal of clinical endocrinology and metabolism 20120901

• Two-year cyclic infusion of pamidronate improves bone mass density and eliminates risk of fractures in a girl with osteoporosis due to Hajdu-Cheney syndrome.

  Minerva endocrinologica 20120901

• Denosumab and bone metastases. No better than a bisphosphonate.

  Prescrire international 20120901

• Hypertrophic osteoarthropathy presenting as unilateral cellulitis with successful treatment using pamidronate disodium.

  The Journal of clinical and aesthetic dermatology 20120901

• Clinical trials of bisphosphonates in multiple myeloma.

  Clinical advances in hematology & oncology : H&O 20120901

• Bisphosphonates modulate the expression of OPG and M-CSF in hMSC-derived osteoblasts.

  Clinical oral investigations 20120801

• A retrospective study evaluating frequency and risk factors of osteonecrosis of the jaw in 576 cancer patients receiving intravenous bisphosphonates.

  American journal of clinical oncology 20120801

• Prolonged administration of bisphosphonates is well-tolerated and effective for skeletal-related events in Chinese breast cancer patients with bone metastasis.

  Breast (Edinburgh, Scotland) 20120801

• Humoral hypercalcemia of malignancy in a patient with hypoparathyroidism.

  European review for medical and pharmacological sciences 20120801

• Children and adolescents treated with neridronate for osteogenesis imperfecta show no evidence of any osteonecrosis of the jaw.

  Journal of bone and mineral metabolism 20120701

• Release of pamidronate from poly(ethyleneimine)/cellulose sulphate complex nanoparticle films: an in situ ATR-FTIR study.

  Journal of pharmaceutical and biomedical analysis 20120701

• Interpreting results from oncology clinical trials: a comparison of denosumab to zoledronic acid for the prevention of skeletal-related events in cancer patients.

  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20120701

• Treatment of chronic hypercalcemia.

  Medicinal chemistry (Shariqah (United Arab Emirates)) 20120701

• What is the role of hyperbaric oxygen in the management of bisphosphonate-related osteonecrosis of the jaw: a randomized controlled trial of hyperbaric oxygen as an adjunct to surgery and antibiotics.

  Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20120701

• SEOM guidelines for the treatment of bone metastases from solid tumours.

  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20120701

• Bisphosphonate metal complexes as selective inhibitors of Trypanosoma cruzi farnesyl diphosphate synthase.

  Dalton transactions (Cambridge, England : 2003) 20120607

• Radical surgical treatment of bisphosphonate related osteonecrosis of the jaw.

  Australian dental journal 20120601

• Modern interpretation of giant cell tumor of bone: predominantly osteoclastogenic stromal tumor.

  Clinics in orthopedic surgery 20120601

• Bisphosphonates in multiple myeloma: a network meta-analysis.

  The Cochrane database of systematic reviews 20120516

• Recurrent femur neck fracture and response to bisphosphonates in polyostotic fibrous dysplasia.

  Indian journal of pediatrics 20120501

• Effects of pamidronate on human alveolar osteoblasts in vitro.

  Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20120501

• The potential benefits of participating in early-phase clinical trials in multiple myeloma: long-term remission in a patient with relapsed multiple myeloma treated with 90 cycles of lenalidomide and bortezomib.

  European journal of haematology 20120501

• Case 181: synovitis acne pustulosis hyperostosis osteitis (SAPHO) syndrome.

  Radiology 20120501

• [Current approaches in multiple myeloma and other cancer-related bone diseases].

  Deutsche medizinische Wochenschrift (1946) 20120501

• Bisphosphonates for osteoporosis in people with cystic fibrosis.

  The Cochrane database of systematic reviews 20120418

• Retrospective analysis of antitumor effects of zoledronic acid in breast cancer patients with bone-only metastases.

  Cancer 20120415

• Bisphosphonates as antimyeloma drugs.

  Leukemia 20120401

• Patient-reported outcome instruments used to assess pain and functioning in studies of bisphosphonate treatment for bone metastases.

  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20120401

• Cutting edge: nitrogen bisphosphonate-induced inflammation is dependent upon mast cells and IL-1.

  Journal of immunology (Baltimore, Md. : 1950) 20120401

• Patient management, and time and health care resource utilization associated with the use of intravenous bisphosphonates for patients with metastatic bone disease: a Delphi study.

  Hospital practice (1995) 20120401

• [Simultaneous determination of alendronate, pamidronate, ibandronate and risedronate using ion chromatography with integrated pulsed amperometric detection].

  Se pu = Chinese journal of chromatography 20120401

• Coercing bisphosphonates to kill cancer cells with nanoscale coordination polymers.

  Chemical communications (Cambridge, England) 20120311

• Pregnancy-associated spinal osteoporosis treated with bisphosphonates: long-term follow-up of maternal and infants outcome.

  Rheumatology international 20120301

• An evaluation of the use of oral bisphosphonates and risk of esophageal cancer.

  The Annals of pharmacotherapy 20120301

• Current recommendations for laboratory testing and use of bone turnover markers in management of osteoporosis.

  Annals of laboratory medicine 20120301

• Denosumab for the prevention of skeletal-related events in patients with bone metastasis from solid tumor.

  Pharmacotherapy 20120301

• Hypophosphatasia presenting with pyridoxine-responsive seizures, hypercalcemia, and pseudotumor cerebri: case report.

  Journal of clinical research in pediatric endocrinology 20120301

• Thalassemia major: the present and the future.

  North American journal of medical sciences 20120301

• Bone disease in thyrotoxicosis.

  The Indian journal of medical research 20120301

• Drug-induced palate osteonecrosis following nasal surgery.

  The Israel Medical Association journal : IMAJ 20120301

• Bisphosphonates and other bone agents for breast cancer.

  The Cochrane database of systematic reviews 20120215

• Preparation of polymer-based multimodal imaging agent to visualize the process of bone regeneration.

  Journal of controlled release : official journal of the Controlled Release Society 20120210

• Counting touching cell nuclei using fast ellipse detection to assess in vitro cell characteristics: a feasibility study.

  Clinical oral investigations 20120201

• The influence of bisphosphonates on viability, migration, and apoptosis of human oral keratinocytes--in vitro study.

  Clinical oral investigations 20120201

• Osteitis condensans of the sternal manubrium and ossification of the costoclavicular ligaments.

  The Journal of rheumatology 20120201

• Extraskeletal benefits and risks of calcium, vitamin D and anti-osteoporosis medications.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20120201

• Zoledronate and pamidronate depress neutrophil functions and survival in mice.

  British journal of pharmacology 20120101

• Fracture after bisphosphonate treatment in children with cerebral palsy: the role of stress risers.

  Pediatric radiology 20120101

• The Medical Research Council Myeloma IX trial: the impact on treatment paradigms.

  European journal of haematology 20120101

• A review of the diagnosis and treatment of Ochratoxin A inhalational exposure associated with human illness and kidney disease including focal segmental glomerulosclerosis.

  Journal of environmental and public health 20120101

• Therapeutic challenges in elderly patients with symptomatic hypercalcaemia caused by primary hyperparathyroidism.

  The Netherlands journal of medicine 20120101

• Hypertrophy of the feet and ankles presenting in primary hypertrophic osteoarthropathy or pachydermoperiostosis: a case report.

  Journal of medical case reports 20120101

• Pamidronic acid and cabergoline as effective long-term therapy in a 12-year-old girl with extended facial polyostotic fibrous dysplasia, prolactinoma and acromegaly in McCune-Albright syndrome: a case report.

  Journal of medical case reports 20120101

• Bilateral atypical insufficiency fractures of the proximal tibia and a unilateral distal femoral fracture associated with long-term intravenous bisphosphonate therapy: a case report.

  Journal of medical case reports 20120101

• Cinacalcet for hypercalcemia caused by pulmonary squamous cell carcinoma producing parathyroid hormone-related Peptide.

  Case reports in oncology 20120101

• Time associated with intravenous zoledronic acid administration in patients with breast or prostate cancer and bone metastasis.

  Cancer management and research 20120101

• Functional parathyroid cyst: a rare cause of malignant hypercalcemia with primary hyperparathyroidism-a case report and review of the literature.

  Case reports in medicine 20120101

• Targeting bone alleviates osteoarthritis in osteopenic mice and modulates cartilage catabolism.

  PloS one 20120101

• Paget's disease of the mandible.

  Journal of oral and maxillofacial pathology : JOMFP 20120101

• Effect of local zoledronate on implant osseointegration in a rat model.

  BMC musculoskeletal disorders 20120101

• Impregnation of bone chips with alendronate and cefazolin, combined with demineralized bone matrix: a bone chamber study in goats.

  BMC musculoskeletal disorders 20120101

• Platelet-rich plasma improves wound healing in multiple myeloma bisphosphonate-associated osteonecrosis of the jaw patients.

  Journal of biological regulators and homeostatic agents 20120101

• Calcific uremic arteriolopathy on multimodal combination therapy: still unmet goal.

  International journal of nephrology 20120101

• Castration-resistant prostate cancer: mechanisms, targets, and treatment.

  Prostate cancer 20120101

• Role of denosumab in the management of skeletal complications in patients with bone metastases from solid tumors.

  Biologics : targets & therapy 20120101

• Imiglucerase in the treatment of Gaucher disease: a history and perspective.

  Drug design, development and therapy 20120101

• Estimated number of prevalent cases of metastatic bone disease in the US adult population.

  Clinical epidemiology 20120101

• A novel mutation in LEPRE1 that eliminates only the KDEL ER- retrieval sequence causes non-lethal osteogenesis imperfecta.

  PloS one 20120101

• The current practice of screening, prevention, and treatment of androgen-deprivation-therapy induced osteoporosis in patients with prostate cancer.

  Journal of oncology 20120101

• Molecular diagnosis of generalized arterial calcification of infancy (GACI).

  Journal of cardiovascular disease research 20120101

• The surgical management of fibrous dysplasia of bone.

  Orphanet journal of rare diseases 20120101

• Clinical guidelines for the management of craniofacial fibrous dysplasia.

  Orphanet journal of rare diseases 20120101

• Pathophysiology and medical treatment of pain in fibrous dysplasia of bone.

  Orphanet journal of rare diseases 20120101

• Novel strategies for immunotherapy in multiple myeloma: previous experience and future directions.

  Clinical & developmental immunology 20120101

• Preparation and evaluation of polymeric microparticulates for improving cellular uptake of gemcitabine.

  International journal of nanomedicine 20120101

• Primary hyperparathyroidism due to an intrathyroidal parathyroid adenoma associated with chronic lymphocytic thyroiditis.

  BMJ case reports 20120101

• Safety and efficacy of a 1-year treatment with zoledronic acid compared with pamidronate in children with osteogenesis imperfecta.

  Journal of pediatric endocrinology & metabolism : JPEM 20120101

• Evaluation and comparison of safety, convenience and cost of administering intravenous pamidronate infusions to children in the home and ambulatory care settings.

  Journal of pediatric endocrinology & metabolism : JPEM 20120101

• Bisphosphonate induced osteonecrosis of jaw in breast cancer patients: A systematic review.

  Journal of oral and maxillofacial pathology : JOMFP 20120101

• Dyselectrolytemias after single dose of pamidronate administration.

  Journal of Nepal Health Research Council 20120101

• In silico investigations of the anti-catabolic effects of pamidronate and denosumab on multiple myeloma-induced bone disease.

  PloS one 20120101

• Cost-effectiveness of zoledronic acid in the prevention of skeletal-related events in patients with bone metastases secondary to advanced renal cell carcinoma: application to France, Germany, and the United Kingdom.

  The European journal of health economics : HEPAC : health economics in prevention and care 20111201

• Nephrotic syndrome induced by pamidronate.

  Medical oncology (Northwood, London, England) 20111201

• The kaleidoscopic presentation of the spondyloarthritis concept in a female patient.

  Joint, bone, spine : revue du rhumatisme 20111201

• Teriparatide increases bone mineral density in a man with osteoporosis pseudoglioma.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20111201

• A prospective clinical trial for assessing the efficacy of a minimally invasive protocol in patients with bisphosphonate-associated osteonecrosis of the jaws.

  Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 20111201

• McCune-Albright syndrome revealed by hyperthyroidism at advanced age.

  Annales d'endocrinologie 20111201

• Preventive effects of zoledronic acid on bone metastasis in mice injected with human breast cancer cells.

  Journal of Korean medical science 20111201

• Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).

  PLoS computational biology 20111201

• Diaqua-bis-(dihydrogen 3-aza-niumyl-1-hy-droxy-propyl-idene-1,1-di-phos-phon-ato-κO,O')cobalt(II).

  Acta crystallographica. Section E, Structure reports online 20111201

• Bone mass, bone markers and prevalence of fractures in adults with osteogenesis imperfecta.

  Archives of osteoporosis 20111201

• Determination of alendronate in low volumes of plasma by column-switching high-performance liquid chromatography method and its application to pharmacokinetic studies in human plasma.

  Archives of pharmacal research 20111201

• Modern management of malignant hypercalcemia.

  The American journal of hospice & palliative care 20111101

• Optimising the use of bone-targeted agents in patients with metastatic cancers: a practical guide for medical oncologists.

  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20111101

• A role of oral bacteria in bisphosphonate-induced osteonecrosis of the jaw.

  Journal of dental research 20111101

• In-vivo near-infrared optical imaging of growing osteosarcoma cell lesions xenografted in mice: dual-channel quantitative evaluation of volume and mineralization.

  Acta radiologica (Stockholm, Sweden : 1987) 20111101

• Comparison of alendronate and pamidronate on bone loss in kidney transplant patients for the first 6 months of transplantation.

  Iranian journal of kidney diseases 20111101

• [Aggressive universal calcinosis complicating dermatomyositis].

  Annales de dermatologie et de venereologie 20111101

• Uncommon transient osteoporosis of pregnancy at multiple sites associated with cytomegalovirus infection: is there a link?

  The Israel Medical Association journal : IMAJ 20111101

• Direct inhibition of osteoclast formation and activity by the vitamin E isomer gamma-tocotrienol.

  International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition 20111101

• Treatment of hypertrophic osteoarthropathy with zoledronic acid: case report and review of the literature.

  Seminars in arthritis and rheumatism 20111001

• Thalidomide, dexamethasone and lovastatin with autologous stem cell transplantation as a salvage immunomodulatory therapy in patients with relapsed and refractory multiple myeloma.

  Annals of hematology 20111001

• Perioperative antibiotic regimen in rats treated with pamidronate plus dexamethasone and subjected to dental extraction: a study of the changes in the jaws.

  Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20111001

• Novel therapy to reverse the cellular effects of bisphosphonates on primary human oral fibroblasts.

  Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20111001

• Paget's disease of bone and calcium homeostasis: focus on bisphosphonate treatment.

  Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 20111001

• Breast cancer medications and vision: effects of treatments for early-stage disease.

  Current eye research 20111001

• [Inflammation of the jaws during treatment with bisphosphonates].

  Deutsche medizinische Wochenschrift (1946) 20111001

• DC-like cell-dependent activation of human natural killer cells by the bisphosphonate zoledronic acid is regulated by γδ T lymphocytes.

  Blood 20110908

• Parenteral bisphosphonates for osteoporosis in patients with primary biliary cirrhosis.

  American journal of therapeutics 20110901

• A comparative study of intravenous ibandronate and pamindronate in patients with bone metastases from breast or lung cancer: effect on metastatic bone pain.

  American journal of therapeutics 20110901

• Decrease in serum FGF23 levels after intravenous infusion of pamidronate in patients with osteogenesis imperfecta.

  Journal of bone and mineral metabolism 20110901

• [Pamidronate: a therapeutic alternative in chronic recurrent mutifocal osteomyelitis].

  Anales de pediatria (Barcelona, Spain : 2003) 20110901

• Antitumor effects of bisphosphonates: from the laboratory to the clinic.

  Current opinion in supportive and palliative care 20110901

• Tolerance and effectiveness on pain control of Pamidronate® intravenous infusions in children with neuromuscular disorders.

  Annals of physical and rehabilitation medicine 20110901

• Efficacy of unipedicular baloon kyphoplasty for treatment of multiple myeloma vertebral lesions.

  Asian spine journal 20110901

• The abnormal phenotypes of cartilage and bone in calcium-sensing receptor deficient mice are dependent on the actions of calcium, phosphorus, and PTH.

  PLoS genetics 20110901

• Bisphosphonate related osteonecrosis of the jaws: report of two cases.

  Imaging science in dentistry 20110901

• Nephrotic syndrome and renal failure in a patient with metastatic breast cancer.

  Clinical and experimental nephrology 20110801

• Pain management in patients with cancer: focus on opioid analgesics.

  Current pain and headache reports 20110801

• Osteonecrosis of the jaw in oncology patients treated with bisphosphonates: prospective experience of a dental oncology referral center.

  Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 20110801

• Management of lower limb deformities in children with osteogenesis imperfecta.

  Indian pediatrics 20110801

• Osteonecrosis of the jaw: dental outcomes in metastatic breast cancer patients treated with bisphosphonates with/without bevacizumab.

  Clinical breast cancer 20110801

• Effects of zoledronic acid versus clodronic acid on skeletal morbidity in patients with newly diagnosed multiple myeloma (MRC Myeloma IX): secondary outcomes from a randomised controlled trial.

  The Lancet. Oncology 20110801

• Interferon alpha and pamidronate in osteoporosis with fracture secondary to mastocytosis.

  The American journal of medicine 20110801

• Images in clinical medicine. Radiographic zebra lines from cyclical pamidronate therapy.

  The New England journal of medicine 20110721

• The relationship between the chemistry and biological activity of the bisphosphonates.

  Bone 20110701

• Risedronate does not reduce mechanical loading-related increases in cortical and trabecular bone mass in mice.

  Bone 20110701

• Anatomical sector analysis of load-bearing tibial bone structure during 90-day bed rest and 1-year recovery.

  Clinical physiology and functional imaging 20110701

• Approach to the child with fractures.

  The Journal of clinical endocrinology and metabolism 20110701

• Combinatorial strategies for alleviation of tumor-associated immune suppression and therapeutic vaccination against ovarian cancer.

  Immunotherapy 20110701

• Zoledronic acid: multiplicity of use across the cancer continuum.

  Expert review of anticancer therapy 20110701

• Tired with all those supplements?

  QJM : monthly journal of the Association of Physicians 20110601

• The influence of a bisphosphonate on bone generation determined using a chick-femur model.

  International endodontic journal 20110601

• A phase 1, single-dose study of fresolimumab, an anti-TGF-β antibody, in treatment-resistant primary focal segmental glomerulosclerosis.

  Kidney international 20110601

• Genetic polymorphisms and other risk factors associated with bisphosphonate induced osteonecrosis of the jaw.

  International journal of oral and maxillofacial surgery 20110601

• Outcome after repair of a sarcoma-related pathologic fracture in dogs: a Veterinary Society of Surgical Oncology Retrospective Study.

  Veterinary surgery : VS 20110601

• Activated protein C inhibits bisphosphonate-induced endothelial cell death via the endothelial protein C receptor and nuclear factor-κB pathways.

  International journal of molecular medicine 20110601

• Bisphosphonates induce senescence in normal human oral keratinocytes.

  Journal of dental research 20110601

• N⁴-[Alkyl-(hydroxyphosphono)phosphonate]-cytidine-new drugs covalently linking antimetabolites (5-FdU, araU or AZT) with bone-targeting bisphosphonates (alendronate or pamidronate).

  Bioorganic & medicinal chemistry 20110601

• Letter to the editor: acute effects of intravenous administration of pamidronate in patients with osteoporosis.

  Journal of Korean medical science 20110601

• Pubic rami and sacral insufficiency fractures resulting in osteomyelitis, vulval abscess, discharging bone fragments and pelvic instability.

  JRSM short reports 20110601

• Engineering alloplastic temporomandibular joint replacements.

  McGill journal of medicine : MJM : an international forum for the advancement of medical sciences by students 20110601

• Treatment of transient osteoporosis of the hip with intravenous zoledronate - a case report -.

  Annals of rehabilitation medicine 20110601

• Advances in imaging and the management of myeloma bone disease.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110510

• Procollagen type I N-propeptide is a predictor of skeletal morbidity in patients with malignant osteolytic bone disease on bisphosphonates.

  Cancer chemotherapy and pharmacology 20110501

• Anatomic site variability in rat skeletal uptake and desorption of fluorescently labeled bisphosphonate.

  Oral diseases 20110501

• Parathyroid-hormone-related protein-mediated hypercalcemia in benign congenital mesoblastic nephroma.

  Pediatric nephrology (Berlin, Germany) 20110501

• Pamidronate versus observation in asymptomatic myeloma: final results with long-term follow-up of a randomized study.

  Leukemia & lymphoma 20110501

• Calcitropic hormones and IGF-I are influenced by dietary protein.

  Endocrinology 20110501

• Msx-1 is suppressed in bisphosphonate-exposed jaw bone analysis of bone turnover-related cell signalling after bisphosphonate treatment.

  Oral diseases 20110501

• The role of bisphosphonate therapy in the global management of multiple myeloma.

  Leukemia & lymphoma 20110501

• Effect of zoledronic acid on acro-osteolysis and osteoporosis in a patient with Hajdu-Cheney syndrome.

  Yonsei medical journal 20110501

• The role of bisphosphonates in multiple myeloma: mechanisms, side effects, and the future.

  The oncologist 20110501

• Novel nephrotoxins.

  Advances in chronic kidney disease 20110501

• Camurati-Engelmann disease: unique variant featuring a novel mutation in TGFβ1 encoding transforming growth factor beta 1 and a missense change in TNFSF11 encoding RANK ligand.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20110501

• Fibrous dysplasia & McCune-Albright syndrome: an experience from a tertiary care centre in north India.

  The Indian journal of medical research 20110501

• Pamidronate infusion improved two cases of intractable seronegative rheumatoid arthritise.

  Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences 20110501

• Addition of pamidronate to chemotherapy for the treatment of osteosarcoma.

  Cancer 20110415

• Three cases of bone metastases in patients with gastrointestinal stromal tumors.

  Rare tumors 20110404

• Pincer nails associated with pamidronate.

  Clinical and experimental dermatology 20110401

• Current evidence of the management of undifferentiated spondyloarthritis: a systematic literature review.

  Seminars in arthritis and rheumatism 20110401

• Evolution of the radiographic appearance of the metaphyses over the first year of life in type V osteogenesis imperfecta: clues to pathogenesis.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20110401

• Skeletal imaging effects of pamidronate therapy in osteosarcoma patients.

  Pediatric radiology 20110401

• Inhibition of the isoprenoid biosynthesis pathway; detection of intermediates by UPLC-MS/MS.

  Biochimica et biophysica acta 20110401

• Neonatal hyperparathyroidism with a heterozygous calcium-sensing receptor (CASR) R185Q mutation: clinical benefit from cinacalcet.

  The Journal of clinical endocrinology and metabolism 20110401

• Local treatment of cancellous bone grafts with BMP-7 and zoledronate increases both the bone formation rate and bone density: a bone chamber study in rats.

  Acta orthopaedica 20110401

• Pamidronate and zoledronate effects in the increment of bone mineral density and histomorphometry in rats.

  Acta cirurgica brasileira 20110401

• Role of matrix metalloproteinases and therapeutic benefits of their inhibition in spinal cord injury.

  Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 20110401

• Decrease in outpatient department visits and operative interventions due to bisphosphonates in children with osteogenesis imperfecta.

  Journal of children's orthopaedics 20110401

• Intravenous pamidronate for refractory lymphedema.

  Iranian Red Crescent medical journal 20110401

• 99mTc(CO)3-labeled pamidronate and alendronate for bone imaging.

  Dalton transactions (Cambridge, England : 2003) 20110328

• American Society of Clinical Oncology executive summary of the clinical practice guideline update on the role of bone-modifying agents in metastatic breast cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110320

• Bisphosphonates affect migration ability and cell viability of HUVEC, fibroblasts and osteoblasts in vitro.

  Oral diseases 20110301

• Comparison of intravenous and intramuscular neridronate regimens for the treatment of Paget disease of bone.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20110301

• Pamidronate, farnesyl transferase, and geranylgeranyl transferase-I inhibitors affects cell proliferation, apoptosis, and OPG/RANKL mRNA expression in stromal cells of giant cell tumor of bone.

  Journal of orthopaedic research : official publication of the Orthopaedic Research Society 20110301

• Evaluation of osteoclastic resorption activity using calcium phosphate coating combined with labeled polyanion.

  Analytical biochemistry 20110301

• Recurrence of multiple myeloma with soft tissue plasmacytoma presenting as unilateral proptosis.

  Orbit (Amsterdam, Netherlands) 20110301

• [Encounter of cancer cells with bone. Treatment of bone metastases from breast cancer].

  Clinical calcium 20110301

• Treatment of lumbar pars interarticularis stress injuries in athletes with intravenous bisphosphonates: five case studies.

  Clinical journal of sport medicine : official journal of the Canadian Academy of Sport Medicine 20110301

• Towards evidence-based emergency medicine: best BETs from the Manchester Royal Infirmary. BET 1: do bisphosphonates relieve pain caused by acute osteoporotic vertebral compression fractures?

  Emergency medicine journal : EMJ 20110301

• Eight-year follow-up of a girl with McCune-Albright syndrome.

  Journal of clinical research in pediatric endocrinology 20110301

• Alendronate therapy in polyostotic fibrous dysplasia presenting with pathologic fracture.

  American journal of orthopedics (Belle Mead, N.J.) 20110301

• Prevalence, pathophysiology, screening and management of osteoporosis in gastric cancer patients.

  Journal of gastric cancer 20110301

• Bisphosphonates: restrictions for vasculogenesis and angiogenesis: inhibition of cell function of endothelial progenitor cells and mature endothelial cells in vitro.

  Clinical oral investigations 20110201

• Effect of bisphosphonates on human gingival fibroblast production of mediators of osteoclastogenesis: RANKL, osteoprotegerin and interleukin-6.

  Journal of periodontal research 20110201

• Breast cancer cells inhibit spontaneous and bisphosphonate-induced osteoclast apoptosis.

  Bone 20110201

• The SAPHO syndrome: a clinical and imaging study.

  Clinical rheumatology 20110201

• Use of bisphosphonates to treat severe idiopathic hypercalcaemia in a young Ragdoll cat.

  Journal of feline medicine and surgery 20110201

• Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20110201

• Severe hypercalcemia associated with uterine leiomyoma in pregnancy.

  Obstetrics and gynecology 20110201

• The role of RANK-ligand inhibition in cancer: the story of denosumab.

  The oncologist 20110201

• Established role of bisphosphonate therapy for prevention of skeletal complications from myeloma bone disease.

  Critical reviews in oncology/hematology 20110201

• Effects of ibandronate-hydroxyapatite on resorptive activity of osteoclasts.

  Archives of medical science : AMS 20110201

• Efficacy of low doses of pamidronate in osteopenic patients administered in the early post-renal transplant.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20110101

• Failure to perceive increased risk of fracture in women 55 years and older: the Global Longitudinal Study of Osteoporosis in Women (GLOW).

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20110101

• Initial results of the treatment of diffuse sclerosing osteomyelitis of the mandible with bisphosphonates.

  Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery 20110101

• Iatrogenic osteoporosis, bilateral HIP osteonecrosis, and secondary adrenal suppression in an HIV-infected man receiving inhaled corticosteroids and ritonavir-boosted highly active antiretroviral therapy.

  Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20110101

• Life-threatening hypercalcemia in patients with rhabdomyolysis-induced oliguric acute renal failure.

  Journal of nephrology 20110101

• Nationwide survey of bisphosphonate therapy for children with reactivated Langerhans cell histiocytosis in Japan.

  Pediatric blood & cancer 20110101

• Computational insights into binding of bisphosphates to farnesyl pyrophosphate synthase.

  Current medicinal chemistry 20110101

• Loading and skeletal development and maintenance.

  Journal of osteoporosis 20110101

• A roadmap to the brittle bones of cystic fibrosis.

  Journal of osteoporosis 20110101

• Paget disease of the bone: does it exist in Saudi Arabia?

  Annals of Saudi medicine 20110101

• γδ T cells cross-link innate and adaptive immunity in Mycobacterium tuberculosis infection.

  Clinical & developmental immunology 20110101

• Incidence of bone metastases and skeletal-related events in breast cancer patients: a population-based cohort study in Denmark.

  BMC cancer 20110101

• Geraniol rescues inflammation in cellular and animal models of mevalonate kinase deficiency.

  In vivo (Athens, Greece) 20110101

• Familial Takayasu arteritis - a pediatric case and a review of the literature.

  Pediatric rheumatology online journal 20110101

• Zoledronic acid treatment in children with osteogenesis imperfecta.

  Hormone research in paediatrics 20110101

• Intravenous pamidronate treatment improves growth in prepubertal osteogenesis imperfecta patients.

  Hormone research in paediatrics 20110101

• Collapsing glomerulopathy in sickle cell disease: a case report.

  Journal of medical case reports 20110101

• Updated recommendations for the diagnosis and management of osteoporosis: a local perspective.

  Annals of Saudi medicine 20110101

• The facial skeleton in patients with osteoporosis: a field for disease signs and treatment complications.

  Journal of osteoporosis 20110101

• Treatment of severe metastatic calcification and calciphylaxis in dialysis patients.

  International journal of nephrology 20110101

• Diffuse 'vertebra-within-vertebra' appearance at the adult age due to biphosphonate (Pamidronate) administration during early adolescence.

  JBR-BTR : organe de la Societe royale belge de radiologie (SRBR) = orgaan van de Koninklijke Belgische Vereniging voor Radiologie (KBVR) 20110101

• Is bisphosphonate therapy for benign bone disease associated with impaired dental healing? A case-controlled study.

  BMC musculoskeletal disorders 20110101

• Nanotechnology for the treatment of coronary in stent restenosis: a clinical perspective.

  Vascular cell 20110101

• Supportive therapy in multiple myeloma.

  Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer 20110101

• Severe hypercalcemia associated with Williams syndrome successfully treated with pamidronate infusion therapy.

  Journal of pediatric endocrinology & metabolism : JPEM 20110101

• Fracture prevention in postmenopausal women.

  BMJ clinical evidence 20110101

• Bisphosphonates can reduce bone hunger after parathyroidectomy in patients with primary hyperparathyroidism and osteitis fibrosa cystica.

  Revista brasileira de reumatologia 20110101

• Role of zoledronic acid in the prevention and treatment of osteoporosis.

  Clinical interventions in aging 20110101

• Bisphosphonates and atypical fractures of femur.

  Journal of osteoporosis 20110101

• Emerging strategies and therapies for treatment of Paget's disease of bone.

  Drug design, development and therapy 20110101

• The effect of gallium nitrate on arresting blood flow from a wound.

  Case reports in medicine 20110101

• Comparing comorbidity measures for predicting mortality and hospitalization in three population-based cohorts.

  BMC health services research 20110101

• Tiludronate treatment improves structural changes and symptoms of osteoarthritis in the canine anterior cruciate ligament model.

  Arthritis research & therapy 20110101

• Fibrous dysplasia of bone associated with soft-tissue myxomas as well as an intra-osseous myxoma in a woman with Mazabraud's syndrome: a case report.

  Journal of medical case reports 20110101

• Bisphosphonate-associated osteonecrosis of the jaw is linked to suppressed TGFβ1-signaling and increased Galectin-3 expression: a histological study on biopsies.

  Journal of translational medicine 20110101

• Calciphylaxis in a morbidly obese woman with rheumatoid arthritis presenting with severe weight loss and vitamin D deficiency.

  Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20110101

• Calcific uremic arteriolopathy in peritoneal dialysis populations.

  International journal of nephrology 20110101

• Osteonecrosis of the jaw in patients with metastatic breast cancer: ethnic and socio-economic aspects.

  The breast journal 20110101

• Bone turnover is adequately suppressed in osteoporotic patients treated with bisphosphonates in daily practice.

  BMC musculoskeletal disorders 20110101

• Long-term persistance of the pathophysiologic response to severe burn injury.

  PloS one 20110101

• Improvement of pain and regional osteoporotic changes in the foot and ankle by low-dose bisphosphonate therapy for complex regional pain syndrome type I: a case series.

  Journal of medical case reports 20110101

• Treatment of symptomatic osteoporosis in children: a comparison of two pamidronate dosage regimens.

  Journal of pediatric endocrinology & metabolism : JPEM 20110101

• Increased human defensine levels hint at an inflammatory etiology of bisphosphonate-associated osteonecrosis of the jaw: an immunohistological study.

  Journal of translational medicine 20110101

• Seven years' experience with etidronate in a woman with anorexia nervosa and vertebral fractures.

  Therapeutics and clinical risk management 20110101

• Autologous bone marrow stem cell intralesional transplantation repairing bisphosphonate related osteonecrosis of the jaw.

  Head & face medicine 20110101

• A review on current osteoporosis research: with special focus on disuse bone loss.

  Journal of osteoporosis 20110101

• Hyperparathyroidism due to eutopic PTH secretion from an ectopic intrathymic parathyroid cyst.

  Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia 20110101

• Indian commentary on the 2009 KDIGO clinical practice guideline for the diagnosis, evaluation, and treatment of chronic kidney disease-mineral and bone disorders.

  Indian journal of nephrology 20110101

• A rare case of zolendronate infusion complication leading to glaucoma filtration surgery.

  Clinical ophthalmology (Auckland, N.Z.) 20110101

• Dental implications of osteogenesis imperfecta: treatment with IV bisphosphonate: report of a case.

  Pediatric dentistry 20110101

• HMGB1 and cord blood: its role as immuno-adjuvant factor in innate immunity.

  PloS one 20110101

• Expansion of human peripheral blood γδ T cells using zoledronate.

  Journal of visualized experiments : JoVE 20110101

• Human ovarian tumor cells escape γδ T cell recognition partly by down regulating surface expression of MICA and limiting cell cycle related molecules.

  PloS one 20110101

• Prognostic and predictive value of clinical and biochemical factors in breast cancer patients with bone metastases receiving 'metronomic' zoledronic acid.

  BMC cancer 20110101

• Osteonecrosis of the jaw as a possible rare side effect of annual bisphosphonate administration for osteoporosis: A case report.

  Journal of medical case reports 20110101

• Reshaping of vertebrae during treatment with neridronate or pamidronate in children with osteogenesis imperfecta.

  Hormone research in paediatrics 20110101

• Ribbing disease: Uncommon cause of a common symptom.

  Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India 20110101

• Tc99m-MDP bone scintigraphy in Engelmann-Camurati disease.

  Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India 20110101

• Osteoimmunology and osteoporosis.

  Arthritis research & therapy 20110101

• Tumour macrophages as potential targets of bisphosphonates.

  Journal of translational medicine 20110101

• Complex regional pain syndrome.

  Indian journal of plastic surgery : official publication of the Association of Plastic Surgeons of India 20110101

• Metastatic bladder cancer: a review of current management.

  ISRN urology 20110101

• Clinical utility of clodronate in the prevention and management of osteoporosis in patients intolerant of oral bisphosphonates.

  Drug design, development and therapy 20110101

• Anti-transforming growth factor ß antibody treatment rescues bone loss and prevents breast cancer metastasis to bone.

  PloS one 20110101

• Use of cone-beam computerized tomography for evaluation of bisphosphonate-associated osteonecrosis of the jaws in an experimental rat model.

  International journal of medical sciences 20110101

• Closure of an open wound associated with bisphosphonate-related osteonecrosis of the jaw in a breast cancer patient.

  The open dentistry journal 20110101

• Tumor cells and tumor-associated macrophages: secreted proteins as potential targets for therapy.

  Clinical & developmental immunology 20110101

• Efficacy and safety of a modular multi-modal exercise program in prostate cancer patients with bone metastases: a randomized controlled trial.

  BMC cancer 20110101

• A case of myeloma with hypercalcemia caused by high serum concentrations of both parathyroid hormone-related peptide (PTHrP) and macrophage inflammatory protein-1α (MIP-1α).

  Internal medicine (Tokyo, Japan) 20110101

• Update in pathological diagnosis of orbital infections and inflammations.

  Middle East African journal of ophthalmology 20110101

• Calciphylaxis presenting in early chronic kidney disease with mixed hyperparathyroidism.

  International journal of nephrology and renovascular disease 20110101

• Efficacy and safety of gonadotropin-releasing hormone agonists used in the treatment of prostate cancer.

  Drug, healthcare and patient safety 20110101

• A randomized controlled trial to compare the efficacy of bisphosphonates in the management of painful bone metastasis.

  Indian journal of palliative care 20110101

• Needle in a haystack-parathyroid gland in a 10-day old infant: a case report and literature review.

  ISRN pediatrics 20110101

• Osteoporosis and bisphosphonate-related osteonecrosis of the jaw bone.

  ISRN rheumatology 20110101

• Multiple myeloma and bisphosphonate-related osteonecrosis of the mandible associated with dental implants.

  Case reports in dentistry 20110101

• Case of hypercalcemia secondary to hypervitaminosis a in a 6-year-old boy with autism.

  Case reports in endocrinology 20110101

• In vivo local co-delivery of recombinant human bone morphogenetic protein-7 and pamidronate via poly-D, L-lactic acid.

  European cells & materials 20101222

• Zoledronic acid in myeloma: MRC Myeloma IX.

  Lancet (London, England) 20101211

• Cancer and renal insufficiency results of the BIRMA study.

  British journal of cancer 20101207

• Possible beneficial effect of bisphosphonates in osteonecrosis of the knee.

  Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA 20101201

• Biochemical bone markers in the assessment and pamidronate treatment of children and adolescents with osteogenesis imperfecta.

  Acta paediatrica (Oslo, Norway : 1992) 20101201

• A predictive ligand-based Bayesian model for human drug-induced liver injury.

  Drug metabolism and disposition: the biological fate of chemicals 20101201

• Analgesic effect of intrathecal ginsenosides in a murine bone cancer pain.

  The Korean journal of pain 20101201

• [Prosthetic rehabilitation after osteonecrosis of the jaws due to histiocytosis X and treatment with bisphosphonates apropos of a case].

  Odonto-stomatologie tropicale = Tropical dental journal 20101201

• Intravenous bisphosphonate treatment and pregnancy: its effects on mother and infant bone health.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20101101

• Characterising and treating osteogenesis imperfecta.

  Early human development 20101101

• Surface immobilized zoledronate improves screw fixation in rat bone: a new method for the coating of metal implants.

  Journal of materials science. Materials in medicine 20101101

• Optimizing clinical benefits of bisphosphonates in cancer patients with bone metastases.

  The oncologist 20101101

• Assessment of the efficacy of pamidronate in ankylosing spondylitis: an open prospective trial.

  Singapore medical journal 20101101

• Nephrotoxicity from chemotherapeutic agents: clinical manifestations, pathobiology, and prevention/therapy.

  Seminars in nephrology 20101101

• First-line treatment with bortezomib rapidly stimulates both osteoblast activity and bone matrix deposition in patients with multiple myeloma, and stimulates osteoblast proliferation and differentiation in vitro.

  European journal of haematology 20101001

• An experimental study of bisphosphonate-induced jaws osteonecrosis in Sprague-Dawley rats.

  Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 20101001

• Intravenous pamidronate for myeloma bone disease: can the dose be lowered?

  The Lancet. Oncology 20101001

• Effect of pamidronate 30 mg versus 90 mg on physical function in patients with newly diagnosed multiple myeloma (Nordic Myeloma Study Group): a double-blind, randomised controlled trial.

  The Lancet. Oncology 20101001

• Bisphosphonates as anticancer therapy for early breast cancer.

  Clinical breast cancer 20101001

• Effects of clodronate combined with hydroxyapatite on multi-directional differentiation of mesenchymal stromal cells.

  Archives of medical science : AMS 20101001

• Targeting isoprenoid biosynthesis for drug discovery: bench to bedside.

  Accounts of chemical research 20100921

• Spinal involvement in chronic recurrent multifocal osteomyelitis (CRMO) in childhood and effect of pamidronate.

  European journal of pediatrics 20100901

• Pamidronate inhibits antiapoptotic bcl-2 expression through inhibition of the mevalonate pathway in prostate cancer PC-3 cells.

  European journal of pharmacology 20100901

• Skeletal phenotype of mandibuloacral dysplasia associated with mutations in ZMPSTE24.

  Bone 20100901

• Bisphosphonate protonation states, conformations, and dynamics on bone mineral probed by solid-state NMR without isotope enrichment.

  European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20100901

• Charcot's foot: newest findings on its pathophysiology, diagnosis and treatment.

  Diabetes & metabolism 20100901

• Decreased fracture incidence after 1 year of pamidronate treatment in children with spastic quadriplegic cerebral palsy.

  Developmental medicine and child neurology 20100901

• Necrosis following skull base irradiation and stem cell transplant for multiple myeloma.

  American journal of hematology 20100901

• Risk of skeletal-related events in patients with advanced prostate cancer treated with pamidronate or zoledronic acid.

  The Annals of pharmacotherapy 20100901

• Skin wounds associated with calciphylaxis in end-stage renal disease patients on dialysis.

  Nutrition (Burbank, Los Angeles County, Calif.) 20100901

• Scintigraphic findings of growth arrest lines after bisphosphonate administration in a steroid-induced osteoporosis patient: a case study.

  Clinical nuclear medicine 20100901

• Fractures in myelomeningocele.

  Journal of orthopaedics and traumatology : official journal of the Italian Society of Orthopaedics and Traumatology 20100901

• Acute effects of intravenous administration of pamidronate in patients with osteoporosis.

  Journal of Korean medical science 20100901

• [A case of bisphosphonate-associated osteonecrosis of the jaw in a patient with bone metastasis of breast cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20100901

• [Relationship between osteonecrosis of the jaw and bisphosphonate treatment].

  Arhiv za higijenu rada i toksikologiju 20100901

• [Bisphosphonates in adjuvant therapy of breast cancer].

  Medizinische Klinik (Munich, Germany : 1983) 20100901

• Near-infrared fluorescent probe traces bisphosphonate delivery and retention in vivo.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20100801

• Risk of corrected QT interval prolongation after pamidronate infusion in children.

  The Journal of clinical endocrinology and metabolism 20100801

• Inhibition of bone resorption blunts osteoarthritis in mice with high bone remodelling.

  Annals of the rheumatic diseases 20100801

• Bone mineral density and fracture rate in response to intravenous and oral bisphosphonates in adult osteogenesis imperfecta.

  Calcified tissue international 20100801

• [Antitumor properties of the bisphosphonate zoledronate and potential therapeutic implications in the clinic].

  Bulletin du cancer 20100801

• Diffuse skeletal pain after administration of alendronate.

  Indian journal of pharmacology 20100801

• [Efficient treatment of hypercalcaemia in neonatal subcutaneous fat necrosis].

  Ugeskrift for laeger 20100719

• The synergistic efficacy of adalimumab and pamidronate in a patient with ankylosing spondylitis.

  Clinical rheumatology 20100701

• Use of bisphosphonates for the treatment of osteonecrosis as a complication of therapy for childhood acute lymphoblastic leukaemia (ALL).

  Pediatric blood & cancer 20100701

• Cell-based immunotherapy with mesenchymal stem cells cures bisphosphonate-related osteonecrosis of the jaw-like disease in mice.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20100701

• Local low-dose lovastatin delivery improves the bone-healing defect caused by Nf1 loss of function in osteoblasts.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20100701

• Treatment outcomes in patients with bisphosphonate-related osteonecrosis of the jaws: a prospective study.

  Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 20100701

• Biological activity of gemcitabine against canine osteosarcoma cell lines in vitro.

  American journal of veterinary research 20100701

• Bisphosphonates for bone pain #113.

  Journal of palliative medicine 20100701

• Pamidronate for fibrous dysplasia due to McCune Albright Syndrome.

  Indian pediatrics 20100701

• Panoramic radiograph, computed tomography or magnetic resonance imaging. Which imaging technique should be preferred in bisphosphonate-associated osteonecrosis of the jaw? A prospective clinical study.

  Clinical oral investigations 20100601

• Importance of microcracks in etiology of bisphosphonate-related osteonecrosis of the jaw: a possible pathogenetic model of symptomatic and non-symptomatic osteonecrosis of the jaw based on scanning electron microscopy findings.

  Clinical oral investigations 20100601

• SAPHO syndrome in an adult with ulcerative colitis responsive to intravenous pamidronate: a case report and review of the literature.

  Rheumatology international 20100601

• PTH improves titanium implant fixation more than pamidronate or renutrition in osteopenic rats chronically fed a low protein diet.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20100601

• Effect of a single dose of pamidronate administered at the time of surgery in a rabbit posterolateral spinal fusion model.

  European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society 20100601

• Increased prevalence of bisphosphonate-related osteonecrosis of the jaw with vitamin D deficiency in rats.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20100601

• A case of hypercalcemia and gastric necrosis from hot pack ingestion.

  Journal of medical toxicology : official journal of the American College of Medical Toxicology 20100601

• [Bone and joint diseases in children. Bisphosphonates in osteogenesis imperfecta].

  Clinical calcium 20100601

• Effective dosage and administration schedule of oral alendronate for non-nociceptive symptoms in rats with chronic constriction injury.

  Journal of Korean medical science 20100601

• The neurological safety of epidural pamidronate in rats.

  The Korean journal of pain 20100601

• Therapeutic options in the management of myeloma bone disease.

  Seminars in oncology 20100601

• An in vitro assay to measure targeted drug delivery to bone mineral.

  ChemMedChem 20100503

• A pilot case-control study on the alveolar bone density measurement in risk assessment for bisphosphonate-related osteonecrosis of the jaw.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20100501

• Hypercalcaemia and acute renal failure after major burns: An under-diagnosed condition.

  Burns : journal of the International Society for Burn Injuries 20100501

• Multiple myeloma: changes in serum C-terminal telopeptide of collagen type I and bone-specific alkaline phosphatase can be used in daily practice to detect imminent osteolysis.

  European journal of haematology 20100501

• Osteonecrosis or metastases of the jaw or both? Case report and review of the literature.

  Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20100501

• Inhibition of necrotic actions of nitrogen-containing bisphosphonates (NBPs) and their elimination from bone by etidronate (a non-NBP): a proposal for possible utilization of etidronate as a substitution drug for NBPs.

  Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20100501

• Use of cone-beam computerized tomography for evaluation of bisphosphonate-associated osteonecrosis of the jaws.

  Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 20100501

• Prognostic variables for survival and skeletal complications in patients with multiple myeloma osteolytic bone disease.

  Leukemia 20100501

• Medical applications and toxicities of gallium compounds.

  International journal of environmental research and public health 20100501

• Farnesyl diphosphate synthase attenuates paclitaxel-induced apoptotic cell death in human glioblastoma U87MG cells.

  Neuroscience letters 20100426

• [Stop in bone remodeling in imperfect osteogenesis].

  Medicina clinica 20100410

• The epidemiology of osteonecrosis: findings from the GPRD and THIN databases in the UK.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20100401

• Effect of low-level laser irradiation on bisphosphonate-induced osteonecrosis of the jaws: preliminary results of a prospective study.

  Photomedicine and laser surgery 20100401

• The successful use of pamidronate in an 11-year-old girl with complex regional pain syndrome: response to treatment demonstrated by serial peripheral quantitative computerised tomographic scans.

  Bone 20100401

• Bisphosphonate-related osteonecrosis of the jaw associated with dental implants.

  Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20100401

• Water-soluble polymer-drug conjugates for combination chemotherapy against visceral leishmaniasis.

  Bioorganic & medicinal chemistry 20100401

• Prosthodontic treatment of a patient with bisphosphonate-induced osteonecrosis of the jaw using a removable dental prosthesis with a heat-polymerized resilient liner: a clinical report.

  The Journal of prosthetic dentistry 20100401

• Feasibility of administering zoledronic acid in palliative patients being cared for in the community: results of a pilot study.

  Current oncology (Toronto, Ont.) 20100401

• [A case of breast cancer with extensive osteonecrosis of maxilla induced by a bisphosphonate].

  Gan to kagaku ryoho. Cancer & chemotherapy 20100401

• Implant failure associated with oral bisphosphonate-related osteonecrosis of the jaw.

  Journal of periodontal & implant science 20100401

• Central dislocation of the hip secondary to insufficiency fracture.

  Orthopedic reviews 20100320

• Combined effects of the bisphosphonate, zoledronic acid and the aromatase inhibitor letrozole on breast cancer cells in vitro: evidence of synergistic interaction.

  British journal of cancer 20100316

• Treatment of HER2-positive metastatic breast cancer with lapatinib and capecitabine in the lapatinib expanded access programme, including efficacy in brain metastases--the UK experience.

  British journal of cancer 20100316

• Bisphosphonates for osteoporosis treatment are associated with reduced breast cancer risk.

  British journal of cancer 20100302

• Zoledronic acid delays wound healing of the tooth extraction socket, inhibits oral epithelial cell migration, and promotes proliferation and adhesion to hydroxyapatite of oral bacteria, without causing osteonecrosis of the jaw, in mice.

  Journal of bone and mineral metabolism 20100301

• Jaw bone changes in rats after treatment with zoledronate and pamidronate.

  Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 20100301

• The effect of zoledronate during bone healing.

  Journal of orthopaedics and traumatology : official journal of the Italian Society of Orthopaedics and Traumatology 20100301

• SAPHO syndrome in an adult with ulcerative colitis responsive to intravenous pamidronate.

  Joint, bone, spine : revue du rhumatisme 20100301

• Effects of intravenous pamidronate on renal function, bone mineral metabolism and bone mass in patients with severe osteoporosis.

  The American journal of the medical sciences 20100301

• Fluorescent risedronate analogues reveal bisphosphonate uptake by bone marrow monocytes and localization around osteocytes in vivo.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20100301

• Protein kinase C is inhibited by bisphosphonates in prostate cancer PC-3 cells.

  European journal of pharmacology 20100210

• Influence of bisphosphonates on endothelial cells, fibroblasts, and osteogenic cells.

  Clinical oral investigations 20100201

• Skeletal-related events (SREs) in breast cancer patients with bone metastases treated in the nontrial setting.

  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20100201

• Expression profile and synthesis of different collagen types I, II, III, and V of human gingival fibroblasts, osteoblasts, and SaOS-2 cells after bisphosphonate treatment.

  Clinical oral investigations 20100201

• Management of massive osteolysis of the mandible: a case report.

  Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 20100201

• Pamidronate improves pain, wellbeing, fracture rate and bone density in 14 children and adolescents with chronic neurological conditions.

  Developmental neurorehabilitation 20100201

• Metaphyseal bands in osteogenesis imperfecta.

  The Indian journal of radiology & imaging 20100201

• Bisphosphonates suppress insulin-like growth factor 1-induced angiogenesis via the HIF-1alpha/VEGF signaling pathways in human breast cancer cells.

  International journal of cancer 20100101

• Cancer treatment dosing regimens of zoledronic acid result in near-complete suppression of mandible intracortical bone remodeling in beagle dogs.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20100101

• Dysuria caused by pelvic metastasis from breast carcinoma was alleviated by multi-modality therapy with zoledronic acid.

  The breast journal 20100101

• Complete resolution of universal calcinosis in a patient with juvenile dermatomyositis using pamidronate.

  Joint, bone, spine : revue du rhumatisme 20100101

• No significant effect on bone mineral density by high doses of vitamin D3 given to overweight subjects for one year.

  Nutrition journal 20100101

• Retrospective French nationwide survey of childhood aggressive vascular anomalies of bone, 1988-2009.

  Orphanet journal of rare diseases 20100101

• [Effect of pamidronate infusion time on renal function in patients with multiple myeloma].

  Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20100101

• Bisphosphonates and risk of atrial fibrillation: a meta-analysis.

  Arthritis research & therapy 20100101

• Atlas of signaling for interpretation of microarray experiments.

  PloS one 20100101

• Unusual phenotypical variations in a boy with McCune-Albright syndrome.

  Hormone research in paediatrics 20100101

• Metastatic breast carcinoma of the coracoid process: two case reports.

  Journal of orthopaedic surgery and research 20100101

• Effectiveness of the treatment with intravenous pamidronate in calcinosis in juvenile dermatomyositis.

  Clinical and experimental rheumatology 20100101

• A novel soft-tissue in vitro model for bisphosphonate-associated osteonecrosis.

  Fibrogenesis & tissue repair 20100101

• Inherited multicentric osteolysis: case report of three siblings treated with bisphosphonate.

  Pediatric rheumatology online journal 20100101

• A mathematical model of bone remodeling dynamics for normal bone cell populations and myeloma bone disease.

  Biology direct 20100101

• Serum tartrate-resistant acid phosphatase 5b activity as a prognostic marker of survival in breast cancer with bone metastasis.

  BMC cancer 20100101

• Cyclic pamidronate therapy in children with osteogenesis imperfecta.

  Journal of pediatric endocrinology & metabolism : JPEM 20100101

• Chronic nonbacterial osteomyelitis in childhood: prospective follow-up during the first year of anti-inflammatory treatment.

  Arthritis research & therapy 20100101

• Alendronate improves QOL of postmenopausal women with osteoporosis.

  Clinical interventions in aging 20100101

• Synthesis, solution, and structural characterization of tetrahydrofuranyl-2,2-bisphosphonic acid disodium salt.

  Bioinorganic chemistry and applications 20100101

• Jaw osteonecrosis related to bisphosphonate treatment of bone metastasis.

  Journal of biological regulators and homeostatic agents 20100101

• Beta-thalassemia.

  Orphanet journal of rare diseases 20100101

• Zoledronic acid treatment of osteoporosis: effects in men.

  Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20100101

• Dihydrotachysterol intoxication treated with pamidronate: a case report.

  Cases journal 20100101

• Skeletal dysplasias associated with mild myopathy-a clinical and molecular review.

  Journal of biomedicine & biotechnology 20100101

• Optical tomographic imaging discriminates between disease-modifying anti-rheumatic drug (DMARD) and non-DMARD efficacy in collagen antibody-induced arthritis.

  Arthritis research & therapy 20100101

• Five-year follow-up of Japanese patients with Paget's disease of the bone after treatment with low-dose oral alendronate: a case series.

  Journal of medical case reports 20100101

• Efficacy and safety of zoledronic acid in the treatment of glucocorticoid-induced osteoporosis.

  Therapeutics and clinical risk management 20100101

• Bisphosphonate treatment in polyostotic fibrous dysplasia of the cranium: case report and literature review.

  Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20100101

• Use of carboxymethyl cellulose and collagen carrier with equine bone lyophilisate suggests late onset bone regenerative effect in a humerus drill defect - a pilot study in six sheep.

  The open orthopaedics journal 20100101

• Short-term bisphosphonate therapy could ameliorate osteonecrosis: a complication in childhood hematologic malignancies.

  Case reports in medicine 20100101

• Prevalence of bisphosphonate associated osteonecrosis of the jaws in multiple myeloma patients.

  Head & face medicine 20100101

• The impact of bisphosphonates on the osteoblast proliferation and Collagen gene expression in vitro.

  Head & face medicine 20100101

• Bone tissue engineering with human stem cells.

  Stem cell research & therapy 20100101

• An open cohort study of bone metastasis incidence following surgery in breast cancer patients.

  BMC cancer 20100101

• Long-term treatment with bisphosphonates and their safety in postmenopausal osteoporosis.

  Therapeutics and clinical risk management 20100101

• State-of-the-Art Management of Complications of Myeloma and Its Treatment.

  Advances in hematology 20100101

• Management of osteoporotic vertebral fractures.

  International journal of general medicine 20100101

• Development of clinical utility of zoledronic acid and patient considerations in the treatment of osteoporosis.

  Patient preference and adherence 20100101

• Post-operative breast cancer patients diagnosed with skeletal metastasis without bone pain had fewer skeletal-related events and deaths than those with bone pain.

  BMC cancer 20100101

• Calcific uremic arteriolopathy: pathophysiology, reactive oxygen species and therapeutic approaches.

  Oxidative medicine and cellular longevity 20100101

• The effect of risedronate on osteogenic lineage is mediated by cyclooxygenase-2 gene upregulation.

  Arthritis research & therapy 20100101

• Bisphosphonate treatment of aggressive primary, recurrent and metastatic Giant Cell Tumour of Bone.

  BMC cancer 20100101

• Current and emerging treatments for the management of osteogenesis imperfecta.

  Therapeutics and clinical risk management 20100101

• [Clinical case of the month. Bilateral optic neuropathy secondary to biphosphonate therapy].

  Revue medicale de Liege 20100101

• Oral lesions and lymphoproliferative disorders.

  Journal of oncology 20100101

• [Effect of a single dose of zoledronic acid in a case of Paget bone disease].

  Medicina 20100101

• Evaluation of an aminobisphosphonate (alendronate) in the management of periodontal osseous defects.

  Journal of Indian Society of Periodontology 20100101

• Mechanical stress activates Smad pathway through PKCδ to enhance interleukin-11 gene transcription in osteoblasts.

  PloS one 20100101

• Expression of Msx-1 is suppressed in bisphosphonate associated osteonecrosis related jaw tissue-etiopathology considerations respecting jaw developmental biology-related unique features.

  Journal of translational medicine 20100101

• Current and developing therapeutic agents in the treatment of Chagas disease.

  Drug design, development and therapy 20100101

• Hypercalcemia and huge splenomegaly presenting in an elderly patient with B-cell non-Hodgkin's lymphoma: a case report.

  Journal of medical case reports 20100101

• Osteoporosis syndrome in thalassaemia major: an overview.

  Journal of osteoporosis 20100101

• Oral Alendronate Treatment for Severe Polyostotic Fibrous Dysplasia due to McCune-Albright Syndrome in a Child: A Case Report.

  International journal of pediatric endocrinology 20100101

• Adverse events and intravenous versus oral bisphosphonate use in patients with osteoporosis and cancer in the U.S.

  General dentistry 20100101

• Lysis of aminobisphosphonate-sensitized MCF-7 breast tumor cells by Vγ9Vδ2 T cells.

  Cancer immunity 20100101

• A SNP in CYP2C8 is not associated with the development of bisphosphonate-related osteonecrosis of the jaw in men with castrate-resistant prostate cancer.

  Therapeutics and clinical risk management 20100101

• Prevention of bone metastases and management of bone health in early breast cancer.

  Breast cancer research : BCR 20100101

• Anti-tumour activity of bisphosphonates in preclinical models of breast cancer.

  Breast cancer research : BCR 20100101

• Effects of an alpha-4 integrin inhibitor on restenosis in a new porcine model combining endothelial denudation and stent placement.

  PloS one 20100101

• Evaluation of degarelix in the management of prostate cancer.

  Cancer management and research 20100101

• Consequences of daily administered parathyroid hormone on myeloma growth, bone disease, and molecular profiling of whole myelomatous bone.

  PloS one 20100101

• Changes in serum and synovial fluid biomarkers after acute injury (NCT00332254).

  Arthritis research & therapy 20100101

• Improving management of patients with advanced cancer.

  Patient preference and adherence 20100101

• Hypercalcaemia Mimicking STEMI on Electrocardiography.

  Case reports in medicine 20100101

• Mesenchymal Progenitor Cells and Their Orthopedic Applications: Forging a Path towards Clinical Trials.

  Stem cells international 20100101

• Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphanates.

  Prilozi 20100101

• Intravenous bisphosphonates for postmenopausal osteoporosis.

  Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences 20100101

• catena-Poly[zinc(II)-μ(3)-{hydrogen [1-hydr-oxy-2-(3-pyridinio)ethane-1,1-di-yl]diphospho-nato}].

  Acta crystallographica. Section E, Structure reports online 20100101

• Management of glucocorticoid-induced osteoporosis: prevalence, and emerging treatment options.

  Drug, healthcare and patient safety 20100101

• Safety and tolerability of zoledronic acid and other bisphosphonates in osteoporosis management.

  Drug, healthcare and patient safety 20100101

• Pharmacoeconomic considerations in the treatment of breast cancer.

  ClinicoEconomics and outcomes research : CEOR 20100101

• Novel therapies delay the progression of smoldering multiple myeloma: Case report and discussion.

  Ecancermedicalscience 20100101

• Mycobacterium microti infection associated with spindle cell pseudotumour and hypercalcaemia: a possible link with an infected alpaca.

  BMJ case reports 20100101

• Transient osteoporosis associated with pregnancy: use of bisphosphonate in treating a lactating mother.

  BMJ case reports 20100101

• Hypercalcemia due to hypervitaminosis D: report of seven patients.

  Journal of tropical pediatrics 20091201

• Pamidronate treatment in rheumatology practice: a comprehensive review.

  Clinical rheumatology 20091201

• Extended use of intravenous bisphosphonate therapy for the prevention of skeletal complications in patients with cancer.

  Cancer investigation 20091201

• [A case of advanced breast cancer with multiple bone metastases responding to docetaxel and high-dose toremifene as fourth-line chemo-endocrine therapy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20091201

• Routine use of pamidronate in NSCLC patients with bone metastasis: results from a retrospective analysis.

  Anticancer research 20091201

• Preserving bone health in patients with hormone-sensitive prostate cancer: the role of bisphosphonates.

  BJU international 20091201

• Longitudinal cohort study of risk factors in cancer patients of bisphosphonate-related osteonecrosis of the jaw.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20091110

• At the bottom of the differential diagnosis list: unusual causes of pediatric hypertension.

  Pediatric nephrology (Berlin, Germany) 20091101

• Prostate cancer survivorship: prevention and treatment of the adverse effects of androgen deprivation therapy.

  Journal of general internal medicine 20091101

• Bisphosphonates and time to osteonecrosis development.

  The oncologist 20091101

• Hypercalcemic crisis successfully treated with prompt calcium-free hemodialysis.

  The American journal of emergency medicine 20091101

• Diaqua-bis[1-hydroxy-2-(imidazol-3-ium-1-yl)-1,1'-ethyl-idenediphophonato-κO,O']zinc(II).

  Acta crystallographica. Section E, Structure reports online 20091101

• Aquabis[1-hydroxy-2-(imidazol-3-ium-1-yl)-1,1'-ethylidenediphophonato-κO,O']zinc(II) dihydrate.

  Acta crystallographica. Section E, Structure reports online 20091101

• Bisphosphonates for osteoporosis in people with cystic fibrosis.

  The Cochrane database of systematic reviews 20091007

• Bisphosphonate incorporation in surgical implant coatings by fast loading and co-precipitation at low drug concentrations.

  Journal of materials science. Materials in medicine 20091001

• Hypercalcemia and osteoblastic lesions induced by 13-Cis-retinoic acid mimicking relapsed neuroblastoma.

  Pediatric blood & cancer 20091001

• In vitro determination of the release of alendronic acid from alendronate tablets of different brands during deglutition.

  Journal of pharmaceutical sciences 20091001

• Osteoporosis in adults with cerebral palsy.

  Developmental medicine and child neurology 20091001

• Percutaneous cementoplasty in the palliative, multimodal treatment of primary bone tumors of the distal aspect of the radius in four dogs.

  Veterinary surgery : VS 20091001

• Female patients with low systemic BMD are prone to bone loss in Gruen zone 7 after cementless total hip arthroplasty.

  Acta orthopaedica 20091001

• MRI in Ribbing disease-a case report.

  Acta orthopaedica 20091001

• [Paget's disease and hypercalcemia: coincidence or causal relationship?].

  Harefuah 20091001

• Enhanced bone morphogenetic protein-2 performance on hydroxyapatite ceramic surfaces.

  Journal of biomedical materials research. Part A 20090915

• The full-length calcium-sensing receptor dampens the calcemic response to 1alpha,25(OH)2 vitamin D3 in vivo independently of parathyroid hormone.

  American journal of physiology. Renal physiology 20090901

• Pamidronate-induced kidney injury in a patient with metastatic breast cancer.

  The American journal of the medical sciences 20090901

• A case of resistant hypercalcemia of malignancy with a proposed treatment algorithm.

  The Annals of pharmacotherapy 20090901

• Intravenous pamidronate therapy in osteogenesis imperfecta: response to treatment and factors influencing outcome: a novel molecular mechanism.

  Journal of pediatric orthopedics 20090901

• Paraneoplastic humorally mediated hypercalcemia induced by parathyroid hormone-related protein in gynecologic malignancies: a systematic review.

  Onkologie 20090901

• Amelioration of hypophosphatemic rickets and osteoporosis with pamidronate and growth hormone in Lowe syndrome.

  Journal of the Formosan Medical Association = Taiwan yi zhi 20090901

• [The efficacy and safety of intravenous bisphosphonates in the treatment of primary hyperparathyroidism complicated by hypercalcemia crisis].

  Zhonghua nei ke za zhi 20090901

• Switching breast cancer patients with progressive bone metastases to third-generation bisphosphonates: measuring impact using the Functional Assessment of Cancer Therapy-Bone Pain.

  Journal of pain and symptom management 20090801

• The use of bisphosphonates in multiple myeloma: recommendations of an expert panel on behalf of the European Myeloma Network.

  Annals of oncology : official journal of the European Society for Medical Oncology 20090801

• Osteonecrosis of the jaw and use of bisphosphonates in adjuvant breast cancer treatment: a meta-analysis.

  Breast cancer research and treatment 20090801

• A systematic MEDLINE analysis of therapeutic approaches in ankylosing spondylitis.

  Rheumatology international 20090801

• Severe osteoporosis and high level TSH in a child before the diagnosis of acute lymphoblastic leukemia.

  Journal of pediatric hematology/oncology 20090801

• The use of intravenous aminobisphosphonates for the treatment of Paget's disease of bone.

  Mini reviews in medicinal chemistry 20090801

• Risedronate in the treatment of mild pediatric osteogenesis imperfecta: a randomized placebo-controlled study.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20090701

• Bone mass and geometry of the tibia and the radius of master sprinters, middle and long distance runners, race-walkers and sedentary control participants: a pQCT study.

  Bone 20090701

• [Biphosphonates and osteogenesis imperfecta in children].

  Archives de pediatrie : organe officiel de la Societe francaise de pediatrie 20090701

• Adjuvant bisphosphonates in breast cancer: are we witnessing the emergence of a new therapeutic strategy?

  European journal of cancer (Oxford, England : 1990) 20090701

• The Global Longitudinal Study of Osteoporosis in Women (GLOW): rationale and study design.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20090701

• Intravenous bisphosphonate-related osteonecrosis of the jaw: bone scintigraphy as an early indicator.

  Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20090701

• Synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome treated with a combination of isotretinoin and pamidronate.

  Journal of the American Academy of Dermatology 20090701

• Acute retinal pigment epithelial detachment secondary to pamidronate administration.

  Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 20090601

• Hypercalcemia and overexpression of CYP27B1 in a patient with nephrogenic systemic fibrosis: clinical vignette and literature review.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20090601

• An open study of pamidronate in the treatment of refractory degenerative lumbar spinal stenosis.

  Clinical rheumatology 20090601

• Precocious puberty and normal variant puberty: definition, etiology, diagnosis and current management.

  Journal of clinical research in pediatric endocrinology 20090601

• Effectiveness of pamidronate in severe neonatal hypercalcemia caused by subcutaneous fat necrosis: a case report.

  European journal of pediatrics 20090501

• Selective modification of bone quality by PTH, pamidronate, or raloxifene.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20090501

• Outcome of surgical management of bisphosphonate-related osteonecrosis of the jaws: review of 33 surgical cases.

  Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20090501

• Effect of pamidronate on bone loss after kidney transplantation: a randomized trial.

  American journal of kidney diseases : the official journal of the National Kidney Foundation 20090501

• Necrotic actions of nitrogen-containing bisphosphonates and their inhibition by clodronate, a non-nitrogen-containing bisphosphonate in mice: potential for utilization of clodronate as a combination drug with a nitrogen-containing bisphosphonate.

  Basic & clinical pharmacology & toxicology 20090501

• Hypercalcemia in pediatric acute megakaryocytic leukemia: case report and review of the literature.

  Journal of pediatric hematology/oncology 20090501

• Hypercalcemia of immobilization.

  Journal of the American Medical Directors Association 20090501

• Bisphosphonate dose and incidence of fractures in postmenopausal osteoporosis.

  Bone 20090501

• Efficacy of clodronate, pamidronate, and zoledronate in reducing morbidity and mortality in cancer patients with bone metastasis: a meta-analysis of randomized clinical trials.

  Clinical therapeutics 20090501

• Incidence of bisphosphonate-associated osteonecrosis of the jaws in breast cancer patients.

  Cancer 20090415

• [Bisphosphonate-induced collapsing focal segmental glomerulosclerosis; two clinical cases and literature review].

  Nephrologie & therapeutique 20090401

• Large osteoclasts in pediatric osteogenesis imperfecta patients receiving intravenous pamidronate.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20090401

• Bisphosphonate-related osteonecrosis of the jaws: a single-center study of 101 patients.

  Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20090401

• Treatment of osteoporosis/osteopenia in pediatric leukemia and lymphoma.

  The Annals of pharmacotherapy 20090401

• Transient migratory osteoporosis or insufficiency fracture?

  Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 20090401

• Hypercalcemia associated with tertiary hyperparathyroidism managed conservatively with pamidronate in a hemodialysis patient.

  The American journal of the medical sciences 20090401

• Hypercalcemia: an evidence-based approach to clinical cases.

  Iranian journal of kidney diseases 20090401

• Indirect antitumor effects of bisphosphonates on prostatic LNCaP cells co-cultured with bone cells.

  Anticancer research 20090401

• Paget's disease of bone and osteonecrosis.

  Dental update 20090401

• Reversal of hypercalcemic acute kidney injury by treatment with intravenous bisphosphonates.

  Pediatric nephrology (Berlin, Germany) 20090301

• Effect of bisphosphonates on vascular calcification and bone metabolism in experimental renal failure.

  Kidney international 20090301

• The effect of surface immobilized bisphosphonates on the fixation of hydroxyapatite-coated titanium implants in ovariectomized rats.

  Biomaterials 20090301

• Intravenous pamidronate in osteogenesis imperfecta type VII.

  Calcified tissue international 20090301

• Sinus tracts--an early sign of bisphosphonate-associated osteonecrosis of the jaws?

  Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20090301

• Bisphosphonates for postmenopausal osteoporosis: determining duration of treatment.

  Current osteoporosis reports 20090301

• Prevention of vascular calcification with bisphosphonates without affecting bone mineralization: a new challenge?

  Kidney international 20090301

• The pharmacological management of skeletal-related events from metastatic tumors.

  Orthopedics 20090301

• Rapid pain relief and marked sclerotic change of multiple bone metastases from a synovial sarcoma after treatment with intravenous pamidronate and chemotherapy.

  Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association 20090301

• Quality of life measurement in cancer patients receiving palliative radiotherapy for symptomatic lung cancer: a literature review.

  Current oncology (Toronto, Ont.) 20090301

• Atypical form of melorheostosis improved by pamidronate.

  La Tunisie medicale 20090301

• Bisphosphonates and implants: an overview.

  Acta orthopaedica 20090226

• Pamidronate in the prevention of bone loss after liver transplantation: a randomized controlled trial.

  Transplant international : official journal of the European Society for Organ Transplantation 20090201

• Recovery of muscle atrophy and bone loss from 90 days bed rest: results from a one-year follow-up.

  Bone 20090201

• Treating low- and medium-potency bisphosphonate-related osteonecrosis of the jaws with a protocol for the treatment of chronic suppurative osteomyelitis: report of 7 cases.

  Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 20090201

• [Bisphosphonates and other new therapeutic agents for the treatmednt of osteogenesis imperfecta].

  Clinical calcium 20090201

• Postmarketing surveillance rates of uveitis and scleritis with bisphosphonates among a national veteran cohort.

  Retina (Philadelphia, Pa.) 20090201

• Growth of infants with osteogenesis imperfecta treated with bisphosphonate.

  Pediatrics international : official journal of the Japan Pediatric Society 20090201

• [Bisphosphonate-associated osteonecrosis of the jaw in patients with multiple myeloma].

  Ugeskrift for laeger 20090105

• Decreased occurrence of osteonecrosis of the jaw after implementation of dental preventive measures in solid tumour patients with bone metastases treated with bisphosphonates. The experience of the National Cancer Institute of Milan.

  Annals of oncology : official journal of the European Society for Medical Oncology 20090101

• Osteonecrosis of the jaw: who gets it, and why?

  Bone 20090101

• Alendronate and Pamidronate calcium phosphate bone cements: setting properties and in vitro response of osteoblast and osteoclast cells.

  Journal of inorganic biochemistry 20090101

• Inhibition of osteoblast function in vitro by aminobisphosphonates.

  Journal of cellular biochemistry 20090101

• Pamidronate treatment of children with moderate-to-severe osteogenesis imperfecta: a note of caution.

  Hormone research 20090101

• Bisphosphonate-induced osteonecrosis of the jaws, bone markers, and a hypothesized candidate gene.

  Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20090101

• Fibrous dysplasia - differential diagnosis of cystic lesions in the proximal femur:a case report.

  Cases journal 20090101

• Dramatic pain relief and resolution of bone inflammation following pamidronate in 9 pediatric patients with persistent chronic recurrent multifocal osteomyelitis (CRMO).

  Pediatric rheumatology online journal 20090101

• Zoledronic acid in metastatic chondrosarcoma and advanced sacrum chordoma: two case reports.

  Journal of experimental & clinical cancer research : CR 20090101

• Double-blind placebo-controlled trial of adjuvant pamidronate with palliative radiotherapy and intravenous doxorubicin for canine appendicular osteosarcoma bone pain.

  Journal of veterinary internal medicine 20090101

• The effects of disodium pamidronate on human polymorphonuclear leukocytes and platelets: an in vitro study.

  Cellular & molecular biology letters 20090101

• Oral bisphosphonates and risk of atrial fibrillation and flutter in women: a self-controlled case-series safety analysis.

  PloS one 20090101

• Radiological changes following second-line zoledronic acid treatment in breast cancer patients with bone metastases.

  Clinical & experimental metastasis 20090101

• Sustained remission of SAPHO syndrome with pamidronate: a follow-up of fourteen cases and a review of the literature.

  Clinical and experimental rheumatology 20090101

• Safety and efficacy of intravenous zoledronic acid in paediatric osteoporosis.

  Journal of pediatric endocrinology & metabolism : JPEM 20090101

• RANKL increases the level of Mcl-1 in osteoclasts and reduces bisphosphonate-induced osteoclast apoptosis in vitro.

  Arthritis research & therapy 20090101

• Biphosphonates-related osteonecrosis of the jaw: Clinical and physiopathological considerations.

  Therapeutics and clinical risk management 20090101

• Potential antitumor effects of nitrogen-containing bisphosphonate in hormone receptor negative breast cancer patients with bone metastases.

  BMC cancer 20090101

• Once-yearly zoledronic acid in hip fracture prevention.

  Clinical interventions in aging 20090101

• Treatment of osteoporosis with annual iv zoledronic acid: effects on hip fracture.

  Therapeutics and clinical risk management 20090101

• Residual (ghost) sockets in bisphosphonate use--evidence of poor healing and slow bone turnover.

  General dentistry 20090101

• Emerging treatments for postmenopausal osteoporosis - focus on denosumab.

  Clinical interventions in aging 20090101

• Bisphosphonate-associated adverse events.

  Hormones (Athens, Greece) 20090101

• Treatment with intravenous pamidronate is a good alternative in case of gastrointestinal side effects or contraindications for oral bisphosphonates.

  BMC musculoskeletal disorders 20090101

• Natural history of malignant bone disease in breast cancer and the use of cumulative mean functions to measure skeletal morbidity.

  BMC cancer 20090101

• Low-energy femoral fractures associated with the long-term use of bisphosphonates: a case series from a Swiss university hospital.

  Drug safety 20090101

• Adverse effects of androgen deprivation therapy in prostate cancer: Current management issues.

  Indian journal of urology : IJU : journal of the Urological Society of India 20090101

• Sterol Biosynthesis Pathway as Target for Anti-trypanosomatid Drugs.

  Interdisciplinary perspectives on infectious diseases 20090101

• Management strategies for pulmonary sarcoidosis.

  Therapeutics and clinical risk management 20090101

• Front line treatment of elderly multiple myeloma in the era of novel agents.

  Biologics : targets & therapy 20090101

• Osteogenesis imperfecta.

  The Journal of the Association of Physicians of India 20090101

• Bisphosphonates and atrial fibrillation: Bayesian meta-analyses of randomized controlled trials and observational studies.

  BMC musculoskeletal disorders 20090101

• Long-term effects of pamidronate in thalassemic patients with severe bone mineral density deficits.

  Hemoglobin 20090101

• Middle aged male with pulmonary tuberculosis and refractory hypercalcemia at a tertiary care centre in South East Asia: a case report.

  Cases journal 20090101

• Alendronate inhibits VEGF expression in growth plate chondrocytes by acting on the mevalonate pathway.

  The open orthopaedics journal 20090101

• Osteoporosis in children: pediatric and pediatric rheumatology perspective: a review.

  Pediatric rheumatology online journal 20090101

• Migrating transient osteoporosis of the hip in a 30-year-old man.

  Indian journal of orthopaedics 20090101

• Clinical experiences with bisphosphonate-associated osteonecrosis of the jaws: analysis of 21 cases.

  American journal of otolaryngology 20090101

• SAPHO syndrome: is a range of pathogen-associated rheumatic diseases extended?

  Arthritis research & therapy 20090101

• Hypercalcemia, metabolic alkalosis and renal failure secondary to calcium bicarbonate intake for osteoporosis prevention--'modern' milk alkali syndrome: a case report.

  Cases journal 20090101

• Bisphosphonates in oncology: evidence for the prevention of skeletal events in patients with bone metastases.

  Drug design, development and therapy 20090101

• SAPHO Syndrome Diagnosis and Treatment: Report of Five Cases and Review of the Literature.

  The open orthopaedics journal 20090101

• Osteopenia-osteoporosis syndrome in patients with thalassemia: understanding of type of bone disease and response to treatment.

  Hemoglobin 20090101

• A combination of methotrexate and zoledronic acid prevents bone erosions and systemic bone mass loss in collagen induced arthritis.

  Arthritis research & therapy 20090101

• Complications and monitoring - Guidelines on Parenteral Nutrition, Chapter 11.

  German medical science : GMS e-journal 20090101

• Pamidronate therapy for hypercalcemia and congenital mesoblastic nephroma: a case report.

  Cases journal 20090101

• Osteoporosis: 'A risk factor for periodontitis'.

  Journal of Indian Society of Periodontology 20090101

• [Results of pamidron acid application in prevention of instability of bones implants].

  Likars'ka sprava 20090101

• The evolving role of zoledronic acid in early breast cancer.

  OncoTargets and therapy 20090101

• Acute uveitis following zoledronic acid infusion.

  Oman journal of ophthalmology 20090101

• Treating postmenopausal osteoporosis in women at increased risk of fracture - critical appraisal of bazedoxifene: a review.

  International journal of women's health 20090101

• Pharmacotherapeutic options for visceral leishmaniasis-current scenario.

  Clinical medicine. Pathology 20090101

• Radiological findings in cyclical administration of intravenous pamidronate in children with osteoporosis.

  BMJ case reports 20090101

• Opposing effects of bisphosphonates and advanced glycation end-products on osteoblastic cells.

  European journal of pharmacology 20081214

• Bisphosphonate treatment in the oim mouse model alters bone modeling during growth.

  Journal of biomechanics 20081205

• Hypercalcemia during pregnancy, puerperium, and lactation: review and a case report of hypercalcemic crisis after delivery due to excessive production of PTH-related protein (PTHrP) without malignancy (humoral hypercalcemia of pregnancy).

  Endocrine journal 20081201

• Bisphosphonate nephrotoxicity.

  Kidney international 20081201

• Detection of nonsterol isoprenoids by HPLC-MS/MS.

  Analytical biochemistry 20081201

• Clinical and radiologic response in patients with bone metastases managed with combined radiotherapy and bisphosphonates.

  Journal of surgical oncology 20081201

• Pharmacovigilance and reporting oversight in US FDA fast-track process: bisphosphonates and osteonecrosis of the jaw.

  The Lancet. Oncology 20081201

• Cyclic pamidronate treatment in Bruck syndrome: proposal of a new modality of treatment.

  Pediatrics international : official journal of the Japan Pediatric Society 20081201

• [Schnitzler syndrome--report on a fourteen-year course of the disease and an overview of information on the disease].

  Vnitrni lekarstvi 20081201

• Optimizing dosing frequencies for bisphosphonates in the management of postmenopausal osteoporosis: patient considerations.

  Clinical interventions in aging 20081201

• Aromatase inhibitors, efficacy and metabolic risk in the treatment of postmenopausal women with early breast cancer.

  Clinical interventions in aging 20081201

• Safe and tolerable one-hour pamidronate infusion for multiple myeloma patients.

  Therapeutics and clinical risk management 20081201

• Juvenile Paget's disease with paranasal sinus aplasia.

  Clinical and experimental otorhinolaryngology 20081201

• Denosumab: an investigational drug for the management of postmenopausal osteoporosis.

  Biologics : targets & therapy 20081201

• [Osteonecrosis of the jaw associated with the use of bisphosphonates in multiple myeloma: report of four cases and literature review].

  Zhonghua yi xue za zhi 20081118

• Determination of bisphosphonate active pharmaceutical ingredients in pharmaceuticals and biological material: a review of analytical methods.

  Journal of pharmaceutical and biomedical analysis 20081104

• Structures of a potent phenylalkyl bisphosphonate inhibitor bound to farnesyl and geranylgeranyl diphosphate synthases.

  Proteins 20081101

• Bisphosphonate-laden acrylic bone cement: mechanical properties, elution performance, and in vivo activity.

  Journal of biomedical materials research. Part B, Applied biomaterials 20081101

• Prevalence and risk factors of bisphosphonate-associated osteonecrosis of the jaw in prostate cancer patients with advanced disease treated with zoledronate.

  European urology 20081101

• Osteonecrosis of the jaw (ONJ) in cancer patients treated with Bisphosphonates: how the knowledge of a phenomenon can change its evolution.

  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20081101

• Tooth extraction socket healing in pediatric patients treated with intravenous pamidronate.

  The Journal of pediatrics 20081101

• Uncovering the cause of 'phossy jaw' Circa 1858 to 1906: oral and maxillofacial surgery closed case files-case closed.

  Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20081101

• NF-kappa B modulates sensitivity to apoptosis, proinflammatory and migratory potential in short- versus long-term cultured human gamma delta lymphocytes.

  Journal of immunology (Baltimore, Md. : 1950) 20081101

• Adjunctive analgesic therapy in veterinary medicine.

  The Veterinary clinics of North America. Small animal practice 20081101

• Numb chin syndrome by biphosphonates.

  European journal of internal medicine 20081101

• [Efficiency of second-generation bisphosphonate in treating patients with prostate cancer and bone metastases].

  Georgian medical news 20081101

• Seven-year median time to progression with thalidomide for smoldering myeloma: partial response identifies subset requiring earlier salvage therapy for symptomatic disease.

  Blood 20081015

• Systemic calciphylaxis.

  Pediatric blood & cancer 20081001

• Bisphosphonate-induced osteopetrosis: novel bone modeling defects, metaphyseal osteopenia, and osteosclerosis fractures after drug exposure ceases.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20081001

• A systematic review of phase II trials of thalidomide/dexamethasone combination therapy in patients with relapsed or refractory multiple myeloma.

  European journal of haematology 20081001

• Correlating sideband patterns with powder patterns for accurate determination of chemical shift parameters in solid-state NMR.

  Magnetic resonance in chemistry : MRC 20081001

• Bisphosphonates activate the 5-fluorouracil/uracil phosphoribosyltransferase activity present in Saccharomyces cerevisiae cell extracts: implications for tumor treatments.

  Biochemical pharmacology 20081001

• Paget disease of bone: therapeutic options.

  Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 20081001

• Safety and clinical responses in ankylosing spondylitis after three months of etanercept therapy.

  Journal of Korean medical science 20081001

• Intravenous pamidronate therapy in Taiwanese patients with osteogenesis imperfecta.

  Pediatrics and neonatology 20081001

• Pathogenesis and management of osteoporosis in thalassemia.

  Pediatric endocrinology reviews : PER 20081001

• Effect of bisphosphonate treatment on bone mineral density in patients with thalassaemia major.

  Pediatric endocrinology reviews : PER 20081001

• Inhibition of geranylgeranyl diphosphate synthase by bisphosphonates: a crystallographic and computational investigation.

  Journal of medicinal chemistry 20080925

• Pamidronate as a treatment option in calciphylaxis.

  Journal of the European Academy of Dermatology and Venereology : JEADV 20080901

• Bisphosphonate-induced osteonecrosis of the jaws: prospective study of 80 patients with multiple myeloma and other malignancies.

  Oral oncology 20080901

• Acute pseudogout after pamidronate infusion.

  Clinical rheumatology 20080901

• Nephronophthisis-like nephritis associated with fibrous dysplasia of bone.

  Pediatric nephrology (Berlin, Germany) 20080901

• Normal serum bone markers in bisphosphonate-induced osteonecrosis of the jaws.

  Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 20080901

• Clinical image: Pamidronate 'zebra' lines.

  Arthritis and rheumatism 20080901

• Current status and perspectives regarding the treatment of osteo-sarcoma: chemotherapy.

  Reviews on recent clinical trials 20080901

• Once-yearly zoledronic acid in the prevention of osteoporotic bone fractures in postmenopausal women.

  Clinical interventions in aging 20080901

• Treatment of experimental renal osteodystrophy with pamidronate.

  Kidney international 20080801

• Bisphosphonate-associated osteonecrosis of the jaw: successful treatment at 2-year follow-up.

  Plastic and reconstructive surgery 20080801

• Osteonecrosis of the maxilla and mandible in patients with advanced cancer treated with bisphosphonate therapy.

  The oncologist 20080801

• Bisphosphonate-associated osteonecrosis: a clinician's reference to patient management.

  Today's FDA : official monthly journal of the Florida Dental Association 20080801

• Three years follow-up of pamidronate therapy in two brothers with osteoporosis-pseudoglioma syndrome (OPPG) carrying an LRP5 mutation.

  Journal of pediatric endocrinology & metabolism : JPEM 20080801

• Adjuvant therapies of bone graft around non-cemented experimental orthopedic implants stereological methods and experiments in dogs.

  Acta orthopaedica. Supplementum 20080801

• In vitro response of hFOB cells to pamidronate modified sodium silicate coated cellulose scaffolds.

  Colloids and surfaces. B, Biointerfaces 20080715

• Bisphosphonate coating on titanium screws increases mechanical fixation in rat tibia after two weeks.

  Journal of biomedical materials research. Part A 20080701

• Vdelta2 T-lymphocyte responses in cord blood samples from Italy and Côte d'Ivoire.

  Immunology 20080701

• The effect of pretreating morselized allograft bone with rhBMP-2 and/or pamidronate on the fixation of porous Ti and HA-coated implants.

  Biomaterials 20080701

• Normalization of bone markers is associated with improved survival in patients with bone metastases from solid tumors and elevated bone resorption receiving zoledronic acid.

  Cancer 20080701

• Rab proteins and Rab-associated proteins: major actors in the mechanism of protein-trafficking disorders.

  European journal of pediatrics 20080701

• Risk of renal stone formation induced by long-term bed rest could be decreased by premedication with bisphosphonate and increased by resistive exercise.

  International journal of urology : official journal of the Japanese Urological Association 20080701

• Symptomatic treatment of a case of Schnitzler's syndrome with pamidronate.

  Joint, bone, spine : revue du rhumatisme 20080701

• [ Sudeck's bone atrophy (reflex sympathetic dystrophy)].

  Clinical calcium 20080701

• Disparate osteogenic response of mandible and iliac crest bone marrow stromal cells to pamidronate.

  Oral diseases 20080701

• Risks and benefits of bisphosphonates.

  British journal of cancer 20080603

• Changes of bone turnover markers and serum PTH after night or morning administration of zoledronic acid in breast cancer patients with bone metastases.

  British journal of cancer 20080603

• Bisphosphonate-associated osteonecrosis of the jaw: does it occur in children?

  Clinical endocrinology 20080601

• The use of bisphosphonate in the treatment of avascular necrosis: a systematic review.

  Clinical rheumatology 20080601

• Preclinical evidence for nitrogen-containing bisphosphonate inhibition of farnesyl diphosphate (FPP) synthase in the kidney: implications for renal safety.

  Toxicology in vitro : an international journal published in association with BIBRA 20080601

• Bisphosphonates induce apoptosis in CLL cells independently of MDR phenotype.

  Cancer chemotherapy and pharmacology 20080601

• Treatment of Paget's disease of bone: a survey of clinical practice in Australia.

  Bone 20080601

• Osteogenesis Imperfecta: update on presentation and management.

  Reviews in endocrine & metabolic disorders 20080601

• The transcription of bradyzoite genes in Toxoplasma gondii is controlled by autonomous promoter elements.

  Molecular microbiology 20080601

• Paget's disease and bisphosphonate-associated osteonecrosis of the jaws.

  Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20080601

• Lung and bone metastases from renal cell carcinoma responsive to bisphosphonates: a case report.

  International journal of urology : official journal of the Japanese Urological Association 20080601

• Farnesyl diphosphate synthase is involved in the resistance to zoledronic acid of osteosarcoma cells.

  Journal of cellular and molecular medicine 20080601

• Successful results of pamidronate treatment in children with osteogenesis imperfecta with emphasis on the interpretation of bone mineral density for local standards.

  Journal of pediatric orthopedics 20080601

• Postmarketing surveillance rates of uveitis and scleritis with bisphosphonates among a national veteran cohort.

  Retina (Philadelphia, Pa.) 20080601

• Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20080601

• [Role of an interdisciplinary approach in the healing of long bone fractures in patients with osteogenesis imperfecta].

  Acta chirurgiae orthopaedicae et traumatologiae Cechoslovaca 20080601

• Bisphosphonates in the management of postmenopausal osteoporosis--optimizing efficacy in clinical practice.

  Clinical interventions in aging 20080601

• Synthesis, properties, and perspectives of gem-diphosphono substituted-thiazoles.

  European journal of medicinal chemistry 20080501

• Two doses of pamidronate in infants with osteogenesis imperfecta.

  Archives of disease in childhood 20080501

• Improvement of bone disease by imiglucerase (Cerezyme) therapy in patients with skeletal manifestations of type 1 Gaucher disease: results of a 48-month longitudinal cohort study.

  Clinical genetics 20080501

• Inhibition of oral mucosal cell wound healing by bisphosphonates.

  Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20080501

• Fibula free flap with endosseous implants for reconstructing a resected mandible in bisphosphonate osteonecrosis.

  Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20080501

• Osteochemonecrosis of the jaws due to bisphosphonate treatments. Update.

  Medicina oral, patologia oral y cirugia bucal 20080501

• Use of intravenous bisphosphonates in older women with breast cancer.

  The oncologist 20080501

• Clinical, radiographic, and biochemical characterization of multiple myeloma patients with osteonecrosis of the jaw.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20080415

• Structure-activity relationships among the nitrogen containing bisphosphonates in clinical use and other analogues: time-dependent inhibition of human farnesyl pyrophosphate synthase.

  Journal of medicinal chemistry 20080410

• European guidance for the diagnosis and management of osteoporosis in postmenopausal women.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20080401

• Effects of alendronate and pamidronate on cultured rat metatarsal bones: failure to prevent dexamethasone-induced growth retardation.

  Bone 20080401

• Updates on bisphosphonates and potential pathobiology of bisphosphonate-induced jaw osteonecrosis.

  Oral diseases 20080401

• Bisphosphonate treatment in chronic recurrent multifocal osteomyelitis.

  The Journal of pediatrics 20080401

• Zoledronate, smoking, and obesity are strong risk factors for osteonecrosis of the jaw: a case-control study.

  Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20080401

• Childhood chronic recurrent multifocal osteomyelitis: pamidronate therapy decreases pain and improves vertebral shape.

  The Journal of rheumatology 20080401

• Osteonecrosis of the jaw.

  Journal of the American Dental Association (1939) 20080401

• Bisphosphonates and osteonecrosis of the jaw: a case report.

  Clinics (Sao Paulo, Brazil) 20080401

• Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates: definition and management of the risk related to zoledronic acid.

  Clinical lymphoma & myeloma 20080401

• Use of ibandronate in the prevention of skeletal events in metastatic breast cancer.

  Therapeutics and clinical risk management 20080401

• A Phase II trial evaluating the palliative benefit of second-line oral ibandronate in breast cancer patients with either a skeletal related event (SRE) or progressive bone metastases (BM) despite standard bisphosphonate (BP) therapy.

  Breast cancer research and treatment 20080301

• Can acute administration of pamidronate help to preserve bone mass in children with severe burn injury?

  Nature clinical practice. Endocrinology & metabolism 20080301

• A review of Paget's disease of bone with a focus on the efficacy and safety of zoledronic acid 5 mg.

  Current medical research and opinion 20080301

• 'Bis-phossy jaws' - high and low risk factors for bisphosphonate-induced osteonecrosis of the jaw.

  Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery 20080301

• Comment on: Bisphosphonates and osteonecrosis of the jaw.

  Rheumatology (Oxford, England) 20080301

• Aminobisphosphonates cause osteoblast apoptosis and inhibit bone nodule formation in vitro.

  Calcified tissue international 20080301

• Bisphosphonate-associated jawbone osteonecrosis: a correlation between imaging techniques and histopathology.

  Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 20080301

• Bisphosphonates can block the deterioration in implant fixation after withdrawal of intermittent doses of parathyroid hormone.

  The Journal of bone and joint surgery. British volume 20080301

• Possible prevention of hungry bone syndrome following parathyroidectomy by preoperative use of pamidronate.

  Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 20080301

• Fibrous dysplasia of bone and McCune-Albright syndrome.

  Best practice & research. Clinical rheumatology 20080301

• Osteogenesis imperfecta.

  Best practice & research. Clinical rheumatology 20080301

• Osteonecrosis of the jaw in patients with bone metastases treated with bisphosphonates: a retrospective study.

  The oncologist 20080301

• Osteonecrosis of the jaws and bisphosphonates.

  Current osteoporosis reports 20080301

• [Phase III clinical study of zoledronic acid in the treatment of pain induced by bone metastasis from solid tumor or multiple myeloma].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20080301

• Myeloma cells with asurophilic granules--an unusual morphological variant--case presentation.

  Journal of medicine and life 20080215

• Nd:YAG laser biostimulation in the treatment of bisphosphonate-associated osteonecrosis of the jaw: clinical experience in 28 cases.

  Photomedicine and laser surgery 20080201

• Acute Charcot arthropathy successfully treated with pamidronate: long-term follow-up.

  The American journal of the medical sciences 20080201

• Treatment of breast cancer with bone metastasis: bisphosphonate treatment - current and future.

  International journal of clinical oncology 20080201

• Alendronate treatment in children with osteogenesis imperfecta.

  Indian pediatrics 20080201

• Bisphosphonates in the treatment of thalassemia-associated osteoporosis.

  Journal of endocrinological investigation 20080201

• Transient osteoporosis of the hip in association with osteogenesis imperfecta: two cases, one complicated by a femoral neck fracture.

  American journal of orthopedics (Belle Mead, N.J.) 20080201

• Zoledronic acid in the management of metastatic bone disease.

  Therapeutics and clinical risk management 20080201

• NMR investigations of the static and dynamic structures of bisphosphonates on human bone: a molecular model.

  Journal of the American Chemical Society 20080130

• Medical image. A sequel of deranged metabolic control. Diabetes mellitus.

  The New Zealand medical journal 20080125

• Cooperative control of striated muscle mass and metabolism by MuRF1 and MuRF2.

  The EMBO journal 20080123

• Intracystic hemorrhage in a mediastinal cystic adenoma causing parathyrotoxic crisis.

  Head & neck 20080101

• The role of surgery in jaw bone necrosis associated with long-term use of bisphosphonates.

  Acta oncologica (Stockholm, Sweden) 20080101

• Thirteen cases of jaw osteonecrosis in patients on bisphosphonate therapy.

  Joint, bone, spine : revue du rhumatisme 20080101

• Bisphosphonates and avascular necrosis of the mandible: case report and review of the literature.

  Journal of plastic, reconstructive & aesthetic surgery : JPRAS 20080101

• Unique diagnostic features and successful management of a patient with disseminated lymphangiomatosis and chylothorax.

  Journal of pediatric hematology/oncology 20080101

• Extracellular calcium increases bisphosphonate-induced growth inhibition of breast cancer cells.

  Breast cancer research : BCR 20080101

• Cancer treatment-related bone loss: a review and synthesis of the literature.

  Current oncology (Toronto, Ont.) 20080101

• A primer of bone metastases management in breast cancer patients.

  Current oncology (Toronto, Ont.) 20080101

• Hypertrophic osteoarthropathy: a palindrome with a pathogenic connotation.

  Current opinion in rheumatology 20080101

• Zoledronic acid: a pharmacoeconomic review of its use in the management of bone metastases.

  PharmacoEconomics 20080101

• Medical treatment of malignancy-associated hypercalcemia.

  Current medicinal chemistry 20080101

• Zoledronic acid : a review of its use in the management of bone metastases of malignancy.

  Drugs 20080101

• Alendronate decreases orthotopic PC-3 prostate tumor growth and metastasis to prostate-draining lymph nodes in nude mice.

  BMC cancer 20080101

• [Cost-effectiveness of oral ibandronate, i.v. zoledronic acid and i.v. generic pamidronate in the management of metastatic bone disease in breast cancer patients: two parallel studies].

  Recenti progressi in medicina 20080101

• Bisphosphonate-associated osteonecrosis. A clinician's reference to patient management.

  The New York state dental journal 20080101

• Cyclic pamidronate therapy in children with osteogenesis imperfecta: results of treatment and follow-up after discontinuation.

  Journal of pediatric endocrinology & metabolism : JPEM 20080101

• Charcot neuro-osteoarthropathy-current standards.

  Diabetes/metabolism research and reviews 20080101

• Bisphosphonate treatment in primary breast cancer: results from a randomised comparison of oral pamidronate versus no pamidronate in patients with primary breast cancer.

  Acta oncologica (Stockholm, Sweden) 20080101

• McCune-Albright syndrome.

  Orphanet journal of rare diseases 20080101

• Protocol for stage 2 of the GaP study (genetic testing acceptability for Paget's disease of bone): a questionnaire study to investigate whether relatives of people with Paget's disease would accept genetic testing and preventive treatment if they were available.

  BMC health services research 20080101

• Unusually prolonged vitamin D intoxication after discontinuation of vitamin D: possible role of primary hyperparathyroidism.

  International urology and nephrology 20080101

• Cost-effectiveness of oral clodronate compared with oral ibandronate, intravenous zoledronate or intravenous pamidronate in breast cancer patients.

  The Journal of international medical research 20080101

• Effect of pathologic fractures on survival in multiple myeloma patients: a case control study.

  Journal of experimental & clinical cancer research : CR 20080101

• Zinc protoporphyrin IX, a heme oxygenase-1 inhibitor, demonstrates potent antitumor effects but is unable to potentiate antitumor effects of chemotherapeutics in mice.

  BMC cancer 20080101

• Paget's disease of the skull causing hyperprolactinemia and erectile dysfunction: a case report.

  Journal of medical case reports 20080101

• The rapid correction of hypercalcemia at presentation of acute lymphoblastic leukemia using high-dose methylprednisolone.

  The Turkish journal of pediatrics 20080101

• Successful treatment of calciphylaxis with pamidronate.

  European journal of dermatology : EJD 20080101

• Therapy with zoledronic acid, 5 mg, for a patient with Paget disease of bone.

  Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20080101

• Health-related quality of life in breast cancer patients: a bibliographic review of the literature from 1974 to 2007.

  Journal of experimental & clinical cancer research : CR 20080101

• Commentary on 'Pamidronate: treatment for severe hypercalcemia in neonatal subcutaneous fat necrosis' by Alos N. et al., Hormone Research 2006;65:289-294.

  Hormone research 20080101

• Longitudinal analysis of vertebral fracture and BMD in a Canadian cohort of adult cystic fibrosis patients.

  BMC musculoskeletal disorders 20080101

• Effect of combined treatment with alendronate and calcitriol on femoral neck strength in osteopenic rats.

  Journal of orthopaedic surgery and research 20080101

• Zoledronic acid: a review of its use in breast cancer.

  Drugs 20080101

• New trends in the treatment of osteogenesis imperfecta type III - own experience.

  Ortopedia, traumatologia, rehabilitacja 20080101

• Long Term Cyclic Pamidronate Reduces Bone Growth by Inhibiting Osteoclast Mediated Cartilage-to-Bone Turnover in the Mouse.

  The open orthopaedics journal 20080101

• Analgesic efficacy of zoledronic acid and its effect on functional status of prostate cancer patients with metastasis.

  Patient preference and adherence 20080101

• Quality of life measurement in bone metastases: A literature review.

  Journal of pain research 20080101

• Innovations in chemotherapy and radiation therapy: Implications and opportunities for the Asia-Pacific Rim.

  Biomedical imaging and intervention journal 20080101

• A prospective, multicenter, open-label trial of zoledronic acid in patients with hormone refractory prostate cancer.

  Yonsei medical journal 20071231

• A retrospective study assessing the incidence, risk factors and comorbidities of pamidronate-related necrosis of the jaws in multiple myeloma patients.

  Annals of oncology : official journal of the European Society for Medical Oncology 20071201

• Pathophysiology, risk factors and management of bisphosphonate-associated osteonecrosis of the jaw: Is there a diverse relationship of amino- and non-aminobisphosphonates?

  Critical reviews in oncology/hematology 20071201

• Bone loss and its management in long-term survivors from allogeneic stem cell transplantation.

  The Journal of clinical endocrinology and metabolism 20071201

• Efficacy of pamidronate in erosive degenerative disk disease: A pilot study.

  Joint, bone, spine : revue du rhumatisme 20071201

• Radiological findings in cyclical administration of intravenous pamidronate in children with osteoporosis.

  Archives of disease in childhood 20071201

• Does pamidronate enhance the analgesic effect of radiotherapy? A randomized trial.

  Palliative medicine 20071201

• Meeting Report:The 7th ESPE Growth Plate Working Group Symposium - EUROGROP June 27th 2007, Helsinki, Finland.

  Pediatric endocrinology reviews : PER 20071201

• Treatment with vitamin k(2) combined with bisphosphonates synergistically inhibits calcification in cultured smooth muscle cells.

  Journal of atherosclerosis and thrombosis 20071201

• Osteoporosis in the aging male: treatment options.

  Clinical interventions in aging 20071201

• What is new in the treatment of steroid-induced osteoporosis?

  Seminars in cutaneous medicine and surgery 20071201

• Bisphosphonate-related osteonecrosis of the jaws: an update on clinical, pathological and management aspects.

  Head and neck pathology 20071201

• [Clinical study of bisphosphonates for bone metastasis in breast cancer].

  Nihon rinsho. Japanese journal of clinical medicine 20071128

• Administration of pamidronate alters bone-titanium attachment in the presence of endotoxin-coated polyethylene particles.

  Journal of biomedical materials research. Part B, Applied biomaterials 20071101

• Treating bisphosphonate osteonecrosis of the jaws: is there a role for resection and vascularized reconstruction?

  Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20071101

• Mechanism of action, pharmacokinetic and pharmacodynamic profile, and clinical applications of nitrogen-containing bisphosphonates.

  Journal of dental research 20071101

• Neonatal hyperparathyroidism and pamidronate therapy in an extremely premature infant.

  Pediatrics 20071101

• Metaphyseal sclerosis associated with bisphosphonate therapy.

  Journal of pediatric endocrinology & metabolism : JPEM 20071101

• Pamidronate treatment of hypercalcemia caused by vitamin D toxicity.

  Journal of pediatric endocrinology & metabolism : JPEM 20071101

• [Usefulness of Pamidronate in the Treatment of Charcot's Arthropathy].

  Reumatologia clinica 20071101

• [Fibrous dysplasia of bone].

  La Revue du praticien 20071031

• [Drug-induced nephrotic syndrome].

  Nihon rinsho. Japanese journal of clinical medicine 20071028

• Bisphosphonate therapy for children and adolescents with secondary osteoporosis.

  The Cochrane database of systematic reviews 20071017

• Pathologic fractures correlate with reduced survival in patients with malignant bone disease.

  Cancer 20071015

• Bone biopsy and densitometry findings in a child with Camurati-Engelmann disease.

  Clinical rheumatology 20071001

• Collapsing focal segmental glomerulosclerosis in a liver transplant recipient on alendronate.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20071001

• Biphosphonate-associated osteonecrosis can be controlled by nonsurgical management.

  Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 20071001

• [Hypercalcaemia and malignant lymphoma. One case report].

  La Revue de medecine interne 20071001

• Defective implant osseointegration under protein undernutrition: prevention by PTH or pamidronate.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20071001

• Comparison of different intravenous bisphosphonate regimens for Paget's disease of bone.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20071001

• Microcrack frequency and bone remodeling in postmenopausal osteoporotic women on long-term bisphosphonates: a bone biopsy study.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20071001

• Bilateral severe fibrinous anterior uveitis--an unusual complication of pamidronate therapy exacerbated by topical latanoprost.

  Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20071001

• Appropriate management of axial spondyloarthritis.

  Current rheumatology reports 20071001

• [A case of recurrent breast cancer with multiple liver metastases responding to combination therapy of capecitabine and MPA].

  Gan to kagaku ryoho. Cancer & chemotherapy 20071001

• Use of zoledronic acid in the treatment of Paget's disease.

  Therapeutics and clinical risk management 20071001

• Osteonecrosis of the jaw. A newly emerging site-specific osseous pathology in patients with cancer treated with bisphosphonates. Report of five cases and review of the literature.

  European journal of internal medicine 20070901

• Zoledronic acid and survival in breast cancer patients with bone metastases and elevated markers of osteoclast activity.

  The oncologist 20070901

• New therapies in multiple myeloma.

  Clinical and experimental medicine 20070901

• Fracture prevention in postmenopausal women.

  BMJ clinical evidence 20070901

• High concentrations of pamidronate in bone weaken the mechanical properties of intact femora in a rat model.

  Yonsei medical journal 20070831

• Milk alkali syndrome without the milk.

  BMJ (Clinical research ed.) 20070825

• Development and application of a high-performance liquid chromatography-mass spectrometry method to determine alendronate in human urine.

  Journal of chromatography. A 20070810

• Can bisphosphonate treatment be stopped in a growing child with skeletal fragility?

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20070801

• Natural history of hyperplastic callus formation in osteogenesis imperfecta type V.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20070801

• Noninvasive optical detection of bone mineral.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20070801

• Pamidronate preserves bone mass for at least 2 years following acute administration for pediatric burn injury.

  Bone 20070801

• Effect of intravenous pamidronate therapy on everyday activities in children with osteogenesis imperfecta.

  Acta paediatrica (Oslo, Norway : 1992) 20070801

• Administration of pamidronate helps prevent immediate postparathyroidectomy hungry bone syndrome.

  Nephrology (Carlton, Vic.) 20070801

• Osteonecrosis of the jaws and bisphosphonates. Report of fifteen cases. Therapeutic recommendations.

  Medicina oral, patologia oral y cirugia bucal 20070801

• Intravenous bisphosphonate therapy for traumatic osteonecrosis of the femoral head in adolescents.

  The Journal of bone and joint surgery. American volume 20070801

• A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.

  Clinical therapeutics 20070801

• Review of thalidomide in the treatment of newly diagnosed multiple myeloma.

  Therapeutics and clinical risk management 20070801

• Inhibition of epidermal growth factor receptor signalling reduces hypercalcaemia induced by human lung squamous-cell carcinoma in athymic mice.

  British journal of cancer 20070716

• Remarkable response of juvenile diffuse sclerosing osteomyelitis of mandible to pamidronate.

  Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 20070701

• Vertical jump performance after 90 days bed rest with and without flywheel resistive exercise, including a 180 days follow-up.

  European journal of applied physiology 20070701

• A different schedule of zoledronic acid can reduce the risk of the osteonecrosis of the jaw in patients with multiple myeloma.

  Leukemia 20070701

• The spine in Paget's disease.

  Skeletal radiology 20070701

• Pediatric DXA: clinical applications.

  Pediatric radiology 20070701

• Bisphosphonates and osteonecrosis of the jaw.

  Rheumatology (Oxford, England) 20070701

• Synthesis and in vitro hydroxyapatite binding of peptides conjugated to calcium-binding moieties.

  Biomacromolecules 20070701

• Antiinflammatory treatment with bisphosphonates in ankylosing spondylitis.

  Current opinion in rheumatology 20070701

• An audit to determine the time taken to administer intravenous bisphosphonate infusions in patients diagnosed with metastatic breast cancer to bone in a hospital setting.

  Current medical research and opinion 20070701

• Incidence of osteonecrosis of the jaw in patients with multiple myeloma and breast or prostate cancer on intravenous bisphosphonate therapy.

  Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20070701

• Pharmacotherapy (excluding biotherapies) for ankylosing spondylitis: development of recommendations for clinical practice based on published evidence and expert opinion.

  Joint, bone, spine : revue du rhumatisme 20070701

• Hypercalcemia and diabetes insipidus in a patient previously treated with lithium.

  Nature clinical practice. Nephrology 20070701

• Zebra lines of pamidronate therapy in children.

  The Journal of bone and joint surgery. American volume 20070701

• Pamidronate treatment of chronic noninfectious inflammatory lesions of the mandible in children.

  The Journal of rheumatology 20070701

• Reversibility of pamidronate-associated glomerulosclerosis.

  Proceedings (Baylor University. Medical Center) 20070701

• Tumor induced hypercalcemia in a patient with mediastinal synovial sarcoma.

  Journal of pediatric endocrinology & metabolism : JPEM 20070701

• Bisphosphonates: are they standard of care for the treatment of breast cancer?

  British journal of cancer 20070618

• American Society of Clinical Oncology 2007 clinical practice guideline update on the role of bisphosphonates in multiple myeloma.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20070610

• Osteonecrosis of the jaws associated with use of risedronate: report of 2 new cases.

  Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 20070601

• Potentiated antitumor effects of the combination treatment with statins and pamidronate in vitro and in vivo.

  International journal of oncology 20070601

• Short-term effects of pamidronate on bone turnover: can bone markers be considered predictive of the analgesic response?

  Oncology reports 20070601

• Bisphosphonate rescue in distraction osteogenesis: a case series.

  Journal of pediatric orthopedics 20070601

• Transient migratory osteoporosis: rapid response to pamidronate treatment.

  Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 20070601

• Severe hypercalcemia as a harbinger of acute lymphoblastic leukemia.

  Pediatric emergency care 20070601

• Nanoparticulate carriers for the treatment of coronary restenosis.

  International journal of nanomedicine 20070601

• Current aproach to cancer pain management: Availability and implications of different treatment options.

  Therapeutics and clinical risk management 20070601

• [Complex regional pain syndrome of the knee: early and beneficial action of diphosphonates on pain and function].

  Annales de readaptation et de medecine physique : revue scientifique de la Societe francaise de reeducation fonctionnelle de readaptation et de medecine physique 20070501

• Hyperthyroidism with fibrous dysplasia: an unusual presentation of McCune-Albright syndrome.

  Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 20070501

• A new strategy of drug treatment in NSAID--unresponsive ankylosing spondylitis.

  The Journal of the Association of Physicians of India 20070501

• [Zoledronate-associated end stage renal failure and hypocalcaemia].

  Praxis 20070425

• [Back pain and acne conglobata: SAPHO syndrome].

  Praxis 20070411

• Intravenous pamidronate treatment of infants with severe osteogenesis imperfecta.

  Archives of disease in childhood 20070401

• Long-bone changes after pamidronate discontinuation in children and adolescents with osteogenesis imperfecta.

  Bone 20070401

• Jaw osteonecrosis related to bisphosphonate therapy: a severe secondary disorder.

  Bone 20070401

• Boosting effect of bisphosphonates on osteoconductive materials: a histologic in vivo evaluation.

  Journal of periodontal research 20070401

• Torg-Winchester syndrome: lack of efficacy of pamidronate therapy.

  Clinical dysmorphology 20070401

• Managing metastatic bone pain: the role of bisphosphonates.

  Journal of pain and symptom management 20070401

• Peripheral ulcerative keratitis-like findings associated with filgrastim.

  Cornea 20070401

• Amino-bisphosphonates decrease hTERT gene expression in breast cancer in vitro.

  Aging clinical and experimental research 20070401

• Short-term efficacy of monthly pamidronate infusion in patients with osteogenesis imperfecta.

  Journal of Korean medical science 20070401

• Inhibition of tooth movement by osteoprotegerin vs. pamidronate under conditions of constant orthodontic force.

  European journal of oral sciences 20070401

• The risk of renal impairment in hormone-refractory prostate cancer patients with bone metastases treated with zoledronic acid.

  Cancer 20070315

• Prolonged bisphosphonate release after treatment in children.

  The New England journal of medicine 20070308

• Osteogenesis imperfecta type VI in childhood and adolescence: effects of cyclical intravenous pamidronate treatment.

  Bone 20070301

• Comparative effects of five bisphosphonates on apoptosis of macrophage cells in vitro.

  Biochemical pharmacology 20070301

• Kinetic properties of the cardiac L-type Ca2+ channel and its role in myocyte electrophysiology: a theoretical investigation.

  Biophysical journal 20070301

• 1alpha,25-Dihydroxyvitamin D3 enhances proliferation of rat prostate cancer cells in the presence of living bone.

  The Journal of steroid biochemistry and molecular biology 20070301

• International Society of Geriatric Oncology (SIOG) clinical practice recommendations for the use of bisphosphonates in elderly patients.

  European journal of cancer (Oxford, England : 1990) 20070301

• Improved outcome from substituting methotrexate with epirubicin: results from a randomised comparison of CMF versus CEF in patients with primary breast cancer.

  European journal of cancer (Oxford, England : 1990) 20070301

• Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia.

  Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20070301

• Intravenous pamidronate therapy in osteogenesis imperfecta: response to treatment and factors influencing outcome.

  Journal of pediatric orthopedics 20070301

• Use of intravenous bisphosphonates in osteoporosis.

  Current osteoporosis reports 20070301

• Inhibition of bone healing by pamidronate in calvarial bony defects.

  Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 20070301

• Bisphosphonates and jaw osteonecrosis: the UAMS experience.

  Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 20070301

• Bisphosphonates: mode of action and pharmacology.

  Pediatrics 20070301

• Experience with bisphosphonates in osteogenesis imperfecta.

  Pediatrics 20070301

• Valuable lessons from SAPHO syndrome.

  Joint, bone, spine : revue du rhumatisme 20070301

• HTLV-1-associated adult T cell leukemia lymphoma presenting as granulomatous pneumocystis jiroveci pneumonia (PJP) and hypercalcemia.

  Journal of general internal medicine 20070301

• A case of McCune-Albright syndrome with associated multiple endocrinopathies.

  The Korean journal of internal medicine 20070301

• Osteochemonecrosis of jaws and bisphosphonates.

  Irish medical journal 20070301

• A new strategy of drug treatment in NSAID-unresponsive ankylosing spondylitis: combination of pamidronate and methylprednisolone monthly intravenous infusions on the background of a combination of disease modifying drugs sulfasalazine and methotrexate.

  The Journal of the Association of Physicians of India 20070301

• The differential effects of bisphosphonates, SERMS (selective estrogen receptor modulators), and parathyroid hormone on bone remodeling in osteoporosis.

  Clinical interventions in aging 20070301

• Treatment of ankylosing spondylitis: focus on etanercept.

  Biologics : targets & therapy 20070301

• Docetaxel-induced onycholysis: the role of subungual hemorrhage and suppuration.

  Yonsei medical journal 20070227

• Differential effects of bisphosphonates on breast cancer cell lines.

  Cancer letters 20070208

• Clinical and densitometric efficacy of the association of interferon alpha and pamidronate in the treatment of osteoporosis in patients with systemic mastocytosis.

  Clinical rheumatology 20070201

• Serum OPG and RANKL levels before and after intravenous bisphosphonate treatment in Paget's disease of bone.

  Bone 20070201

• [Bisphosphonate therapy for children and adolescents with primary and secondary osteoporotic diseases].

  Der Orthopade 20070201

• Outcomes of patients with prostate cancer receiving zoledronic acid or pamidronate for prevention of skeletal-related events.

  Pharmacotherapy 20070201

• Bisphosphonate-induced osteonecrosis of the jaw.

  The Annals of pharmacotherapy 20070201

• New multidisciplinary prostate bone metastases clinic: first of its kind in Canada.

  Current oncology (Toronto, Ont.) 20070201

• Combined effects of a third-generation bisphosphonate, zoledronic acid with other anticancer agents against murine osteosarcoma.

  British journal of cancer 20070129

• Pamidronate and osteoporosis prevention in liver transplant recipients.

  Rheumatology international 20070101

• Osteitis fibrosa cystica and secondary hyperparathyroidism in multiple myeloma.

  British journal of haematology 20070101

• Bisphosphonate-associated osteonecrosis of the jaw in patients with multiple myeloma and breast cancer.

  Acta haematologica 20070101

• Hypercalcaemia in a patient with a gastrointestinal stromal tumour.

  Clinical endocrinology 20070101

• Ocular adverse effects associated with systemic medications : recognition and management.

  Drugs 20070101

• Assessment of 186Re chelate-conjugated bisphosphonate for the development of new radiopharmaceuticals for bones.

  Nuclear medicine and biology 20070101

• [Therapeutic agents for disorders of bone and calcium metabolism: Zoledronic acid].

  Clinical calcium 20070101

• Anti-tumor effect of bisphosphonate (YM529) on non-small cell lung cancer cell lines.

  BMC cancer 20070101

• Morphoproteomic expression of H-ras (p21ras) correlates with serum monoclonal immunoglobulin reduction in multiple myeloma patients following pamidronate treatment.

  Annals of clinical and laboratory science 20070101

• Bisphosphonate-associated osteonecrosis of the jaw: a review of 35 cases and an evaluation of its frequency in multiple myeloma patients.

  Leukemia & lymphoma 20070101

• Mechanisms of osteopontin and CD44 as metastatic principles in prostate cancer cells.

  Molecular cancer 20070101

• [Cost analysis of tumor-induced osteolysis treated with intravenous zoledronic acid and pamidronate: a time-motion study].

  Recenti progressi in medicina 20070101

• Congenital craniopharyngioma and hypercalcemia induced by parathyroid hormone-related protein.

  Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20070101

• Vinorelbine plus 3-weekly trastuzumab in metastatic breast cancer: a single-centre phase 2 trial.

  BMC cancer 20070101

• The Interleukin-6 inflammation pathway from cholesterol to aging--role of statins, bisphosphonates and plant polyphenols in aging and age-related diseases.

  Immunity & ageing : I & A 20070101

• [Bisphosphonates-associated osteonecrosis of the jaw: review on reported cases].

  Therapie 20070101

• Effect of pamidronate on the action of catecholamines on blood pressure in the marrow cavity of long bones in rats with prednisolone-induced osteoporosis.

  Pharmacological reports : PR 20070101

• Impact of cytokines and T lymphocytes upon osteoclast differentiation and function.

  Arthritis research & therapy 20070101

• Clinical usefulness of bisphosphonates in oncology: treatment of bone metastases, antitumoral activity and effect on bone resorption markers.

  The International journal of biological markers 20070101

• The boy who refused an IV: a case report of subcutaneous clodronate for bone pain in a child with Ewing Sarcoma.

  Journal of medical case reports 20070101

• Oral bisphosphonate therapy and osteonecrosis of the jaw: what to tell the concerned patient.

  The International journal of prosthodontics 20070101

• Palliative treatment of bone metastases in hormone-refractory prostate cancer: effects of pamidronate on the carboxyterminal telopeptide of type-I collagen level in patients with increasing prostate-specific antigen levels.

  Urologia internationalis 20070101

• Maternal and fetal outcome of pamidronate treatment before conception: a case report.

  Clinical and experimental rheumatology 20070101

• Single-agent pamidronate for palliative therapy of canine appendicular osteosarcoma bone pain.

  Journal of veterinary internal medicine 20070101

• Rapid determination of bisphosphonates by ion chromatography with indirect UV detection.

  Journal of chromatographic science 20070101

• Bisphosphonates and osteonecrosis of the jaw: a retrospective study.

  Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20070101

• Multiple myeloma/hypercalcemia.

  Arthritis research & therapy 20070101

• Clinical development of anti-RANKL therapy.

  Arthritis research & therapy 20070101

• Rare clinical experiences for surgical treatment of melanoma with osseous metastases in Taiwan.

  BMC musculoskeletal disorders 20070101

• Severe hypercalcaemia and lymphoma in an HTLV-1 positive Jamaican woman: a case report.

  Journal of medical case reports 20070101

• The association between compliance and persistence with bisphosphonate therapy and fracture risk: a review.

  BMC musculoskeletal disorders 20070101

• High-dose bisphosphonate therapy in an urgent case of spontaneous multiple vertebral fractures in a 55 year old woman.

  Wiener medizinische Wochenschrift (1946) 20070101

• Effect of bisphosphonates on nitric oxide production by inflammatory activated chondrocytes.

  Clinical and experimental rheumatology 20070101

• Treatment of osteogenesis imperfecta: who, why, what?

  Hormone research 20070101

• Decrease of serum alkaline phosphatase after three cycles of pamidronate disodium in children with severe osteogenesis imperfecta.

  Hormone research 20070101

• Pamidronate down-regulates urokinase-type plasminogen activator expression in PC-3 prostate cancer cells.

  Anticancer research 20070101

• Adverse effects of bisphosphonates: current issues.

  The journal of supportive oncology 20070101

• Treatment of bone metastases and bone pain with bisphosphonates.

  Supportive cancer therapy 20070101

• Use of bisphosphonates in prostate cancer: Current status.

  Indian journal of urology : IJU : journal of the Urological Society of India 20070101

• Treatment of giant cell tumor of bone: Current concepts.

  Indian journal of orthopaedics 20070101

• Giant cell tumor of bone: Is curettage the answer?

  Indian journal of orthopaedics 20070101

• Adalimumab in ankylosing spondylitis: an evidence-based review of its place in therapy.

  Core evidence 20070101

• Osteonecrosis of the myeloma patients treated with bisphosphonates.

  Clinical cases in mineral and bone metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases 20070101

• Bisphosphonate-related osteonecrosis of the jaw: the Florence experience.

  Clinical cases in mineral and bone metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases 20070101

• Bisphosphonate - related osteonecrosis of the jaws: the point of view of the oral pathologist.

  Clinical cases in mineral and bone metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases 20070101

• Isoprenoid biosynthesis as a drug target: bisphosphonate inhibition of Escherichia coli K12 growth and synergistic effects of fosmidomycin.

  Journal of medicinal chemistry 20061214

• Pamidronate distribution in pediatric renal and rheumatologic patients.

  European journal of clinical pharmacology 20061201

• Osteogenesis imperfecta: new treatment options.

  Current rheumatology reports 20061201

• Pamidronate infusion in patients with systemic sclerosis results in changes in blood mononuclear cell cytokine profiles.

  Clinical and experimental immunology 20061201

• Cyclic intravenous pamidronate treatment in children with nodulosis, arthropathy and osteolysis syndrome.

  Annals of the rheumatic diseases 20061201

• Treatment of children with osteogenesis imperfecta.

  Current osteoporosis reports 20061201

• Platelet-derived growth factor receptor-beta in Gorham's disease.

  Nature clinical practice. Oncology 20061201

• Novel therapeutic agents for bone resorption. Part 1. Synthesis and protonation thermodynamics of poly(amido-amine)s containing bis-phosphonate residues.

  Biomacromolecules 20061201

• Renal safety of 1-hour pamidronate infusion for breast cancer and multiple myeloma patients: comparison between clinical trials and population-based database.

  Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 20061201

• Medical therapy in adults with fibrous dysplasia of bone.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20061201

• Acquired resistance to bisphosphonates in Paget's disease of bone.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20061201

• Medical management of Paget's disease of bone: indications for treatment and review of current therapies.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20061201

• [Advances in the research of bisphosphonate-associated osteonecrosis of the jaws].

  Shanghai kou qiang yi xue = Shanghai journal of stomatology 20061201

• Images in clinical medicine. Bisphosphonate-associated osteonecrosis of the jaw.

  The New England journal of medicine 20061130

• Maintenance therapy with thalidomide improves survival in patients with multiple myeloma.

  Blood 20061115

• Adsorption of bisphosphonate onto hydroxyapatite using a novel co-precipitation technique for bone growth enhancement.

  Journal of biomedical materials research. Part A 20061101

• Development and validation of a simple tape-based measurement tool for recording cervical rotation in patients with ankylosing spondylitis: comparison with a goniometer-based approach.

  The Journal of rheumatology 20061101

• Differences in nephrotoxicity of intravenous bisphosphonates for the treatment of malignancy-related bone disease.

  Onkologie 20061101

• Antitumor effects of aminobisphosphonates on renal cell carcinoma cell lines.

  The Journal of urology 20061101

• A role for geranylgeranylation in interleukin-1beta secretion.

  Arthritis and rheumatism 20061101

• Clinical response of cutaneous squamous-cell carcinoma to bortezomib given for myeloma.

  The Lancet. Oncology 20061101

• Motor function improvement after intravenous pamidronate in osteoporosis pseudoglioma syndrome.

  The Journal of pediatrics 20061101

• Serum soluble factors induce the proliferation, alkaline phosphatase activity and transforming growth factor-beta signal in osteoblastic cells in the patient with hepatitis C-associated osteosclerosis.

  Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 20061101

• I'm taking bisphosphonates for my osteoporosis, but I've heard it can cause a serious jaw condition. Is this something I should be concerned about?

  DukeMedicine healthnews 20061101

• Last generation of amino-bisphosphonates (N-BPs) and cancer angio-genesis: a new role for these drugs?

  Recent patents on anti-cancer drug discovery 20061101

• Phase II trial evaluating the palliative benefit of second-line zoledronic acid in breast cancer patients with either a skeletal-related event or progressive bone metastases despite first-line bisphosphonate therapy.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20061020

• Breast cancer: bisphosphonate therapy for metastatic bone disease.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20061015

• Treatment for myeloma bone disease.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20061015

• Evaluation of multidimensional capillary electrophoretic methodologies for determination of amino bisphosphonate pharmaceuticals.

  Journal of chromatography. A 20061013

• Vertebral morphometry in children and adolescents with osteogenesis imperfecta: effect of intravenous pamidronate treatment.

  Bone 20061001

• Pamidronate reduces bone loss after allogeneic stem cell transplantation.

  The Journal of clinical endocrinology and metabolism 20061001

• Clinical and radiological outcome of total hip replacement five years after pamidronate therapy. A trial extension.

  The Journal of bone and joint surgery. British volume 20061001

• Evaluation of biodistribution by local versus systemic administration of 99mTc-labeled pamidronate.

  Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association 20061001

• Vertebral fractures and increased sensitivity to corticosteroids in a child with ulcerative colitis: successful use of pamidronate.

  Journal of pediatric gastroenterology and nutrition 20061001

• [Treatment of Paget's disease of bone: importance of the zoledronic acid].

  Arquivos brasileiros de endocrinologia e metabologia 20061001

• Selective excision of chain-terminating nucleotides by HIV-1 reverse transcriptase with phosphonoformate as substrate.

  The Journal of biological chemistry 20060922

• Antioxidant effect of bisphosphonates and simvastatin on chondrocyte lipid peroxidation.

  Biochemical and biophysical research communications 20060922

• Activity of nitrogen-containing and non-nitrogen-containing bisphosphonates on tumor cell lines.

  Journal of medicinal chemistry 20060921

• Comparison of the analgesic efficacy of pamidronate and synthetic human calcitonin in osteoporotic vertebral fractures: a double-blind controlled study.

  Clinical rheumatology 20060901

• Pamidronate does not adversely affect bone intrinsic material properties in children with osteogenesis imperfecta.

  Bone 20060901

• Incidence, risk factors and management of osteonecrosis of the jaw in patients with multiple myeloma: a single-centre experience in 303 patients.

  British journal of haematology 20060901

• Low doses of pamidronate for the treatment of osteopenia in non-ambulatory children.

  Developmental medicine and child neurology 20060901

• Low doses of pamidronate to treat osteopenia in children with severe cerebral palsy: a pilot study.

  Developmental medicine and child neurology 20060901

• Osteoclast differentiation and bone resorption in multicentric reticulohistiocytosis.

  Human pathology 20060901

• Dental endosseous implants in patients on bisphosphonate therapy.

  Implant dentistry 20060901

• [Retrospective evaluation of the safety of pamidronate administration at the dose of 90 mg/day/month in Japanese breast cancer patients with bone metastasis].

  Gan to kagaku ryoho. Cancer & chemotherapy 20060901

• Bone complications in multiple myeloma.

  Cancer biology & therapy 20060901

• Effect of physical inactivity on the oxidation of saturated and monounsaturated dietary Fatty acids: results of a randomized trial.

  PLoS clinical trials 20060901

• Malignant hypercalcemia in pregnancy: effect of pamidronate on uterine contractions.

  Obstetrics and gynecology 20060901

• Scleritis complicating zoledronic acid infusion.

  Clinical lymphoma & myeloma 20060901

• [Osteonecrosis associated with the use of biphosphonates: Case report].

  Revista medica de Chile 20060901

• Management of age-related osteoporosis and prevention of associated fractures.

  Therapeutics and clinical risk management 20060901

• Development and validation of the Edmonton Ankylosing Spondylitis Metrology Index.

  Arthritis and rheumatism 20060815

• Bisphosphonates and osteonecrosis of the jaw: cause and effect or a post hoc fallacy?

  Annals of oncology : official journal of the European Society for Medical Oncology 20060801

• Clinical and radiological manifestations of osteogenesis imperfecta type V.

  Journal of Korean medical science 20060801

• The analgesic effect of pamidronate is not caused by the elevation of beta endorphin level in Paget's disease--a controlled pilot study.

  Neuro endocrinology letters 20060801

• Mayo clinic consensus statement for the use of bisphosphonates in multiple myeloma.

  Mayo Clinic proceedings 20060801

• Primary surgical therapy for osteonecrosis of the jaw secondary to bisphosphonate therapy.

  Mayo Clinic proceedings 20060801

• [The incidence and management of bone metastasis from breast cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20060801

• Disodium pamidronate for treating severe hypercalcemia in a hemodialysis patient.

  Nature clinical practice. Nephrology 20060801

• The use of bisphosphonates in men with hormone-refractory prostate cancer: a systematic review of randomized trials.

  The Canadian journal of urology 20060801

• Osteonecrosis of the jaws and bisphosphonate treatment in cancer patients.

  Wiener klinische Wochenschrift 20060801

• Aromatase inhibitors and bone loss.

  Oncology (Williston Park, N.Y.) 20060801

• Bone necrosis of the jaws associated with bisphosphonate treatment: a report of twenty-nine cases.

  Acta bio-medica : Atenei Parmensis 20060801

• Involvement of CD166 in the activation of human gamma delta T cells by tumor cells sensitized with nonpeptide antigens.

  Journal of immunology (Baltimore, Md. : 1950) 20060715

• The first pamidronate containing polymer and copolymer.

  Chemical communications (Cambridge, England) 20060714

• The use of pamidronate in a leukemic child with immobilization hypercalcemia.

  Leukemia research 20060701

• Bisphosphonate-induced avascular osteonecrosis of the jaws: a clinical report of 11 cases.

  International journal of oral and maxillofacial surgery 20060701

• Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates: evidence of increased risk after treatment with zoledronic acid.

  Haematologica 20060701

• Proliferating cells in HIV and pamidronate-associated collapsing focal segmental glomerulosclerosis are parietal epithelial cells.

  Kidney international 20060701

• Effect of bisphosphonates on the stimulation of macrophages by alumina ceramic particles: a comparison with ultra-high-molecular-weight polyethylene.

  Journal of materials science. Materials in medicine 20060701

• Myeloma bone disease and treatment options.

  European journal of cancer (Oxford, England : 1990) 20060701

• In vitro inhibition of matrix metalloproteinase activity in tracheal epithelial lining fluid from horses with recurrent airway obstruction.

  American journal of veterinary research 20060701

• Paget's disease of bone: experience from a centre in southern India.

  The Journal of the Association of Physicians of India 20060701

• Paget's disease of the bone: a report of three cases.

  The Journal of the Association of Physicians of India 20060701

• Denosumab: a promising drug for the prevention and treatment of osteoporosis.

  Women's health (London, England) 20060701

• Muscle weakness as presenting symptom of osteogenesis imperfecta.

  European journal of pediatrics 20060601

• Management of the adverse effects associated with intravenous bisphosphonates.

  Annals of oncology : official journal of the European Society for Medical Oncology 20060601

• Maternal and infant outcome after pamidronate treatment of polyostotic fibrous dysplasia and osteogenesis imperfecta before conception: a report of four cases.

  The Journal of clinical endocrinology and metabolism 20060601

• Nephrotic-range proteinuria following pamidronate therapy in a patient with metastatic breast cancer: mitochondrial toxicity as a pathogenetic concept?

  American journal of kidney diseases : the official journal of the National Kidney Foundation 20060601

• Bisphosphonate-associated osteonecrosis: a long-term complication of bisphosphonate treatment.

  The Lancet. Oncology 20060601

• Bisphosphonate-associated arthritis.

  Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 20060601

• Elimination and clearance of pamidronate by haemodialysis.

  Nephrology (Carlton, Vic.) 20060601

• Ankylosing spondylitis and symptom-modifying vs disease-modifying therapy.

  Best practice & research. Clinical rheumatology 20060601

• Jaw osteonecrosis associated with use of bisphosphonates and chemotherapy: paradoxical complication of treatment of bone lesions in multiple myeloma patients.

  International journal of hematology 20060601

• Fracture prevention in postmenopausal women.

  Clinical evidence 20060601

• [Bisphosphonates and osteonecrosis of the jaws in patients with myelomatosis].

  Ugeskrift for laeger 20060522

• Relative binding affinities of bisphosphonates for human bone and relationship to antiresorptive efficacy.

  Bone 20060501

• Bisphosphonates for malignancy-related bone disease: current status, future developments.

  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20060501

• Surgery versus surgery plus pamidronate in the management of osteogenesis imperfecta patients: a comparative study.

  Journal of pediatric orthopedics. Part B 20060501

• Treatment of ankylosing spondylitis with pamidronate: an open label study.

  Annals of the rheumatic diseases 20060501

• Ibandronate, an experimental intravenous bisphosphonate for osteoporosis, bone metastases, and hypercalcemia of malignancy.

  Pharmacotherapy 20060501

• Long-term survival after second-line therapy with docetaxel and carboplatin and monthly pamidronic acid in a woman with metastatic non-small cell lung cancer.

  Onkologie 20060501

• Bisphosphonate treatment of bone fibrous dysplasia in McCune-Albright syndrome.

  Journal of pediatric endocrinology & metabolism : JPEM 20060501

• [Diphosphonates can cause necrosis of the jaw. Patients with malignant skeletal diseases are at risk].

  Lakartidningen 20060501

• A case of parathyroid carcinoma with hypercalcemia responsive to cinacalcet therapy.

  Nature clinical practice. Endocrinology & metabolism 20060501

• Inhibitory effects of bisphosphonates on the proliferation of human ovarian cancer cell lines and the mechanism.

  Medicinal chemistry (Shariqah (United Arab Emirates)) 20060501

• Effects of vitamin K2 on the development of osteopenia in rats as the models of osteoporosis.

  Yonsei medical journal 20060430

• Progressive osseous heteroplasia controlled by intravenous administration of pamidronate.

  American journal of medical genetics. Part A 20060415

• The bisphosphonate olpadronate inhibits skeletal prostate cancer progression in a green fluorescent protein nude mouse model.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20060415

• Involvement of the jaw bones in systemic mastocytosis.

  The British journal of oral & maxillofacial surgery 20060401

• Pamidronate in children and adolescents with osteogenesis imperfecta: effect of treatment discontinuation.

  The Journal of clinical endocrinology and metabolism 20060401

• Alendronate in bone cement: fatigue life degraded by liquid, not by powder.

  Clinical orthopaedics and related research 20060401

• A comparison of the gastrointestinal effects of the nitrogen-containing bisphosphonates pamidronate, alendronate, and olpadronate in humans.

  Journal of clinical pharmacology 20060401

• Alendronate treatment in osteogenesis imperfecta.

  Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 20060401

• An unrecognized cause of recurrent hypercalcemia: immobilization.

  Southern medical journal 20060401

• Effect of intravenous pamidronate therapy on functional abilities and level of ambulation in children with osteogenesis imperfecta.

  The Journal of pediatrics 20060401

• Bisphosphonates: from bench to bedside.

  Annals of the New York Academy of Sciences 20060401

• Pachydermoperiostitis and bisphosphonates.

  The Journal of the Association of Physicians of India 20060401

• Role of bisphosphonates for the management of skeletal complications and bone pain from skeletal metastases.

  Supportive cancer therapy 20060401

• Enthalpy versus entropy-driven binding of bisphosphonates to farnesyl diphosphate synthase.

  Journal of the American Chemical Society 20060322

• [Reversible posterior leucoencephalopathy due to hypercalcaemia].

  Nederlands tijdschrift voor geneeskunde 20060304

• The usefulness of bone remodelling markers in predicting the efficacy of pamidronate treatment in SAPHO syndrome.

  Rheumatology (Oxford, England) 20060301

• [Bisphosphonate-associated osteonecrosis of the jaw].

  Mund-, Kiefer- und Gesichtschirurgie : MKG 20060301

• Cyclical intravenous pamidronate treatment affects metaphyseal modeling in growing patients with osteogenesis imperfecta.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20060301

• Osteogenesis imperfecta: anthropometric, skeletal and mineral metabolic effects of long-term intravenous pamidronate therapy.

  Acta paediatrica (Oslo, Norway : 1992) 20060301

• Association of osteonecrosis of the jaws and bisphosphonate pharmacotherapy: dental implications.

  The New Zealand dental journal 20060301

• Effects of 3 years of intravenous pamidronate treatment on bone markers and bone mineral density in a patient with osteoporosis-pseudoglioma syndrome (OPPG).

  Journal of pediatric endocrinology & metabolism : JPEM 20060301

• Ibandronate: the first once-monthly oral bisphosphonate for treatment of postmenopausal osteoporosis.

  Therapeutics and clinical risk management 20060301

• Differences between the bisphosphonates for the prevention and treatment of osteoporosis.

  Therapeutics and clinical risk management 20060301

• Osteonecrosis of the jaw in multiple myeloma patients: clinical features and risk factors.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060220

• Maintaining bone health in patients with prostate cancer.

  The Medical journal of Australia 20060220

• A study of the biological receptor activator of nuclear factor-kappaB ligand inhibitor, denosumab, in patients with multiple myeloma or bone metastases from breast cancer.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20060215

• Simple analysis of four bisphosphonates simultaneously by reverse phase liquid chromatography using n-amylamine as volatile ion-pairing agent.

  Journal of chromatography. A 20060203

• Pamidronate in children with osteogenesis imperfecta: histomorphometric effects of long-term therapy.

  The Journal of clinical endocrinology and metabolism 20060201

• Potentiation of antigen-stimulated V gamma 9V delta 2 T cell cytokine production by immature dendritic cells (DC) and reciprocal effect on DC maturation.

  Journal of immunology (Baltimore, Md. : 1950) 20060201

• Intravenous pamidronate in combination with calcium and vitamin D: highly effective in the treatment of low bone mineral density in inflammatory bowel disease.

  Scandinavian journal of gastroenterology 20060201

• [Two cases of stage IV breast cancer with severe hypercalcemia].

  Gan to kagaku ryoho. Cancer & chemotherapy 20060201

• Multiple myeloma, nephrotic syndrome and crystalloid inclusions in podocytes.

  Kidney international 20060201

• Pamidronate treatment of steroid associated osteonecrosis in young patients treated for acute lymphoblastic leukaemia--two-year outcomes.

  Journal of pediatric endocrinology & metabolism : JPEM 20060201

• [Influence of bisphosphonate treatment on the radiological features of osteogenesis imperfecta in children].

  Georgian medical news 20060201

• Relationship between periodontal disease and systemic diseases.

  Texas dental journal 20060201

• Update of current therapeutic options for the treatment of postmenopausal osteoporosis.

  Clinical therapeutics 20060201

• High-performance liquid chromatography method for determining alendronate sodium in human plasma by detecting fluorescence: application to a pharmacokinetic study in humans.

  Journal of pharmaceutical and biomedical analysis 20060123

• The effect of cyclical intravenous pamidronate in children and adolescents with osteogenesis imperfecta type V.

  Bone 20060101

• Long-term prevention of skeletal complications by pamidronate in a patient with bone metastasis from endometrial carcinoma: a case report.

  Gynecologic oncology 20060101

• Calcaneal osteomyelitis due to fistulization of an ulcerated rheumatoid nodule.

  Joint, bone, spine : revue du rhumatisme 20060101

• Pamidronate therapy for preventing steroid-induced osteoporosis in children with nephropathy.

  Nephron. Clinical practice 20060101

• Pamidronate induced anti-proliferative, apoptotic, and anti-migratory effects in hepatocellular carcinoma.

  Journal of hepatology 20060101

• Treatment of stress fractures: the fundamentals.

  Clinics in sports medicine 20060101

• Two-year clinical trial of oral alendronate versus intravenous pamidronate in children with osteogenesis imperfecta.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20060101

• Osteonecrosis of the jaw associated with pamidronate therapy.

  American journal of hematology 20060101

• Osteonecrosis of the jaws and bisphosphonates. Report of three cases.

  Medicina oral, patologia oral y cirugia bucal 20060101

• Administration of zoledronic acid enhances the effects of docetaxel on growth of prostate cancer in the bone environment.

  BMC cancer 20060101

• Serum osteoprotegerin and receptor activator of nuclear factor-kappaB ligand (RANKL) concentrations in allogeneic stem cell transplant-recipients: a role in bone loss?

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20060101

• Looking at calcimimetics impact on hypercalcemia of immobilization: hypotheses and a case study.

  Hemodialysis international. International Symposium on Home Hemodialysis 20060101

• Minimally symptomatic severe hypercalcaemia in a patient with parathyroid carcinoma.

  JPMA. The Journal of the Pakistan Medical Association 20060101

• Osteonecrosis of the mandible or maxilla associated with the use of new generation bisphosphonates.

  The Laryngoscope 20060101

• Pamidronate treatment of polyostotic fibrous dysplasia: failure to prevent expansion of dysplastic lesions during childhood.

  Journal of pediatric endocrinology & metabolism : JPEM 20060101

• The effect of bisphosphonates on gene expression: GAPDH as a housekeeping or a new target gene?

  BMC cancer 20060101

• Bisphosphonate-induced hypocalcemia: report of 3 cases and review of literature.

  Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20060101

• Zoledronic acid treatment impairs protein geranyl-geranylation for biological effects in prostatic cells.

  BMC cancer 20060101

• Synthesis of novel (1-alkanoyloxy-4-alkanoylaminobutylidene)-1,1-bisphosphonic acid derivatives.

  Beilstein journal of organic chemistry 20060101

• Reduction in bone relapse and improved survival with oral clodronate for adjuvant treatment of operable breast cancer [ISRCTN83688026].

  Breast cancer research : BCR 20060101

• Administration of bisphosphonate for hypercalcemia associated with oral cancer.

  Head & face medicine 20060101

• Pamidronate: Treatment for severe hypercalcemia in neonatal subcutaneous fat necrosis.

  Hormone research 20060101

• Hypercalcemia of malignancy remains a clinically relevant problem.

  Cancer journal (Sudbury, Mass.) 20060101

• Randomized, double-blind, phase II trial of gallium nitrate compared with pamidronate for acute control of cancer-related hypercalcemia.

  Cancer journal (Sudbury, Mass.) 20060101

• Bisphosphonate pretreatment attenuates hungry bone syndrome postoperatively in subjects with primary hyperparathyroidism.

  Journal of bone and mineral metabolism 20060101

• Jaw complications associated with bisphosphonate use in patients with plasma cell dyscrasias.

  Medical oncology (Northwood, London, England) 20060101

• [A case of polyostotic fibrous dysplasia].

  Wiadomosci lekarskie (Warsaw, Poland : 1960) 20060101

• Brainstem and cerebellar hypoplasia associated with osteogenesis imperfecta type-5.

  Journal of postgraduate medicine 20060101

• [Fibrous dysplasia of bone in a 12-year old girl].

  Endokrynologia, diabetologia i choroby przemiany materii wieku rozwojowego : organ Polskiego Towarzystwa Endokrynologow Dzieciecych 20060101

• Anti-inflammatory and immunosuppressive drugs and reproduction.

  Arthritis research & therapy 20060101

• Loss of BRCA1 expression may predict shorter time-to-progression in metastatic breast cancer patients treated with taxanes.

  Anticancer research 20060101

• Protocol for stage 1 of the GaP study (Genetic testing acceptability for Paget's disease of bone): an interview study about genetic testing and preventive treatment: would relatives of people with Paget's disease want testing and treatment if they were available?

  BMC health services research 20060101

• Pamidronate treatment and posttreatment bone density in children with spastic quadriplegic cerebral palsy.

  Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 20060101

• Low-dose intravenous pamidronate treatment in osteogenesis imperfecta.

  The Turkish journal of pediatrics 20060101

• Transient efficacy of pulse pamidronate treatment in active spondylarthropathies: an open study of 35 cases.

  Clinical and experimental rheumatology 20060101

• Osteogenesis imperfecta : current treatment options and future prospects.

  Treatments in endocrinology 20060101

• Drug induced osteonecrosis of the jaws.

  The Journal of the Tennessee Dental Association 20060101

• Intravenous pamidronate for pain relief in recent osteoporotic vertebral compression fracture: a randomized double-blind controlled study.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20060101

• Burn-induced bone loss: importance, mechanisms, and management.

  Journal of burns and wounds 20060101

• Case studies in metastatic bone disease: understanding the unique nature of bone loss due to malignancy.

  ONS news 20060101

• In vitro synergistic cytoreductive effects of zoledronic acid and radiation on breast cancer cells.

  Breast cancer research : BCR 20060101

• [Ankylosing spondylitis--the current situation and new therapeutic options].

  Vnitrni lekarstvi 20060101

• The role of bisphosphonates in early breast cancer.

  The oncologist 20060101

• Ibandronate: its role in metastatic breast cancer.

  The oncologist 20060101

• Effect of a convenient single 90-mg pamidronate dose on biochemical markers of bone metabolism in patients with acute spinal cord injury.

  The journal of spinal cord medicine 20060101

• Metabolic bone disease in patients receiving home parenteral nutrition: a Canadian study and review.

  JPEN. Journal of parenteral and enteral nutrition 20060101

• Bisphosphonate-associated osteonecrosis of the jaw: the rheumatologist's role.

  Arthritis research & therapy 20060101

• [Back pain and dorsal kyphosis in childhood].

  Acta reumatologica portuguesa 20060101

• Bisphosphonate complications including osteonecrosis of the jaw.

  Hematology. American Society of Hematology. Education Program 20060101

• Use of bisphosphonates for resistant hypercalcemia in children with acute lymphoblastic leukemia: report of two cases and review of the literature.

  The Turkish journal of pediatrics 20060101

• Parathyroid cancer: etiology, clinical presentation and treatment.

  Anticancer research 20060101

• The incidence of jaw osteonecrosis in multiple myeloma patients treated with bisphosphonates.

  Acta poloniae pharmaceutica 20060101

• Metabolite antigens and pathway incompatibility.

  Genome informatics. International Conference on Genome Informatics 20060101

• Comparison of effect of treatment with etidronate and alendronate on lumbar bone mineral density in elderly women with osteoporosis.

  Yonsei medical journal 20051231

• Consumer groups look to improve adverse event reporting systems.

  Journal of the National Cancer Institute 20051221

• Cost-effectiveness of oral ibandronate compared with intravenous (i.v.) zoledronic acid or i.v. generic pamidronate in breast cancer patients with metastatic bone disease undergoing i.v. chemotherapy.

  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20051201

• Bone involvement in myelofibrosis: effectiveness of bisphosphonates.

  Joint, bone, spine : revue du rhumatisme 20051201

• Symptomatic hypocalcaemia and renal impairment associated with bisphosphonate treatment in patients with multiple myeloma.

  Internal medicine journal 20051201

• Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20051201

• Endothelin-1 levels in patients with Paget's disease of bone.

  Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 20051201

• [Phase II randomized clinical trail of zoledronic acid in treating metastatic bone pain of malignancy].

  Ai zheng = Aizheng = Chinese journal of cancer 20051201

• In vitro comparison of clodronate, pamidronate and zoledronic acid effects on rat osteoclasts and human stem cell-derived osteoblasts.

  Basic & clinical pharmacology & toxicology 20051201

• By the way, doctor. I've heard that taking Fosamax for a long time causes the jawbone to deteriorate. Do you know anything about this?

  Harvard women's health watch 20051201

• Is pamidronate effective in preventing chemotherapy-induced bone loss?

  Nature clinical practice. Endocrinology & metabolism 20051201

• Osteogenesis imperfecta, current and future medical treatment.

  American journal of medical genetics. Part C, Seminars in medical genetics 20051115

• [Pamidronate and uveitis].

  Medicina clinica 20051112

• Caspase-independent induction of apoptosis in human melanoma cells by the proapoptotic Bcl-2-related protein Nbk / Bik.

  Oncogene 20051110

• Bisphosphonates for treatment and prevention of bone metastases.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20051110

• The effect of intravenous pamidronate versus oral alendronate on bone mineral density in patients with osteoporosis.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20051101

• Jaw bone necrosis without previous dental extractions associated with the use of bisphosphonates (pamidronate and zoledronate): a four-case report.

  Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 20051101

• Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment.

  Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20051101

• Attempted randomized controlled trial of pamidronate versus calcium and calcitriol supplements for management of steroid-induced osteoporosis in children and adolescents.

  Journal of paediatrics and child health 20051101

• Amino-bisphosphonates in heterotopic ossification: first experience in five consecutive cases.

  Spinal cord 20051001

• Stimulation of resorption in cultured mouse calvarial bones by thiazolidinediones.

  Endocrinology 20051001

• Prognosis of hypercalcemia in aerodigestive tract cancers: study of 136 recent cases.

  Oral oncology 20051001

• Bisphosphonate-associated osteonecrosis of the jaws and endodontic treatment: two case reports.

  Journal of endodontics 20051001

• Predictive factors for skeletal complications in hormone-refractory prostate cancer patients with metastatic bone disease.

  British journal of cancer 20050919

• [Bisphosphonates-related jaw osteonecrosis].

  Presse medicale (Paris, France : 1983) 20050910

• Skeletal retention of bisphosphonate (pamidronate) and its relation to the rate of bone resorption in patients with breast cancer and bone metastases.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20050901

• Chronic hypercalcemia as a reversible cause of cognitive impairment: improvement after a single administration of pamidronate.

  Journal of the American Geriatrics Society 20050901

• A single systemic dose of pamidronate improves bone mineral content and accelerates restoration of strength in a rat model of fracture repair.

  Journal of orthopaedic research : official publication of the Orthopaedic Research Society 20050901

• Pamidronate lines.

  Indian pediatrics 20050901

• Cyclical intravenous pamidronate therapy in children with osteogenesis imperfecta.

  The Ceylon medical journal 20050901

• Bisphosphonates decrease telomerase activity and hTERT expression in MCF-7 breast cancer cells.

  Molecular and cellular endocrinology 20050830

• Studies in osteonecrosis.

  British dental journal 20050827

• Influence of bisphosphonates on the production of pro-inflammatory cytokines by activated human articular chondrocytes.

  Cytokine 20050821

• MICA expressed by multiple myeloma and monoclonal gammopathy of undetermined significance plasma cells Costimulates pamidronate-activated gammadelta lymphocytes.

  Cancer research 20050815

• The inhibition of RANKL causes greater suppression of bone resorption and hypercalcemia compared with bisphosphonates in two models of humoral hypercalcemia of malignancy.

  Endocrinology 20050801

• Myeloma bone disease: pathophysiology and management.

  Annals of oncology : official journal of the European Society for Medical Oncology 20050801

• Predictive value of bone resorption and formation markers in cancer patients with bone metastases receiving the bisphosphonate zoledronic acid.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050801

• Pamidronate prevents bone loss and decreased bone strength in adult female and male rats fed an isocaloric low-protein diet.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20050801

• Drug-induced expansion and differentiation of V gamma 9V delta 2 T cells in vivo: the role of exogenous IL-2.

  Journal of immunology (Baltimore, Md. : 1950) 20050801

• Bone loss and the aromatase inhibitors.

  British journal of cancer 20050801

• [Avascular necrosis of the jaw bone after bisphosphonate therapy].

  Harefuah 20050801

• Cost-effectiveness of oral ibandronate versus IV zoledronic acid or IV pamidronate for bone metastases in patients receiving oral hormonal therapy for breast cancer in the United Kingdom.

  Clinical therapeutics 20050801

• Evolving therapeutic role of bisphosphonates in multiple myeloma.

  British journal of cancer 20050725

• Bisphosphonates for breast cancer.

  The Cochrane database of systematic reviews 20050720

• Osteonecrosis of the jaw and bisphosphonates.

  The New England journal of medicine 20050707

• Osteonecrosis of the jaw and bisphosphonates.

  The New England journal of medicine 20050707

• Prevention of bone loss after allogeneic stem cell transplantation by calcium, vitamin D, and sex hormone replacement with or without pamidronate.

  The Journal of clinical endocrinology and metabolism 20050701

• Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy.

  Cancer 20050701

• Effects of intravenous pamidronate treatment in infants with osteogenesis imperfecta: clinical and histomorphometric outcome.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20050701

• Bisphosphonates, as a new cause of drug-induced jaw osteonecrosis: an update.

  Medicina oral, patologia oral y cirugia bucal 20050701

• Defective osteoblast function may be responsible for bone loss from the proximal femur despite pamidronate therapy.

  The Journal of clinical endocrinology and metabolism 20050701

• Benefits of pamidronate in children with osteogenesis imperfecta: an open prospective study.

  Joint, bone, spine : revue du rhumatisme 20050701

• Ionized calcium in isolation may not detect all cases of symptomatic hypercalcaemia.

  Palliative medicine 20050701

• [Osteonecrosis of the jaws as a possible adverse effect of the use of bisphosphonates].

  Mund-, Kiefer- und Gesichtschirurgie : MKG 20050701

• Survival-adjusted multiple-event analysis for the evaluation of treatment effects of zoledronic Acid in patients with bone metastases from solid tumors.

  Supportive cancer therapy 20050701

• The efficacy of acute administration of pamidronate on the conservation of bone mass following severe burn injury in children: a double-blind, randomized, controlled study.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20050601

• Pamidronate in the prevention of chemotherapy-induced bone loss in premenopausal women with breast cancer: a randomized controlled trial.

  The Journal of clinical endocrinology and metabolism 20050601

• Muscle atrophy and bone loss after 90 days' bed rest and the effects of flywheel resistive exercise and pamidronate: results from the LTBR study.

  Bone 20050601

• Quantification of metaphyseal modeling in children treated with bisphosphonates.

  Bone 20050601

• Controlled trial of pamidronate in children with types III and IV osteogenesis imperfecta confirms vertebral gains but not short-term functional improvement.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20050601

• [Osteogenesis imperfecta and bisphosphonates].

  Archives de pediatrie : organe officiel de la Societe francaise de pediatrie 20050601

• [Hypercalcemia and childhood cancer].

  Archives de pediatrie : organe officiel de la Societe francaise de pediatrie 20050601

• Hearing loss treated with pamidronate.

  Journal of the Royal Society of Medicine 20050601

• Overproduction of an amino-terminal form of PTH distinct from human PTH(1-84) in a case of severe primary hyperparathyroidism: influence of medical treatment and surgery.

  Clinical endocrinology 20050601

• New therapeutic agents for the treatment of bone diseases.

  Expert opinion on biological therapy 20050601

• Prediction of genotoxicity of chemical compounds by statistical learning methods.

  Chemical research in toxicology 20050601

• Efficacy and safety of intravenous bisphosphonates for patients with breast cancer metastatic to bone: a review of randomized, double-blind, phase III trials.

  Clinical breast cancer 20050601

• Zoledronic acid significantly improves pain scores and quality of life in breast cancer patients with bone metastases: a randomised, crossover study of community vs hospital bisphosphonate administration.

  British journal of cancer 20050523

• Bisphosphonate inhibitors of Toxoplasma gondi growth: in vitro, QSAR, and in vivo investigations.

  Journal of medicinal chemistry 20050505

• Bone densitometry in pediatric patients treated with pamidronate.

  Pediatric radiology 20050501

• Bisphosphonates in breast cancer.

  Annals of oncology : official journal of the European Society for Medical Oncology 20050501

• The issue of renal safety of zoledronic acid from a nephrologist's point of view.

  The oncologist 20050501

• 'Safety and convenience of a 15-minute infusion of zoledronic acid': not so safe.

  The oncologist 20050501

• Aseptic osteonecrosis in children and adolescents treated for hemato-oncologic diseases: a 13-year longitudinal observational study.

  Journal of pediatric hematology/oncology 20050501

• Bone-specific alkaline phosphatase activity is inhibited by bisphosphonates: role of divalent cations.

  Biological trace element research 20050501

• Investigation of the effect of pamidronate disodium on the in vitro viability of osteosarcoma cells from dogs.

  American journal of veterinary research 20050501

• Bisphosphonates, cancer, and osteonecrosis--a single practice experience.

  Delaware medical journal 20050501

• Costs and consequences of using pamidronate compared with zoledronic acid in the management of breast cancer patients in the UK.

  Current medical research and opinion 20050501

• [Paget's disease and its therapeutic management].

  Presse medicale (Paris, France : 1983) 20050423

• Pyridinium-1-yl bisphosphonates are potent inhibitors of farnesyl diphosphate synthase and bone resorption.

  Journal of medicinal chemistry 20050421

• Bisphosphonates and avascular necrosis of the jaw: a possible association.

  The Medical journal of Australia 20050418

• Bacterial adhesion to bisphosphonate coated hydroxyapatite.

  Journal of materials science. Materials in medicine 20050401

• Should oral bisphosphonates be standard of care in women with early breast cancer?

  Breast cancer research and treatment 20050401

• [Rapid drug information].

  Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 20050401

• [What is the place of diphosphonates in the treatment of complex regional pain syndrome I?].

  Annales de readaptation et de medecine physique : revue scientifique de la Societe francaise de reeducation fonctionnelle de readaptation et de medecine physique 20050401

• Vascular calcifications in chronic kidney disease: are there new treatments?

  Current vascular pharmacology 20050401

• Pamidronate--a promising new candidate for the management of spondyloarthropathy.

  Indian journal of medical sciences 20050401

• Optimizing the management of postmenopausal osteoporosis with bisphosphonates: the emerging role of intermittent therapy.

  Clinical therapeutics 20050401

• [Use of 153Sm-EDTMP to relieve pain from bone metastasis in lung cancer].

  Revue des maladies respiratoires 20050401

• Pamidronate treatment of pediatric fracture patients on chronic steroid therapy.

  Pediatric nephrology (Berlin, Germany) 20050301

• Nordic Myeloma Study Group, the first 15 years: scientific collaboration and improvement of patient care.

  European journal of haematology 20050301

• Management of bone metastases in breast cancer.

  Current treatment options in oncology 20050301

• Treatment of stress fractures in athletes with intravenous pamidronate.

  Clinical journal of sport medicine : official journal of the Canadian Academy of Sport Medicine 20050301

• Cyclic bisphosphonate therapy in osteogenesis imperfecta type V.

  Journal of paediatrics and child health 20050301

• [Multiple myeloma--recent advances in diagnosis and treatment].

  Gan to kagaku ryoho. Cancer & chemotherapy 20050301

• [Clinical value of combined therapy with 188Re-HEDP and pamidronate in breast cancer with bone metastasis].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20050301

• Gemcitabine and docetaxel as first-line treatment for advanced urothelial carcinoma: a phase II study.

  British journal of cancer 20050227

• [Pharmacological treatment of osteitis deformans (Paget's bone disease)].

  Ugeskrift for laeger 20050227

• Monitoring of skeletal progression of prostate cancer by GFP imaging, X-ray, and serum OPG and PTHrP.

  The Prostate 20050215

• Modulation of TNF-alpha gene expression by IFN-gamma and pamidronate in murine macrophages: regulation by STAT1-dependent pathways.

  Journal of immunology (Baltimore, Md. : 1950) 20050215

• Paget's disease of bone.

  The Medical journal of Australia 20050207

• An open study of pulse pamidronate treatment in severe ankylosing spondylitis, and its effect on biochemical markers of bone turnover.

  Annals of the rheumatic diseases 20050201

• The bisphosphonate pamidronate on the surface of titanium stimulates bone formation around tibial implants in rats.

  Biomaterials 20050201

• The treatment of Paget's disease.

  Rheumatology (Oxford, England) 20050201

• An instrument to measure skeletal burden and predict functional outcome in fibrous dysplasia of bone.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20050201

• Gorham-Stout disease--stabilization during bisphosphonate treatment.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20050201

• Economic evaluation of zoledronic acid versus pamidronate for the prevention of skeletal-related events in metastatic breast cancer and multiple myeloma.

  American journal of clinical oncology 20050201

• Cyclic administration of pamidronate to treat osteoporosis in children with cerebral palsy or a neuromuscular disorder: a clinical study.

  Acta orthopaedica Belgica 20050201

• Evolving role of bisphosphonates in women undergoing treatment for localized and advanced breast cancer.

  Clinical breast cancer 20050201

• Comparison of intravenous pamidronate to standard therapy for osteoporosis: use in patients unable to take oral bisphosphonates.

  Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 20050201

• Rat model of the hypercalcaemia induced by parathyroid hormone-related protein: characteristics of three bisphosphonates.

  European journal of pharmacology 20050110

• 2005 Medicare payments for chemotherapy will exceed costs.

  Journal of the National Cancer Institute 20050105

• Re: Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer.

  Journal of the National Cancer Institute 20050105

• Effect of pamidronate on bone turnover and implant migration after total hip arthroplasty: a randomized trial.

  Journal of orthopaedic research : official publication of the Orthopaedic Research Society 20050101

• Reciprocal activating interaction between dendritic cells and pamidronate-stimulated gammadelta T cells: role of CD86 and inflammatory cytokines.

  Journal of immunology (Baltimore, Md. : 1950) 20050101

• SAPHO syndrome and pamidronate revisited.

  Rheumatology (Oxford, England) 20050101

• Hypercalcemia and childhood cancer: a 7-year experience.

  Journal of pediatric hematology/oncology 20050101

• Paediatric management of endocrine complications in McCune-Albright syndrome.

  Journal of pediatric endocrinology & metabolism : JPEM 20050101

• A comparison of oral and intravenous bisphosphonate therapy for children with osteogenesis imperfecta.

  Journal of pediatric endocrinology & metabolism : JPEM 20050101

• Bisphosphonates as anti-inflammatory agents in ankylosing spondylitis and spondylarthropathies.

  Expert opinion on pharmacotherapy 20050101

• Uses and effectiveness of pamidronate disodium for treatment of dogs and cats with hypercalcemia.

  Journal of veterinary internal medicine 20050101

• Evaluation of intravenous pamidronate administration in 33 cancer-bearing dogs with primary or secondary bone involvement.

  Journal of veterinary internal medicine 20050101

• Mechanical properties of femoral trabecular bone in dogs.

  Biomedical engineering online 20050101

• The role of bisphosphonates in the management of advanced cancer with a focus on non-small-cell lung cancer. Part 1: Mechanisms of action, role of biomarkers and preclinical applications.

  Oncology 20050101

• Patients' experience of ambulatory self-administration of pamidronate in multiple myeloma.

  Cancer nursing 20050101

• Bone healing in children with osteogenesis imperfecta treated with bisphosphonates.

  Journal of pediatric orthopedics 20050101

• The role of fibroblast growth factor 23 for hypophosphatemia and abnormal regulation of vitamin D metabolism in patients with McCune-Albright syndrome.

  Journal of bone and mineral metabolism 20050101

• Unilateral exophthalmos associated with severe fibrous dysplasia.

  Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde 20050101

• Nephrotoxicity related to new therapeutic compounds.

  Renal failure 20050101

• Successful treatment of osteolytic epithelioid hemangioendothelioma with pamidronate.

  Clinical and experimental rheumatology 20050101

• Late-onset ankylosing spondylitis and related spondylarthropathies: clinical and radiological characteristics and pharmacological treatment options.

  Drugs & aging 20050101

• Calcium carbonate toxicity: the updated milk-alkali syndrome; report of 3 cases and review of the literature.

  Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20050101

• Bisphosphonate treatment in osteogenesis imperfecta: which drug, for whom, for how long?

  Annals of medicine 20050101

• Myeloma bone disease.

  Best practice & research. Clinical haematology 20050101

• Off-trial evaluation of bisphosphonates in patients with metastatic breast cancer.

  BMC cancer 20050101

• Alendronate inhibits proliferation and invasion of human epidermoid carcinoma cells in vitro.

  Anticancer research 20050101

• Oral pamidronate prevents high-dose glucocorticoid-induced lumbar spine bone loss in premenopausal connective tissue disease (mainly lupus) patients.

  Lupus 20050101

• The effects of the antiresorptive agents calcitonin and pamidronate on spine fusion in a rabbit model.

  The spine journal : official journal of the North American Spine Society 20050101

• Pamidronate and 1,24(S)-dihydroxyvitamin D2 synergistically inhibit the growth of myeloma, breast and prostate cancer cells.

  Anticancer research 20050101

• Osteoporosis at presentation of childhood ALL: management with pamidronate.

  Pediatric hematology and oncology 20050101

• Effect of pamidronate administration on bone in patients with acute spinal cord injury.

  Journal of rehabilitation research and development 20050101

• Calcinosis cutis with siliconomas complicated by hypercalcemia.

  Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20050101

• Effectiveness of pamidronate for treating intractable chronic neuropathic pain: case report of two adolescents.

  The Clinical journal of pain 20050101

• Bisphosphonates and atherosclerosis: why?

  Lupus 20050101

• Drug-induced osteonecrosis of the jaws: a new clinical entity.

  CDS review 20050101

• Pharmacological treatment of ankylosing spondylitis: a systematic review.

  Drugs 20050101

• Effects of catecholamines on blood pressure in the long bone marrow cavity in rats with bisphosphonate-induced osteopetrosis.

  Pharmacological reports : PR 20050101

• Zoledronic acid to prevent skeletal complications in cancer: corroborating the evidence.

  Cancer treatment reviews 20050101

• Hypercalcemia and local production of parathyroid hormone-related protein by a perisellar rhabdomyosarcoma after remote pituitary irradiation.

  Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20050101

• Impact of alendronate on quality of life in children with osteogenesis imperfecta.

  Journal of pediatric orthopedics 20050101

• Renal safety and efficacy of i.v. bisphosphonates in patients with skeletal metastases treated for up to 10 Years.

  The oncologist 20050101

• Unilateral anterior uveitis complicating zoledronic acid therapy in breast cancer.

  BMC cancer 20050101

• SAPHO syndrome treated with pamidronate.

  Indian journal of dermatology, venereology and leprology 20050101

• [Zoledronic acid and bone pathology in the course of neoplasia. Part I].

  Tumori 20050101

• Atypical cystic adenoma of the parathyroid gland: case report and review of literature.

  Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20050101

• The buzz about bisphosphonates.

  LDA journal 20050101

• Cost analysis of secondary prophylaxis with oral clodronate versus pamidronate in metastatic breast cancer patients.

  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20041201

• Biochemical effects from treatment with bisphosphonate and surgery in patients with primary hyperparathyroidism.

  World journal of surgery 20041201

• Clinimetric evaluation of the bath ankylosing spondylitis metrology index in a controlled trial of pamidronate therapy.

  The Journal of rheumatology 20041201

• The role of bisphosphonates in breast cancer.

  Breast (Edinburgh, Scotland) 20041201

• Optimizing bisphosphonate therapy in patients with breast cancer on endocrine therapy.

  Seminars in oncology 20041201

• [Ankylosing spondylitis].

  Presse medicale (Paris, France : 1983) 20041120

• Effect of a bisphosphonate, disodium pamidronate, on the quasi-static flexural properties of Palacos R acrylic bone cement.

  Journal of biomedical materials research. Part B, Applied biomaterials 20041115

• [Gaucher disease with multiple bone necrosis treated by enzyme replacement therapy and pamidronate].

  Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 20041110

• Pamidronate used to attenuate post-renal transplant bone loss is not associated with renal dysfunction.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20041101

• Intravenous pamidronate prevents femoral bone loss and renal stone formation during 90-day bed rest.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20041101

• Delayed osteotomy but not fracture healing in pediatric osteogenesis imperfecta patients receiving pamidronate.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20041101

• Steroid-free medium discloses oestrogenic effects of the bisphosphonate clodronate on breast cancer cells.

  British journal of cancer 20041101

• Pain from myelofibrosis treated with regular pamidronate.

  British journal of haematology 20041101

• Treatment of bone disease in cystic fibrosis.

  Current opinion in pulmonary medicine 20041101

• Intravenous pamidronate treatment of children under 36 months of age with osteogenesis imperfecta.

  Bone 20041101

• [Pamidronate in treatment of pain caused by bone metastasis].

  Ai zheng = Aizheng = Chinese journal of cancer 20041101

• Pamidronate treatment of less severe forms of osteogenesis imperfecta in children.

  Journal of pediatric endocrinology & metabolism : JPEM 20041101

• Radiological features of bisphosphonate therapy in children with osteogenesis imperfecta.

  Saudi medical journal 20041101

• Pamidronate in the treatment of childhood SAPHO syndrome.

  Rheumatology (Oxford, England) 20041001

• Neonatal severe hyperparathyroidism: genotype/phenotype correlation and the use of pamidronate as rescue therapy.

  European journal of pediatrics 20041001

• Osteoclast-targeted therapy for prostate cancer.

  Current treatment options in oncology 20041001

• Maternal and fetal outcome after long-term pamidronate treatment before conception: a report of two cases.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20041001

• Severe infantile hypercalcemia associated with Williams syndrome successfully treated with intravenously administered pamidronate.

  Pediatrics 20041001

• Pamidronate increases bone mineral density in women with postmenopausal or steroid-induced osteoporosis.

  Journal of clinical pharmacy and therapeutics 20041001

• Bisphosphonates in the treatment of skeletal metastases.

  Seminars in oncology 20041001

• Profiling the safety and tolerability of bisphosphonates.

  Seminars in oncology 20041001

• Patient management issues in metastatic bone disease.

  Seminars in oncology 20041001

• Pathologic hepatic Tc-99m-MDP uptake in polyostotic fibrous dysplasia.

  Annals of nuclear medicine 20041001

• The farnesyl transferase inhibitor R115777 (Zarnestra) synergistically enhances growth inhibition and apoptosis induced on epidermoid cancer cells by Zoledronic acid (Zometa) and Pamidronate.

  Oncogene 20040909

• Paget's disease of bone.

  The Medical journal of Australia 20040906

• The purine transferase from Trypanosoma cruzi as a potential target for bisphosphonate-based chemotherapeutic compounds.

  Bioorganic & medicinal chemistry letters 20040906

• Risedronate and pamidronate treatment in the clinical management of patients with severe Paget's disease of bone and acquired resistance to bisphosphonates.

  Calcified tissue international 20040901

• Zoledronate in a patient with pamidronate refractory hypercalcemia syndrome.

  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20040901

• Differential inhibition of invasion and proliferation by bisphosphonates: anti-metastatic potential of Zoledronic acid in prostate cancer.

  European urology 20040901

• Comparison of the predicted in vivo behaviour of the Sn(II)-APDDMP complex and the results as studied in a rodent model.

  Journal of inorganic biochemistry 20040901

• Short term whole body retention in relation to rate of bone resorption and cartilage degradation after intravenous bisphosphonate (pamidronate) in rheumatoid arthritis.

  The Journal of rheumatology 20040901

• Bisphosphonates may reduce recurrence in giant cell tumor by inducing apoptosis.

  Clinical orthopaedics and related research 20040901

• Intravenous bisphosphonates and osteonecrosis.

  Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 20040901

• Efficacy of pamidronate in complex regional pain syndrome type I.

  Pain medicine (Malden, Mass.) 20040901

• In vitro toxicity of bisphosphonates on human neuroblastoma cell lines.

  Anti-cancer drugs 20040901

• Liver transplantation-associated hypercalcemia followed by acute renal dysfunction.

  Internal medicine (Tokyo, Japan) 20040901

• Nitrogen-containing bisphosphonates inhibit cell cycle progression in human melanoma cells.

  British journal of cancer 20040816

• Rapid improvement of calciphylaxis after intravenous pamidronate therapy in a patient with chronic renal failure.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20040801

• Hypertrophic pulmonary osteoarthropathy: control of pain and symptoms with pamidronate.

  Clinical rheumatology 20040801

• [Primary hyperparathyroidism in a patient with systemic lupus erythematosus].

  Arquivos brasileiros de endocrinologia e metabologia 20040801

• Bisphosphonates induce apoptosis of stromal tumor cells in giant cell tumor of bone.

  Calcified tissue international 20040701

• CD19 negative precursor B acute lymphoblastic leukemia presenting with hypercalcemia.

  Pediatric blood & cancer 20040701

• Sclerotic metaphyseal lines in a child treated with pamidronate: histomorphometric analysis.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20040701

• Chronic idiopathic hyperphosphatasia: normalization of bone turnover with cyclical intravenous pamidronate therapy.

  Bone 20040701

• Respiratory distress with pamidronate treatment in infants with severe osteogenesis imperfecta.

  Bone 20040701

• Treatment of fibrous dysplasia of bone with intravenous pamidronate: long-term effectiveness and evaluation of predictors of response to treatment.

  Bone 20040701

• Bone health in children and adolescents: a symposium at the annual meeting of the Pediatric Academic Societies/Lawson Wilkins Pediatric Endocrine Society, May 2003.

  Current problems in pediatric and adolescent health care 20040701

• The combination of pamidronate and calcitriol reverses particle- and TNF-alpha-induced altered functions of bone-marrow-derived stromal cells with osteoblastic phenotype.

  The Journal of bone and joint surgery. British volume 20040701

• Pamidronate treatment for hypercalcemia in an infant receiving parenteral nutrition.

  Pharmacotherapy 20040701

• Long-term control of hypercalcaemia in an infant with williams-Beuren syndrome after a single infusion of biphosphonate (Pamidronate).

  Acta paediatrica (Oslo, Norway : 1992) 20040701

• Systematic review of bisphosphonates for hypercalcaemia of malignancy.

  Palliative medicine 20040701

• Bisphosphonate infusions: patient preference, safety and clinic use.

  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20040601

• No difference between pamidronate disodium and placebo in relieving bone pain in men with advanced prostate cancer.

  Cancer treatment reviews 20040601

• Recognition of nonpeptide antigens by human V gamma 9V delta 2 T cells requires contact with cells of human origin.

  Clinical and experimental immunology 20040601

• The role of bisphosphonates in breast and prostate cancers.

  Endocrine-related cancer 20040601

• Duration of bisphosphonate treatment: results of a non-randomised study in patients previously treated with local irradiation for bone metastases from breast cancer.

  Current medical research and opinion 20040601

• By the way, doctor. My wife is 80. In order to increase her bone calcium, she takes calcium citrate tablets. Her doctor now wants to put her on Aredia by IV injection every three months. Since this is not FDA approved, is it a good idea?

  Harvard health letter 20040601

• Alendronate-induced auditory hallucinations and visual disturbances.

  Pharmacotherapy 20040601

• Second autologous transplantation for multiple myeloma patients relapsing after the first autograft -- a pilot study for the evaluation of experimental maintenance therapies. Report of the prospective non-randomized pilot study of the Czech Myeloma Group.

  Onkologie 20040601

• Anaplastic thyroid carcinoma with humoral hypercalcemia of malignancy (HHM): an autopsy case report.

  Endocrine journal 20040601

• Thymic squamous cell carcinoma producing parathyroid hormone-related protein and CYFRA 21-1.

  Internal medicine (Tokyo, Japan) 20040601

• Pamidronate, hypocalcemia, and calcium and vitamin D supplementation.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040515

• Surface immobilized bisphosphonate improves stainless-steel screw fixation in rats.

  Biomaterials 20040501

• SAPHO syndrome treated with pamidronate: an open-label study of 10 patients.

  Rheumatology (Oxford, England) 20040501

• Treatment of idiopathic hyperphosphatasia with intensive bisphosphonate therapy.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20040501

• Using pamidronate for osteoporosis.

  The Journal of pediatrics 20040501

• [Effective weekly paclitaxel therapy for massive metastatic breast cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20040501

• New generation of bisphosphonates: broad clinical utility in breast and prostate cancer.

  Oncology (Williston Park, N.Y.) 20040501

• [Treatment of bone disease in chronic kidney disease and in renal transplant recipients under K/DOQI clinical practice guidelines].

  Clinical calcium 20040501

• Effect of pamidronate on new vertebral fractures and bone mineral density in patients with malignant lymphoma receiving chemotherapy.

  The American journal of medicine 20040415

• Cytostatic and apoptotic effects of bisphosphonates on prostate cancer cells.

  European urology 20040401

• A randomized clinical trial comparing oral alendronate and intravenous pamidronate for the treatment of Paget's disease of bone.

  Bone 20040401

• Intravenous pamidronate in the treatment and prevention of osteoporosis.

  Internal medicine journal 20040401

• Serum syndecan-1, basic fibroblast growth factor and osteoprotegerin in myeloma patients at diagnosis and during the course of the disease.

  European journal of haematology 20040401

• Oral ibandronate reduces the risk of skeletal complications in breast cancer patients with metastatic bone disease: results from two randomised, placebo-controlled phase III studies.

  British journal of cancer 20040322

• Vitamin D intoxication and hypercalcaemia in an infant treated with pamidronate infusions.

  European journal of pediatrics 20040301

• Collapsing glomerulopathy induced by long-term treatment with standard-dose pamidronate in a myeloma patient.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20040301

• Intravenous pamidronate treatment in children with moderate to severe osteogenesis imperfecta: assessment of indices of dual-energy X-ray absorptiometry and bone metabolic markers during the first year of therapy.

  Bone 20040301

• Determination of pamidronate in human whole blood and urine by reversed-phase HPLC with fluorescence detection.

  Biomedical chromatography : BMC 20040301

• Home care versus hospital care in patients with multiple myeloma treated with pamidronate.

  International journal of palliative nursing 20040301

• Microencapsulation of hydrophilic drug substances using biodegradable polyesters. Part II: Implants allowing controlled drug release--a feasibility study using bisphosphonates.

  Journal of microencapsulation 20040301

• Podocyte injury associated glomerulopathies induced by pamidronate.

  Kidney international 20040201

• Treatment of monostotic fibrous dysplasia with pamidronate.

  Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery 20040201

• Health-related quality of life among patients with breast cancer receiving zoledronic acid or pamidronate disodium for metastatic bone lesions.

  Medical care 20040201

• The Zn2+ salt of pamidronate: a role for water in the metal-cation binding properties of bisphosphonates.

  Acta crystallographica. Section C, Crystal structure communications 20040201

• [Bisphosphonate as an adjuvant therapy for the pain of bone metastases, 3 cases].

  Gan to kagaku ryoho. Cancer & chemotherapy 20040201

• Effectiveness of pretreatment in decreasing adverse events associated with pamidronate in children and adolescents.

  Pharmacotherapy 20040201

• [Bisphosphonates in malignant hypercalcemia and bone pain].

  Revue medicale de la Suisse romande 20040201

• Dynamic contrast enhanced magnetic resonance imaging in monitoring bone metastases in breast cancer patients receiving bisphosphonates and endocrine therapy.

  Acta radiologica (Stockholm, Sweden : 1987) 20040201

• Quantitative structure-activity relationships for gammadelta T cell activation by bisphosphonates.

  Journal of medicinal chemistry 20040115

• Effect of bisphosphonate treatment in patients with Paget's disease of the skull.

  Rheumatology (Oxford, England) 20040101

• Utilization of palliative radiotherapy for breast cancer patients with bone metastases treated with bisphosphonates-Toronto Sunnybrook Regional Cancer Centre experience.

  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20040101

• Role of bisphosphonates in prostate cancer.

  European urology 20040101

• Effect of pamidronate treatment on vertebral deformity in children with primary osteoporosis. A pilot study using radiographic morphometry.

  Hormone research 20040101

• Zoledronic acid is superior to pamidronate for the treatment of bone metastases in breast carcinoma patients with at least one osteolytic lesion.

  Cancer 20040101

• Effects of bisphosphonates on the growth of Entamoeba histolytica and Plasmodium species in vitro and in vivo.

  Journal of medicinal chemistry 20040101

• Diplopia following intravenous administration of pamidronate.

  Eye (London, England) 20040101

• Management of osteoporosis in adults with cystic fibrosis.

  Drugs 20040101

• Hypercalcemia in patients with disseminated coccidioidomycosis.

  The American journal of the medical sciences 20040101

• Hypercalcemia of malignancy.

  Seminars in nephrology 20040101

• Electrolyte disturbances and cardiac arrhythmias in a dog following pamidronate, calcitonin, and furosemide administration for hypercalcemia of malignancy.

  Journal of the American Animal Hospital Association 20040101

• Tests for multivariate recurrent events in the presence of a terminal event.

  Biostatistics (Oxford, England) 20040101

• A systematic review of the role of bisphosphonates in metastatic disease.

  Health technology assessment (Winchester, England) 20040101

• Pamidronate-induced nephrotoxic tubular necrosis--a case report.

  Clinical nephrology 20040101

• [Clinical observation on effect of combined therapy of pamidronati sodium and shenfu injection in treating multiple myeloma caused ostealgia].

  Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine 20040101

• Systemic lupus erythematosus presenting as acute symptomatic hypercalcemia.

  Lupus 20040101

• Extensive calcinosis cutis in relapsed acute lymphoblastic leukaemia.

  Annals of the Academy of Medicine, Singapore 20040101

• Zoledronic acid: a review of its use in patients with advanced cancer.

  Drugs 20040101

• Safety and convenience of a 15-minute infusion of zoledronic acid.

  The oncologist 20040101

• Do physicians follow systemic treatment and funding policy guidelines?

  The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique 20040101

• [Treatment of multiple myeloma with intravenous pamidronate. Pain prevention and suppression of hypercalcemia risk].

  Medicina 20040101

• Syndromes with congenital brittle bones.

  BMC pediatrics 20040101

• Oral alendronate treatment for polyostotic fibrous dysplasia: a case report.

  Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association 20040101

• Bisphosphonates: clinical experience.

  The oncologist 20040101

• Safety of intravenous and oral bisphosphonates and compliance with dosing regimens.

  The oncologist 20040101

• Toward new horizons: the future of bisphosphonate therapy.

  The oncologist 20040101

• Bisphosphonates for the treatment of Charcot neuroarthropathy.

  The Journal of foot and ankle surgery : official publication of the American College of Foot and Ankle Surgeons 20040101

• Pamidronate resistance and associated low ras levels in breast cancer cells: a role for combinatorial therapy.

  Annals of clinical and laboratory science 20040101

• Calcium and vitamin D supplementation during bisphosphonate administration may increase osteoclastic activity in patients with bone metastasis.

  Medical hypotheses 20040101

• Pamidronate treatment in acute vitamin D intoxication.

  Journal of endocrinological investigation 20040101

• Safety of long-term administration of bisphosphonates in elderly cancer patients.

  Oncology 20040101

• Inhibition of bone metastasis from breast cancer with pamidronate resulting in reduction of urinary pyridinoline and deoxypyridinoline in a rat model.

  Breast cancer (Tokyo, Japan) 20040101

• [Pharmacotherapy for spondyloarthropathies].

  Reumatizam 20040101

• [Osteogenesis imperfecta as an interdisciplinary medical problem].

  Chirurgia narzadow ruchu i ortopedia polska 20040101

• Treating cancer-related hypercalcemia with gallium nitrate.

  The journal of supportive oncology 20040101

• The clinical and radiological assessment of cyclic intravenous pamidronate administration in children with osteogenesis imperfecta.

  The Turkish journal of pediatrics 20040101

• Higher farnesyl diphosphate synthase activity in human colorectal cancer inhibition of cellular apoptosis.

  Oncology 20040101

• [Metabolic emergencies in the oncology patient].

  Anales del sistema sanitario de Navarra 20040101

• [AIOM Conference 2004. Endocrine therapy and management of patients with bone metastasis of breast cancer].

  Tumori 20040101

• [Cyclic intravenous pamidronate in treatment of osteoporosis].

  Medicinski pregled 20040101

• Hypercalcemia and gallium nitrate.

  The journal of supportive oncology 20040101

• The role of pamidronate in pediatric patients with severe osteogenesis imperfecta.

  The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG 20040101

• [Essential osteolysis].

  Praxis 20031217

• [How to treat tumor-induced hypercalcemia].

  La Revue du praticien 20031215

• Low estrogen and high parathyroid hormone-related peptide levels contribute to accelerated bone resorption and bone loss in lactating mice.

  Endocrinology 20031201

• Combined analysis of two multicenter, randomized, placebo-controlled studies of pamidronate disodium for the palliation of bone pain in men with metastatic prostate cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20031201

• Bisphosphonates for men with prostate cancer: sifting through the rubble.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20031201

• Use of a retrograde femoral nail in a patient with McCune-Albright syndrome.

  ANZ journal of surgery 20031201

• Bone resorption predicts for skeletal complications in metastatic bone disease.

  British journal of cancer 20031201

• A randomized controlled trial of calcium with vitamin D, alone or in combination with intravenous pamidronate, for the treatment of low bone mineral density associated with Crohn's disease.

  Alimentary pharmacology & therapeutics 20031201

• Acute effect of pamidronate on PTH secretion in postmenopausal hemodialysis patients with secondary hyperparathyroidism.

  American journal of kidney diseases : the official journal of the National Kidney Foundation 20031201

• Patterns of pain in Paget's disease of bone and their outcomes on treatment with pamidronate.

  Clinical rheumatology 20031201

• [Therapy of osteoporosis: bisphosphonates, SERM's, teriparatide and strontium].

  Zeitschrift fur Rheumatologie 20031201

• Treatment strategies for myeloma bone disease.

  Oncology (Williston Park, N.Y.) 20031201

• Bisphosphonates and avascular necrosis of the jaws.

  Australian dental journal 20031201

• A single bisphosphonate infusion is associated with improved functional capacity in elderly subjects with primary hyperparathyroidism.

  Aging clinical and experimental research 20031201

• [Osteoporosis in osteogenesis imperfecta].

  Clinical calcium 20031201

• Low-dose thalidomide plus monthly high-dose oral dexamethasone (Thali-Dexa): results, prognostic factors and side effects in eight patients previously treated with multiple myeloma.

  Journal of experimental & clinical cancer research : CR 20031201

• 3-D QSAR investigations of the inhibition of Leishmania major farnesyl pyrophosphate synthase by bisphosphonates.

  Journal of medicinal chemistry 20031120

• Bisphosphonates in children with bone diseases.

  The New England journal of medicine 20031120

• Bisphosphonates in children with bone diseases.

  The New England journal of medicine 20031120

• Properties of bisphosphonates in the 13762 rat mammary carcinoma model of tumor-induced bone resorption.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20031115

• Follow-up of collagen crosslink excretion in patients with oral squamous cell carcinoma and analysis of tissue samples.

  British journal of cancer 20031103

• American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20031101

• Systemic depletion of macrophages by liposomal bisphosphonates reduces neointimal formation following balloon-injury in the rat carotid artery.

  Journal of cardiovascular pharmacology 20031101

• Pamidronate is an effective treatment for osteoporosis in patients with beta-thalassaemia.

  British journal of haematology 20031101

• Differentiating the mechanisms of antiresorptive action of nitrogen containing bisphosphonates.

  Bone 20031101

• Bisphosphonate therapy in the oncology setting.

  Expert opinion on emerging drugs 20031101

• Zoledronic acid: a new parenteral bisphosphonate.

  Clinical therapeutics 20031101

• Conditional expression of exogenous Bcl-X(S) triggers apoptosis in human melanoma cells in vitro and delays growth of melanoma xenografts.

  FEBS letters 20031023

• Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma: a randomized, double-blind, multicenter, comparative trial.

  Cancer 20031015

• [Prospective study of pamidronate disodium in treatment of Paget's disease of bone].

  Zhonghua yi xue za zhi 20031010

• Effect of pamidronate on excretion of pyridinium crosslinks of collagen after total hip arthroplasty.

  Calcified tissue international 20031001

• Medical treatment of vertebral osteoporosis.

  European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society 20031001

• Radiographic long bone appearance in a child administered cyclical pamidronate.

  Archives of disease in childhood 20031001

• Prevention of bone loss in renal transplant recipients: a prospective, randomized trial of intravenous pamidronate.

  Journal of the American Society of Nephrology : JASN 20031001

• The bisphosphonate pamidronate is a potent inhibitor of Ewing's sarcoma cell growth in vitro.

  Anti-cancer drugs 20031001

• Long-term analgesic effect of clodronate in rodents.

  Bone 20031001

• Effect of intravenous pamidronate on bone markers and local bone mineral density in fibrous dysplasia.

  Bone 20031001

• Effect of pamidronate treatment in children with polyostotic fibrous dysplasia of bone.

  The Journal of clinical endocrinology and metabolism 20031001

• Avascular necrosis of the jaws: risk factors in metastatic cancer patients.

  Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20031001

• PMMA to stabilize bone and deliver antineoplastic and antiresorptive agents.

  Clinical orthopaedics and related research 20031001

• Zoledronic acid for the treatment of bone metastases in patients with breast cancer and other solid tumors.

  Seminars in oncology 20031001

• Successful management of severe facial pain in patients with diffuse sclerosing osteomyelitis (DSO) of the mandible using disodium clodronate.

  International journal of oral and maxillofacial surgery 20031001

• Regulation of MMP-9 (gelatinase B) in activated human monocyte/macrophages by two different types of bisphosphonates.

  Life sciences 20030926

• The third-generation bisphosphonate zoledronate synergistically augments the anti-Ph+ leukemia activity of imatinib mesylate.

  Blood 20030915

• Bisphosphonates in prostate cancer: where are we and where should we go?

  Journal of the National Cancer Institute 20030903

• Tartrate-resistant acid phosphatase isoform 5b: a novel serum marker for monitoring bone disease in multiple myeloma.

  International journal of cancer 20030901

• Radiotherapy in conjunction with intravenous infusion of 180 mg of disodium pamidronate in management of osteolytic metastases from breast cancer: clinical evaluation, biochemical markers, quality of life, and monitoring of recalcification using assessments of gray-level histogram in plain radiographs.

  International journal of radiation oncology, biology, physics 20030901

• Cellular mechanism of inhibition of osteoclastic resorption of bone and calcified cartilage by long-term pamidronate administration in ovariectomized mature rats.

  The anatomical record. Part A, Discoveries in molecular, cellular, and evolutionary biology 20030901

• Osteoporosis and prostate cancer.

  British journal of cancer 20030901

• Orbital inflammatory disease after pamidronate treatment for metastatic prostate cancer.

  Archives of ophthalmology (Chicago, Ill. : 1960) 20030901

• Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic.

  Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 20030901

• Effects of high dose IV pamidronate on disease activity and bone metabolism in patients with active RA: a randomized, double-blind, placebo-controlled trial.

  The Journal of rheumatology 20030901

• Increased bone remodeling due to ovariectomy dramatically increases tumoral growth in the 5T2 multiple myeloma mouse model.

  Bone 20030901

• The use of zoledronic acid in the management of metastatic bone disease and hypercalcaemia.

  Palliative medicine 20030901

• Pamidronate reduces skeletal events but does not improve progression-free survival in early-stage untreated myeloma: results of a randomized trial.

  Leukemia & lymphoma 20030901

• Pamidronate for early-stage, untreated myeloma.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030815

• Efficacy and safety of ibandronate in the treatment of hypercalcemia of malignancy: a randomized multicentric comparison to pamidronate.

  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20030801

• Treatment of active ankylosing spondylitis with pamidronate.

  Rheumatology (Oxford, England) 20030801

• Isolated adrenocorticotropic hormone deficiency presenting with hypercalcemia in a patient on long-term hemodialysis.

  American journal of kidney diseases : the official journal of the National Kidney Foundation 20030801

• Bisphosphonate resistance in Paget's disease of bone.

  Arthritis and rheumatism 20030801

• New therapies for ankylosing spondylitis: etanercept, thalidomide, and pamidronate.

  Rheumatic diseases clinics of North America 20030801

• Cancer patients with bone complications prefer infusion of zoledronic acid.

  Oncology (Williston Park, N.Y.) 20030801

• Effects of Seocalcitol (EB1089) on nitrosomethyl urea-induced rat mammary tumors.

  Breast cancer research and treatment 20030801

• Proven efficacy of zoledronic acid in the treatment of bone metastases in patients with breast cancer and other malignancies.

  Breast (Edinburgh, Scotland) 20030801

• Rationale for the use of bisphosphonates in osteoblastic and osteolytic bone lesions.

  Breast (Edinburgh, Scotland) 20030801

• Injectable bisphosphonates in the treatment of postmenopausal osteoporosis.

  Aging clinical and experimental research 20030801

• Bisphosphonate-induced osteopetrosis.

  The New England journal of medicine 20030731

• Bisphosphonates antagonise bone growth factors' effects on human breast cancer cells survival.

  British journal of cancer 20030707

• A quantitative structure-activity relationship and pharmacophore modeling investigation of aryl-X and heterocyclic bisphosphonates as bone resorption agents.

  Journal of medicinal chemistry 20030703

• Gammadelta T cells for immune therapy of patients with lymphoid malignancies.

  Blood 20030701

• Three-year effectiveness of intravenous pamidronate versus pamidronate plus slow-release sodium fluoride for postmenopausal osteoporosis.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20030701

• Pamidronate in a girl with chronic renal insufficiency dependent on parenteral nutrition.

  Pediatric nephrology (Berlin, Germany) 20030701

• Toxic acute tubular necrosis following treatment with zoledronate (Zometa).

  Kidney international 20030701

• Nitrogen containing bisphosphonates induce apoptosis and inhibit the mevalonate pathway, impairing Ras membrane localization in prostate cancer cells.

  The Journal of urology 20030701

• An intra-patient dose-escalation study of disodium pamidronate plus radiotherapy versus radiotherapy alone for the treatment of osteolytic metastases. Monitoring of recalcification using image-processing techniques.

  Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20030701

• The use of subcutaneous pamidronate.

  Journal of pain and symptom management 20030701

• Treatment of chronic mechanical spinal pain with intravenous pamidronate: a review of medical records.

  Journal of pain and symptom management 20030701

• Approval summary for zoledronic acid for treatment of multiple myeloma and cancer bone metastases.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20030701

• Precocious puberty: McCune-Albright syndrome and beyond.

  The Journal of pediatrics 20030701

• Zoledronic acid induces antiproliferative and apoptotic effects in human pancreatic cancer cells in vitro.

  British journal of cancer 20030616

• Osseous fragility in Marshall-Smith syndrome.

  American journal of medical genetics. Part A 20030601

• Usefulness of pamidronate in severe secondary hyperparathyroidism in patients undergoing hemodialysis.

  Kidney international. Supplement 20030601

• Long-term effects on bone mineral density of pamidronate given at the time of renal transplantation.

  Kidney international 20030601

• Palliative care in a national cancer center: results in 1987 vs. 1993 vs. 2000.

  Journal of pain and symptom management 20030601

• Management of treatment-related osteoporosis in men with prostate cancer.

  Cancer treatment reviews 20030601

• [Malignancy-associated hypercalcemia].

  Nihon rinsho. Japanese journal of clinical medicine 20030601

• Late-onset spondyloarthropathy mimicking reflex sympathetic dystrophy syndrome.

  Joint, bone, spine : revue du rhumatisme 20030601

• New insights into the actions of bisphosphonate zoledronic acid in breast cancer cells by dual RhoA-dependent and -independent effects.

  British journal of cancer 20030519

• Farnesyl pyrophosphate synthase is an essential enzyme in Trypanosoma brucei. In vitro RNA interference and in vivo inhibition studies.

  The Journal of biological chemistry 20030509

• Calcium-free hemodialysis for hypercalcemia of malignancy in a newborn.

  Pediatric nephrology (Berlin, Germany) 20030501

• Biochemical markers of bone turnover and development of heterotopic ossification after total hip arthroplasty.

  Journal of orthopaedic research : official publication of the Orthopaedic Research Society 20030501

• Maternal inheritance of diabetes is associated with inactive ALDH2 genotype in diabetics with renal failure in Japanese.

  Diabetes research and clinical practice 20030501

• Comment on systemic mastocytosis study.

  British journal of haematology 20030501

• Height and weight development during four years of therapy with cyclical intravenous pamidronate in children and adolescents with osteogenesis imperfecta types I, III, and IV.

  Pediatrics 20030501

• Rapid increase in grip force after start of pamidronate therapy in children and adolescents with severe osteogenesis imperfecta.

  Pediatrics 20030501

• Therapeutic benefit of bisphosphonates in the management of prostate cancer-related bone disease.

  Expert opinion on pharmacotherapy 20030501

• Short-term, high-dose pamidronate-induced acute tubular necrosis: the postulated mechanisms of bisphosphonate nephrotoxicity.

  American journal of kidney diseases : the official journal of the National Kidney Foundation 20030501

• Bisphosphonate treatment of osteoporosis.

  Clinics in geriatric medicine 20030501

• Clodronate in the management of breast cancer and multiple myeloma.

  Ortopedia, traumatologia, rehabilitacja 20030430

• Preliminary results of combined application of radioisotopes and biphosphonates in the management of pain associated with osteoblastic-osteolytic bone metastases of breast cancer.

  Ortopedia, traumatologia, rehabilitacja 20030430

• Role of RANKL-induced osteoclast formation and MMP-dependent matrix degradation in bone destruction by breast cancer metastasis.

  British journal of cancer 20030422

• Severe hypocalcemia after intravenous bisphosphonate therapy in occult vitamin D deficiency.

  The New England journal of medicine 20030410

• Collagen crosslink excretion and staging of oral cancer.

  British journal of cancer 20030407

• Bone metastases in breast cancer.

  Current treatment options in oncology 20030401

• Pamidronate prevents the development of skeletal metastasis in nude mice transplanted with human breast cancer cells by reducing tumor burden within bone.

  International journal of oncology 20030401

• Pamidronate-induced tubulointerstitial nephritis with Fanconi syndrome in a patient with primary hyperparathyroidism.

  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20030401

• Requirement of species-specific interactions for the activation of human gamma delta T cells by pamidronate.

  Journal of immunology (Baltimore, Md. : 1950) 20030401

• Signet ring-like light chain myeloma with systemic spread.

  European journal of haematology 20030401

• Zoledronic acid: an advance in tumour bone disease therapy and a new hope for osteoporosis.

  Expert opinion on pharmacotherapy 20030401

• Bone mass, size, and density in children and adolescents with osteogenesis imperfecta: effect of intravenous pamidronate therapy.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20030401

• The renal clearance of free and peptide-bound deoxypyridinoline: response to pamidronate treatment of Paget's disease.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20030401

• [Regression of an uveal metastatic tumor from breast cancer during chemotherapy--a case report].

  Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 20030401

• Osteoporosis after liver transplantation.

  Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20030401

• Combination of a 1,25-dihydroxyvitamin D3 analog and a bisphosphonate prevents experimental autoimmune encephalomyelitis and preserves bone.

  Bone 20030401

• Radiographic features of bisphosphonate therapy in pediatric patients.

  Pediatric radiology 20030401

• Treatment of symptomatic pediatric osteoporosis with cyclic single-day intravenous pamidronate infusions.

  The Journal of pediatrics 20030401

• Treatment of tumor-induced hypercalcemia: a solved problem?

  Expert review of anticancer therapy 20030401

• Mandible and maxilla bone mineral density and threshold analysis studies by pQCT in two edentulous women receiving pamidronate.

  Cranio : the journal of craniomandibular practice 20030401

• Treatment of acute lymphoblastic leukemia-induced extreme hypercalcemia with pamidronate and calcitonin.

  Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies 20030401

• Treatment of cancer-related hypercalcemia: the role of gallium nitrate.

  Seminars in oncology 20030401

• The role of bisphosphonates in breast cancer.

  Journal of the National Comprehensive Cancer Network : JNCCN 20030401

• Modern approach to children with osteogenesis imperfecta.

  Journal of pediatric orthopedics. Part B 20030301

• Use of bisphosphonate therapy for osteoporosis in childhood and adolescence.

  Journal of paediatrics and child health 20030301

• Hypercalcemia due to sun exposure in a patient with multiple myeloma and elevated parathyroid hormone-related protein.

  European journal of endocrinology 20030301

• Intravenous bisphosphonate therapy in children with osteogenesis imperfecta.

  Pediatrics 20030301

• Pamidronate for SAPHO syndrome.

  Rheumatology (Oxford, England) 20030301

• Improvement of bone in patients with osteogenesis imperfecta treated with pamidronate-lessons from biochemistry.

  The Journal of clinical endocrinology and metabolism 20030301

• Osteogenesis imperfecta types I, III, and IV: effect of pamidronate therapy on bone and mineral metabolism.

  The Journal of clinical endocrinology and metabolism 20030301

• Collapsing glomerulopathy.

  Seminars in nephrology 20030301

• Bisphosphonate treatment of benign multifocal and unifocal osteolytic tumours of bone.

  Sarcoma 20030301

• Response to alendronate in osteoporotic women previously treated with pamidronate.

  Maturitas 20030225

• The effect of intravenous pamidronate on bone mineral density, bone histomorphometry, and parameters of bone turnover in adults with type IA osteogenesis imperfecta.

  Calcified tissue international 20030201

• Diagnosis and management of treatment-related osteoporosis in men with prostate carcinoma.

  Cancer 20030201

• Mechanisms of osteolytic bone metastases in breast carcinoma.

  Cancer 20030201

• Antitumor effects of bisphosphonates.

  Cancer 20030201

• Bisphosphonates and metastatic breast carcinoma.

  Cancer 20030201

• Bisphosphonate therapy for patients with breast carcinoma.

  Cancer 20030201

• Effectiveness and cost of bisphosphonate therapy in tumor bone disease.

  Cancer 20030201

• A phase I study of AMGN-0007, a recombinant osteoprotegerin construct, in patients with multiple myeloma or breast carcinoma related bone metastases.

  Cancer 20030201

• Scleritis and other ocular side effects associated with pamidronate disodium.

  American journal of ophthalmology 20030201

• A six-month randomized, controlled, double-blind, dose-response comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of nonsteroidal antiinflammatory drug-refractory ankylosing spondylitis: comment on the article by Maksymowych et al.

  Arthritis and rheumatism 20030201

• Hypocalcemia following pamidronate administration for bone metastases of solid tumor: three clinical case reports.

  Journal of pain and symptom management 20030201

• The treatment of ankylosing spondylitis.

  Clinical and experimental medicine 20030201

• Maintenance with pamidronate following first-line MP or VAD therapy in multiple myeloma.

  Leukemia & lymphoma 20030201

• Staying in bed to benefit ESA's astronauts and Europe's citizens.

  ESA bulletin. Bulletin ASE. European Space Agency 20030201

• [Bisphosphonate for GnRH therapy].

  Clinical calcium 20030201

• [Uterine and ovarian metastases 28 years after the discovery of breast cancer].

  Presse medicale (Paris, France : 1983) 20030118

• Investigation of bone disease using isomerized and racemized fragments of type I collagen.

  Calcified tissue international 20030101

• Effect of pamidronate on the stimulation of macrophage TNF-alpha release by ultra-high-molecular-weight polyethylene particles: a role for apoptosis.

  Journal of orthopaedic research : official publication of the Orthopaedic Research Society 20030101

• Intravenous neridronate in adults with osteogenesis imperfecta.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20030101

• Recent progress in ankylosing spondylitis treatment.

  Expert opinion on pharmacotherapy 20030101

• Clinical efficacy of bisphosphonate therapy for bone metastasis from breast cancer.

  Breast cancer (Tokyo, Japan) 20030101

• Prevention of bone metastases from breast cancer by adjuvant bisphosphonate therapy.

  Breast cancer (Tokyo, Japan) 20030101

• Use of bisphosphonates in patients with myeloma and renal failure.

  Mayo Clinic proceedings 20030101

• Zoledronic acid: a review of its use in the management of bone metastases and hypercalcaemia of malignancy.

  Drugs 20030101

• Better late than never? Experience with intravenous pamidronate treatment in patients with low bone mass or fractures following cardiac or liver transplantation.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20030101

• Changes in serum HDL and LDL cholesterol in patients with Paget's bone disease treated with pamidronate.

  Bone 20030101

• Bone density changes in Paget's disease 2 years after iv pamidronate: profound, sustained increases in pagetic bone with severity-related loss in forearm nonpagetic cortical bone.

  Bone 20030101

• The diagnosis and management of hypercalcaemia.

  Annals of the Academy of Medicine, Singapore 20030101

• Pamidronate is superior to ibandronate in decreasing bone resorption, interleukin-6 and beta 2-microglobulin in multiple myeloma.

  European journal of haematology 20030101

• A comparative study of samarium-153-ethylenediaminetetramethylene phosphonic acid with pamidronate disodium in the treatment of patients with painful metastatic bone cancer.

  Medical principles and practice : international journal of the Kuwait University, Health Science Centre 20030101

• Cost-effectiveness of a transplantation strategy compared to melphalan and prednisone in younger patients with multiple myeloma.

  Leukemia & lymphoma 20030101

• Bone histology at autopsy and matched bone scintigraphy findings in patients with hormone refractory prostate cancer: the effect of bisphosphonate therapy on bone scintigraphy results.

  Clinical & experimental metastasis 20030101

• Drugs in development: bisphosphonates and metalloproteinase inhibitors.

  Arthritis research & therapy 20030101

• Bisphosphonates, a new treatment for glucocorticoid-induced osteoporosis in children.

  Journal of pediatric endocrinology & metabolism : JPEM 20030101

• Clinical and economic issues in the treatment of advanced breast cancer with bisphosphonates.

  Drugs & aging 20030101

• Microencapsulation of hydrophilic drug substances using biodegradable polyesters. Part I: evaluation of different techniques for the encapsulation of pamidronate di-sodium salt.

  Journal of microencapsulation 20030101

• Breakthroughs in the management of multiple myeloma.

  Drugs 20030101

• Bisphosphonates in oncology: physiopathologic bases and clinical activity.

  Tumori 20030101

• Advances in supportive care of patients with cancer and bone metastases: nursing implications of zoledronic acid.

  Clinical journal of oncology nursing 20030101

• The role of osteoprotegerin in arthritis.

  Arthritis research & therapy 20030101

• Low-dose intravenous pamidronate reduces fractures in childhood osteoporosis.

  Journal of pediatric endocrinology & metabolism : JPEM 20030101

• New insights into the molecular mechanisms of action of bisphosphonates.

  Current pharmaceutical design 20030101

• Lack of efficacy of the combination of pamidronate and vitamin D on regression of prostate cancer in the Dunning rat model.

  Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer 20030101

• Symptomatic and scintigraphic improvement after intravenous pamidronate treatment of Paget's disease of bone in patients with normal serum alkaline phosphatase levels.

  Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20030101

• Cytochemical and ultrastructural changes in the osteoclast-like giant cells of giant cell tumor of bone following bisphosphonate administration.

  Ultrastructural pathology 20030101

• Perspective study on pamidronate in stage I multiple myeloma.

  The hematology journal : the official journal of the European Haematology Association 20030101

• Clodronate as a single-dose intravenous infusion effectively provides short-term correction of malignant hypercalcemia.

  Acta oncologica (Stockholm, Sweden) 20030101

• Persistent elevated serum levels of intact parathyroid hormone after reoperation for primary hyperparathyroidism and after pamidronate therapy.

  The Turkish journal of pediatrics 20030101

• Posterior uveitis: an under-recognized adverse effect of pamidronate: 2 case reports.

  Bulletin de la Societe belge d'ophtalmologie 20030101

• [Efficacy and feasibility evaluation in long term pamidronate treatment of bone metastases].

  Przeglad lekarski 20030101

• Current management strategies for hypercalcemia.

  Treatments in endocrinology 20030101

• Cyclosporine A-induced hypercalciuria in calbindin-D28k knockout and wild-type mice.

  Kidney international 20021201

• Intravenous pamidronate in treatment of non-steroidal anti-inflammatory drug-refractory ankylosing spondylitis.

  Current rheumatology reports 20021201

• Osteogenesis imperfecta and intravenous pamidronate.

  Archives of disease in childhood 20021201

• Disease modifying and anti-nociceptive effects of the bisphosphonate, zoledronic acid in a model of bone cancer pain.

  Pain 20021201

• The anti-tumour activity of bisphosphonates.

  Cancer treatment reviews 20021201

• New uses of bisphosphonates: osteogenesis imperfecta.

  Current opinion in pharmacology 20021201

• Atypical form of active melorheostosis and its treatment with bisphosphonate.

  Skeletal radiology 20021201

• Ribbing disease: radiographic and biochemical characterization, lack of response to pamidronate.

  Skeletal radiology 20021201

• [Treatment of hypercalcemia of malignancy with pamidronate in a patient with advanced recurrent oral cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20021201

• Advances in the biology and treatment of myeloma bone disease.

  Seminars in oncology 20021201

• Efficacy of bisphosphonates in the management of skeletal complications of bone metastases and selection of clinical endpoints.

  American journal of clinical oncology 20021201

• Broad clinical activity of zoledronic acid in osteolytic to osteoblastic bone lesions in patients with a broad range of solid tumors.

  American journal of clinical oncology 20021201

• Efficacy of zoledronic acid and pamidronate in breast cancer patients: a comparative analysis of randomized phase III trials.

  American journal of clinical oncology 20021201

• Future directions in the treatment and prevention of bone metastases.

  American journal of clinical oncology 20021201

• Immobilization hypercalcemia in critical illness following bariatric surgery.

  Obesity surgery 20021201

• Preclinical pharmacology of zoledronic acid.

  Seminars in oncology 20021201

• Treatment of hypercalcemia of malignancy with bisphosphonates.

  Seminars in oncology 20021201

• Bisphosphonates for the prevention of bone metastases.

  Seminars in oncology 20021201

• The osteodystrophy of mucolipidosis type III and the effects of intravenous pamidronate treatment.

  Journal of inherited metabolic disease 20021201

• Ten-Year Follow-Up of a Patient with Metastatic Ewing's Sarcoma of the Pelvis.

  Sarcoma 20021201

• Conventional treatments for ankylosing spondylitis.

  Annals of the rheumatic diseases 20021101

• Pamidronate causes apoptosis of plasma cells in vivo in patients with multiple myeloma.

  British journal of haematology 20021101

• Nephrotic proteinuria associated with high-dose pamidronate in multiple myeloma.

  British journal of haematology 20021101

• Bisphosphonates to treat osteopenia in children with quadriplegic cerebral palsy: a randomized, placebo-controlled clinical trial.

  The Journal of pediatrics 20021101

• Magnetic resonance imaging presentation of lytic Paget's disease of the cervical spine.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20021101

• Modeling the benefits of pamidronate in children with osteogenesis imperfecta.

  The Journal of clinical investigation 20021101

• The effects of intravenous pamidronate on the bone tissue of children and adolescents with osteogenesis imperfecta.

  The Journal of clinical investigation 20021101

• Megakaryoblastic transformation of polycythemia vera with hypercalcemia.

  Annals of hematology 20021101

• Pamidronate treatment of severe osteogenesis imperfecta in a newborn infant.

  Journal of inherited metabolic disease 20021101

• [Fibrous dysplasia: differential diagnosis from Paget's disease].

  Deutsche medizinische Wochenschrift (1946) 20021025

• Tumoral calcinosis inducing systemic inflammatory response in a hemodialysis patient.

  Nephron 20021001

• Effect of bisphosphonates on viability, proliferation, and dexamethasone-induced apoptosis of articular chondrocytes.

  Annals of the rheumatic diseases 20021001

• The antisteoporotic efficacy of intravenous pamidronate in men with prostate carcinoma receiving combined androgen blockade. A double blind, randomized, placebo-controlled crossover study.

  The Journal of urology 20021001

• The calcium-binding properties of pamidronate, a bone-resorption inhibitor.

  Acta crystallographica. Section C, Crystal structure communications 20021001

• Treatment of SAPHO with pamidronate.

  Rheumatology (Oxford, England) 20021001

• Zoledronic acid: new preparation. Just a me-too: no advance in hypercalcemia of malignancy.

  Prescrire international 20021001

• [Effects of pamidronate disodium (Bonin) combined with chemotherapy on bone pain in multiple myeloma].

  Hang tian yi xue yu yi xue gong cheng = Space medicine & medical engineering 20021001

• Effect of cyclical intravenous pamidronate therapy in children with osteogenesis imperfecta. Open-label study in seven patients.

  Joint, bone, spine : revue du rhumatisme 20021001

• Bisphosphonates for RSDS and prostate cancer--more benefit then revealed!

  Joint, bone, spine : revue du rhumatisme 20021001

• The interactions of bisphosphonates in solution and as coatings on hydroxyapatite with osteoblasts.

  Journal of materials science. Materials in medicine 20021001

• [Bisphosphonates in bone metastases. Fewer fractures, less pain].

  MMW Fortschritte der Medizin 20020926

• Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid.

  The Journal of pharmacology and experimental therapeutics 20020901

• Juvenile spondyloarthropathies and related arthritis.

  Current opinion in rheumatology 20020901

• American Society of Clinical Oncology clinical practice guidelines: the role of bisphosphonates in multiple myeloma.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020901

• Clodronate inhibits adrenocortical cell proliferation and P450c21 activity.

  The Journal of endocrinology 20020901

• Osteoporosis during androgen deprivation therapy for prostate cancer.

  Urology 20020901

• Pamidronate after heart transplantation.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20020901

• Palliative treatment of painful bone metastases from non-Hodgkin lymphoma with disodium pamidronate.

  Journal of experimental & clinical cancer research : CR 20020901

• Geraldine Ferraro. The fight of her life. Interview by Jo Cavallo.

  InTouch (Melville, N.Y.) 20020901

• Pamidronate treatment improves bone mineral density in children with Menkes disease.

  Journal of inherited metabolic disease 20020901

• Clinical evaluation of onset of analgesia using intravenous pamidronate in metastatic bone pain.

  Journal of pain and symptom management 20020901

• Intravenous pamidronate compared with oral alendronate for the treatment of postmenopausal osteoporosis.

  The Netherlands journal of medicine 20020901

• Highly potent geminal bisphosphonates. From pamidronate disodium (Aredia) to zoledronic acid (Zometa).

  Journal of medicinal chemistry 20020815

• Successful treatment of optic neuropathy in osteitis deformans.

  Rheumatology (Oxford, England) 20020801

• Bisphosphonates: biological response modifiers in breast cancer.

  Clinical breast cancer 20020801

• Bone turnover in children and adolescents with McCune-Albright syndrome treated with pamidronate for bone fibrous dysplasia.

  Calcified tissue international 20020801

• The bisphosphonate pamidronate induces apoptosis in human melanoma cells in vitro.

  British journal of cancer 20020729

• An investigation of bone resorption and Dictyostelium discoideum growth inhibition by bisphosphonate drugs.

  Journal of medicinal chemistry 20020704

• Activity of bisphosphonates against Trypanosoma brucei rhodesiense.

  Journal of medicinal chemistry 20020704

• Leptomeningeal relapse of multiple myeloma following allogeneic stem cell transplantation.

  Leukemia research 20020701

• Bone response to calcium phosphate-coated and bisphosphonate-immobilized titanium implants.

  Biomaterials 20020701

• Lack of effect of intravenous pamidronate on fracture incidence and bone mineral density after orthotopic liver transplantation.

  Journal of hepatology 20020701

• Pamidronate-associated nephrotoxicity in a patient with Langerhans's histiocytosis.

  American journal of kidney diseases : the official journal of the National Kidney Foundation 20020701

• Radical cure of experimental cutaneous leishmaniasis by the bisphosphonate pamidronate.

  The Journal of infectious diseases 20020701

• Pamidronate induces bone formation in patients with smouldering or indolent myeloma, with no significant anti-tumour effect.

  British journal of haematology 20020701

• Intravenous pamidronate in the treatment of transient osteoporosis of the hip.

  Bone 20020701

• Osteopenia in children with acute lymphoblastic leukemia: a pilot study of amelioration with Pamidronate.

  Medical and pediatric oncology 20020701

• Bisphosphonates for cancer patients: why, how, and when?

  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20020701

• Lack of effect of a bisphosphonate (pamidronate disodium) infusion on subsequent skeletal uptake of Sm-153 EDTMP.

  Clinical nuclear medicine 20020601

• Daily oral pamidronate in women and men with osteoporosis: a 3-year randomized placebo-controlled clinical trial with a 2-year open extension.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20020601

• Effects of a single infusion of pamidronate prior to liver transplantation: a bone histomorphometric study.

  Transplant international : official journal of the European Society for Organ Transplantation 20020601

• Synergistic growth inhibition of YM529 with biologic response modifiers (BRMs) in myeloma cells.

  International journal of hematology 20020601

• Bisphosphonates influence the proliferation and the maturation of normal human osteoblasts.

  Journal of endocrinological investigation 20020601

• Novel approaches to the management of bone metastases in patients with breast cancer.

  Seminars in oncology 20020601

• Pamidronate treatment in SAPHO syndrome.

  Joint, bone, spine : revue du rhumatisme 20020601

• Inhibitory action of bisphosphonates on bone resorption does not involve the regulation of RANKL and OPG expression.

  Experimental & molecular medicine 20020531

• Inhibition of geranylgeranyl diphosphate synthase by bisphosphonates and diphosphates: a potential route to new bone antiresorption and antiparasitic agents.

  Journal of medicinal chemistry 20020523

• Innate T cell immunity to HIV-infection. Immunotherapy with phosphocarbohydrates, a novel strategy of immune intervention?

  Vaccine 20020506

• The bisphosphonate zoledronic acid impairs Ras membrane [correction of impairs membrane] localisation and induces cytochrome c release in breast cancer cells.

  British journal of cancer 20020506

• Beneficial effect of long term intravenous bisphosphonate treatment of osteogenesis imperfecta.

  Archives of disease in childhood 20020501

• Nephrotic syndrome after treatment with pamidronate.

  American journal of kidney diseases : the official journal of the National Kidney Foundation 20020501

• Treatment of malignant hypercalcaemia.

  Expert opinion on pharmacotherapy 20020501

• Pamidronate induces modifications of circulating angiogenetic factors in cancer patients.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20020501

• Hypercalcemia induced by 13-cis-retinoic acid in a patient with neuroblastoma.

  Pharmacotherapy 20020501

• [A case of breast cancer with multiple bone metastases that responded remarkably to doxifluridine (5'-DFUR), cyclophosphamide (CPA), medroxyprogesterone acetate (MPA) and pamidronate disodium therapy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20020501

• Gastrointestinal pneumatosis after docetaxel chemotherapy.

  Journal of clinical gastroenterology 20020401

• Osteoporosis and bone marrow mastocytosis: dissociation of skeletal responses and mast cell activity during long-term bisphosphonate therapy.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20020401

• Synthesis, characterization and biodistribution of bisphosphonates Sm-153 complexes: correlation with molecular modeling interaction studies.

  Nuclear medicine and biology 20020401

• Pamidronate results in symptom control of hypertrophic pulmonary osteoarthropathy in cystic fibrosis.

  Chest 20020401

• Combination of pamidronate and thalidomide in the therapy of treatment-resistant multiple myeloma.

  Medical science monitor : international medical journal of experimental and clinical research 20020401

• Combination treatment of osteoporosis: a clinical review.

  Journal of women's health & gender-based medicine 20020401

• Generation and activity of equine osteoclasts in vitro: effects of the bisphosphonate pamidronate (APD).

  Research in veterinary science 20020401

• [Is pamidronate or clodronate better?].

  Vnitrni lekarstvi 20020401

• Anti-tumor activity of pamidronate in human multiple myeloma.

  Leukemia & lymphoma 20020401

• Bisphosphonates pamidronate and zoledronic acid stimulate osteoprotegerin production by primary human osteoblasts.

  Biochemical and biophysical research communications 20020301

• A six-month randomized, controlled, double-blind, dose-response comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of nonsteroidal antiinflammatory drug-refractory ankylosing spondylitis.

  Arthritis and rheumatism 20020301

• Tumor necrosis factor alpha-mediated joint destruction is inhibited by targeting osteoclasts with osteoprotegerin.

  Arthritis and rheumatism 20020301

• Bisphosphonates inhibit stromelysin-1 (MMP-3), matrix metalloelastase (MMP-12), collagenase-3 (MMP-13) and enamelysin (MMP-20), but not urokinase-type plasminogen activator, and diminish invasion and migration of human malignant and endothelial cell lines.

  Anti-cancer drugs 20020301

• Is pamidronate effective for acute rheumatic pain?

  Annals of the rheumatic diseases 20020201

• Prospective evaluation of the peptide-bound collagen type I cross-links N-telopeptide and C-telopeptide in predicting bone metastases status.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020201

• Disodium pamidronate.

  Acta crystallographica. Section C, Crystal structure communications 20020201

• Changes in body composition during androgen deprivation therapy for prostate cancer.

  The Journal of clinical endocrinology and metabolism 20020201

• Myeloma interacts with the bone marrow microenvironment to induce osteoclastogenesis and is dependent on osteoclast activity.

  British journal of haematology 20020201

• Pamidronate treatment of osteogenesis imperfecta--lack of correlation between clinical severity, age at onset of treatment, predicted collagen mutation and treatment response.

  Journal of pediatric endocrinology & metabolism : JPEM 20020201

• Pamidronate: a novel treatment for the SAPHO syndrome?

  Rheumatology (Oxford, England) 20020201

• A pharmacokinetic and pharmacodynamic model for intravenous bisphosphonate (pamidronate) in osteoporosis.

  European journal of clinical pharmacology 20020201

• [Bone evaluation in ten adults with cutaneous mastocytosis].

  Annales de dermatologie et de venereologie 20020201

• Distinct mechanisms of bisphosphonate action between osteoblasts and breast cancer cells: identity of a potent new bisphosphonate analogue.

  Breast cancer research and treatment 20020201

• Pathologic fracture of the femoral neck in a female soccer player.

  Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 20020201

• Multiple myeloma: present and future.

  Current opinion in oncology 20020101

• Recovery of proximal tibia bone mineral density and strength, but not cancellous bone architecture, after long-term bisphosphonate or selective estrogen receptor modulator therapy in aged rats.

  Bone 20020101

• Hypercalcemia in a patient with tuberculous adrenal insufficiency.

  Joint, bone, spine : revue du rhumatisme 20020101

• Bisphosphonates for breast cancer.

  The Cochrane database of systematic reviews 20020101

• Direct effects of bisphosphonates on breast cancer cells.

  Breast cancer research : BCR 20020101

• The present and future role of bisphosphonates in the management of patients with breast cancer.

  Breast cancer research : BCR 20020101

• Development of bisphosphonates.

  Breast cancer research : BCR 20020101

• Actions of bisphosphonates in animal models of breast cancer.

  Breast cancer research : BCR 20020101

• [Use of disodium pamidronate in patients with bone metastases in patients with pulmonary carcinoma].

  Vojnosanitetski pregled 20020101

• Congenital sucrase-isomaltase deficiency presenting with failure to thrive, hypercalcemia, and nephrocalcinosis.

  BMC pediatrics 20020101

• Fibrous dysplasia.

  Hormone research 20020101

• Bisphosphonates for the relief of pain secondary to bone metastases.

  The Cochrane database of systematic reviews 20020101

• Use of image processing techniques to assess effect of disodium pamidronate in conjunction with radiotherapy in patients with bone metastases.

  Acta oncologica (Stockholm, Sweden) 20020101

• Efficacy and tolerability of cyclical intravenous pamidronate in patients with low bone mass.

  Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 20020101

• Immobilization-related hypercalcemia after renal failure in burn injury.

  Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20020101

• Medical treatment of Charcot's arthropathy.

  Journal of the American Podiatric Medical Association 20020101

• Bisphosphonates in multiple myeloma.

  The Cochrane database of systematic reviews 20020101

• Electrolyte abnormalities with zoledronic acid therapy.

  Cancer journal (Sudbury, Mass.) 20020101

• McCune-Albright syndrome--the German experience.

  Journal of pediatric endocrinology & metabolism : JPEM 20020101

• Pamidronate treatment in bone fibrous dysplasia in children and adolescents with McCune-Albright syndrome.

  Journal of pediatric endocrinology & metabolism : JPEM 20020101

• Therapy of ankylosing spondylitis and other spondyloarthritides: established medical treatment, anti-TNF-alpha therapy and other novel approaches.

  Arthritis research 20020101

• Comparable bioavailability of two esophago-gastric protective formulations containing pamidronate. A cross-over trial in healthy young adults.

  Medicina 20020101

• [Pamidronate in the treatment of bone metastases from breast cancer].

  Magyar onkologia 20020101

• Bone lesions in malignant diseases--II. Therapeutic management.

  Folia medica 20020101

• The new bisphosphonate, Zometa (zoledronic acid), decreases skeletal complications in both osteolytic and osteoblastic lesions: a comparison to pamidronate.

  Cancer investigation 20020101

• Bisphosphonate therapy in multiple myeloma: past, present, future.

  European journal of haematology 20020101

• Bisphosphonates--targeting bone in the treatment of spondyloarthritis.

  Clinical and experimental rheumatology 20020101

• Osteoporosis and other adverse body composition changes during androgen deprivation therapy for prostate cancer.

  Cancer metastasis reviews 20020101

• The use of zoledronic acid, a novel, highly potent bisphosphonate, for the treatment of hypercalcemia of malignancy.

  The oncologist 20020101

• The use of bisphosphonates in patients with breast cancer.

  Cancer control : journal of the Moffitt Cancer Center 20020101

• Metabolic effects of single-dose pamidronate administration in prostate cancer patients with bone metastases.

  The International journal of biological markers 20020101

• Serum levels of tartrate-resistant acid phosphatase-5b in breast cancer patients treated with pamidronate.

  The International journal of biological markers 20020101

• Comparative evaluation of safety and efficacy of pamidronate and zoledronic acid in multiple myeloma patients (single center experience).

  Acta poloniae pharmaceutica 20020101

• [Effect of pamidronate on bone blood flow and serum levels of IGF-I in sham-operated and oophorectomized female rats].

  Sbornik lekarsky 20020101

• Essential contribution of germline-encoded lysine residues in Jgamma1.2 segment to the recognition of nonpeptide antigens by human gammadelta T cells.

  Journal of immunology (Baltimore, Md. : 1950) 20011215

• Pamidronate-related nephrotoxicity (tubulointerstitial nephritis) in a patient with osteolytic bone metastases.

  Nephron 20011201

• In vivo near-infrared fluorescence imaging of osteoblastic activity.

  Nature biotechnology 20011201

• Hypercalcemia due to all-trans retinoic acid therapy for acute promyelocytic leukemia: a case report of effective treatment with bisphosphonate.

  Pediatrics international : official journal of the Japan Pediatric Society 20011201

• Novel therapeutic approaches to cancer patients with bone metastasis.

  Critical reviews in oncology/hematology 20011201

• Pamidronate in the treatment of diffuse sclerosing osteomyelitis of the mandible.

  Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 20011201

• Treatment of reflex sympathetic dystrophy with pamidronate: 29 cases.

  Rheumatology (Oxford, England) 20011201

• Treatment of refractory symphysitis pubis with intravenous pamidronate.

  The Journal of rheumatology 20011201

• Effect of pamidronate on distraction osteogenesis and fixator-related osteoporosis.

  Injury 20011201

• Advances in the biology and treatment of myeloma bone disease.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20011115

• Conventional treatment of hypercalcemia of malignancy.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20011115

• More on pamidronate in Langerhans'-cell histiocytosis.

  The New England journal of medicine 20011115

• More on pamidronate in Langerhans'-cell histiocytosis.

  The New England journal of medicine 20011115

• Targeting of tumor cells for human gammadelta T cells by nonpeptide antigens.

  Journal of immunology (Baltimore, Md. : 1950) 20011101

• Antibacterial effect of human V gamma 2V delta 2 T cells in vivo.

  The Journal of clinical investigation 20011101

• Extracellular signal-regulated kinases and calcium channels are involved in the proliferative effect of bisphosphonates on osteoblastic cells in vitro.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20011101

• Bisphosphonates in the treatment of Charcot neuroarthropathy: a double-blind randomised controlled trial.

  Diabetologia 20011101

• [Two cases of effective weekly paclitaxel administration for metastatic breast cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20011101

• Cyclic pamidronate infusion improves bone mineralisation and reduces fracture incidence in osteogenesis imperfecta.

  European journal of pediatrics 20011101

• Do different aminobisphosphonates have similar preventive effect on experimental thyroid hormone-induced osteopenia in rats?

  Calcified tissue international 20011101

• [Intravenous pamidronate delivery to a case with multiple bone metastasis of breast cancer].

  Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics 20011101

• Prevention of bone loss and fracture after lung transplantation: a pilot study.

  Transplantation 20011015

• The use of a whole body index with bone scintigraphy to monitor the response to therapy in Paget's disease.

  Nuclear medicine communications 20011001

• Pamidronate-induced remission of pain associated with hypertrophic pulmonary osteoarthropathy in chemoendocrine therapy-refractory inoperable metastatic breast carcinoma.

  Anti-cancer drugs 20011001

• Nitrogen-containing bisphosphonates induce apoptosis of Caco-2 cells in vitro by inhibiting the mevalonate pathway: a model of bisphosphonate-induced gastrointestinal toxicity.

  Bone 20011001

• A microcosting analysis of zoledronic acid and pamidronate therapy in patients with metastatic bone disease.

  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20011001

• Paget's disease of the spine and its management.

  European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society 20011001

• Comparison of the effects of intravenous pamidronate and oral clodronate on symptoms and bone resorption in patients with metastatic bone disease.

  Annals of oncology : official journal of the European Society for Medical Oncology 20011001

• Testicular germ cell tumor with rhabdomyosarcoma successfully treated by disease-adapted chemotherapy including high-dose chemotherapy: case report and review of the literature.

  Bone marrow transplantation 20011001

• Bones, groans and blasts.

  Journal of paediatrics and child health 20011001

• Bisphosphonates in the treatment of metastatic breast cancer.

  Journal of mammary gland biology and neoplasia 20011001

• Pamidronate to prevent bone loss during androgen-deprivation therapy for prostate cancer.

  The New England journal of medicine 20010927

• Bone loss accompanying medical therapies.

  The New England journal of medicine 20010927

• Trastuzumab and breast cancer.

  The New England journal of medicine 20010927

• The antiosteoporotic efficacy of intravenous pamidronate in men with prostate carcinoma receiving combined androgen blockade: a double blind, randomized, placebo-controlled crossover study.

  Cancer 20010915

• Bisphosphonates are potent inhibitors of Trypanosoma cruzi farnesyl pyrophosphate synthase.

  The Journal of biological chemistry 20010907

• Vgamma2Vdelta2 T-cell receptor-mediated recognition of aminobisphosphonates.

  Blood 20010901

• Severe osteopenia in a young boy with Kostmann's congenital neutropenia treated with granulocyte colony-stimulating factor: suggested therapeutic approach.

  Pediatrics 20010901

• Bisphosphonate therapy for Paget's disease in a patient with hypoparathyroidism: profound hypocalcemia, rapid response, and prolonged remission.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20010901

• Isoprenoid biosynthesis. Metabolite profiling of peppermint oil gland secretory cells and application to herbicide target analysis.

  Plant physiology 20010901

• Bisphosphonates for osteoporosis.

  Drug and therapeutics bulletin 20010901

• Bisphosphonates and nephrocalcinosis in a rabbit leg lengthening model: a histological and therapeutic comparison.

  Pharmacology & toxicology 20010901

• Intravenous pamidronate reduces osteoporosis and improves formation of the regenerate during distraction osteogenesis. A study in immature rabbits.

  The Journal of bone and joint surgery. British volume 20010901

• Hypercalcemia in patients with oral squamous cell carcinoma.

  Clinical oral investigations 20010901

• Scintigraphic evaluation of pamidronate and corticosteroid therapy in a patient with progressive diaphyseal dysplasia (Camurati-Engelmann disease).

  Clinical nuclear medicine 20010801

• Pamidronate in incident pain due to bone metastases.

  Journal of pain and symptom management 20010801

• Idiopathic orbital inflammation following intravenous pamidronate.

  Rheumatology (Oxford, England) 20010801

• Effects of a bisphosphonate on the expression of bone specific genes after autogenous free bone grafting in rats.

  Journal of periodontal research 20010801

• Analysis of skeletal-related events in breast cancer and response to therapy.

  Seminars in oncology 20010801

• Dosing regimens and main adverse events of bisphosphonates.

  Seminars in oncology 20010801

• Adjuvant bisphosphonate therapy: the future.

  Seminars in oncology 20010801

• [Bisphosphonates in the treatment of breast carcinoma].

  Polskie Archiwum Medycyny Wewnetrznej 20010801

• Pamidronate for bone pain from osteolytic lesions in Langerhans'-cell histiocytosis.

  The New England journal of medicine 20010719

• Bisphosphonates may be useful in treatment of bone metastases.

  Journal of the National Cancer Institute 20010718

• Safety and efficacy of bisphosphonates beyond 24 months in cancer patients.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010715

• [Tumor-induced hypercalcemia. Review of bisphosphonate treatment].

  La Revue de medecine interne 20010701

• Pamidronate decreases tumor-induced osteoclastogenesis in osteopetrotic mice.

  Journal of orthopaedic research : official publication of the Orthopaedic Research Society 20010701

• The role of disodium pamidronate in the management of bone pain due to malignancy.

  Palliative medicine 20010701

• Mode of administration-dependent pharmacokinetics of bisphosphonates and bioavailability determination.

  International journal of pharmaceutics 20010604

• Collapsing focal segmental glomerulosclerosis following treatment with high-dose pamidronate.

  Journal of the American Society of Nephrology : JASN 20010601

• The bisphosphonate pamidronate is a potent inhibitor of human osteosarcoma cell growth in vitro.

  Anti-cancer drugs 20010601

• Pamidronate improves the quality of life and induces clinical remission of bone metastases in patients with thyroid cancer.

  British journal of cancer 20010601

• The sugar absorption test in the evaluation of the gastrointestinal intolerance to bisphosphonates: studies with oral pamidronate.

  Clinical pharmacology and therapeutics 20010601

• Disease controlling antirheumatic therapy in spondyloarthropathy.

  The Journal of rheumatology. Supplement 20010601

• [Analgesic effect of Pamidronate on bone pain in patient with hypertrophic pulmonary osteoarthropathy].

  Revue de pneumologie clinique 20010601

• [Chronic recurrent multifocal osteomyelitis in children: report of 17 cases].

  Archives de pediatrie : organe officiel de la Societe francaise de pediatrie 20010601

• Ocular adverse effects of alendronic acid.

  Prescrire international 20010601

• Bone disease in myeloma.

  Current treatment options in oncology 20010601

• Metastatic bone disease and tumour-induced hypercalcaemia: the role of bisphosphonates.

  International journal of palliative nursing 20010601

• Successful pamidronate treatment of severe and refractory regional migratory osteoporosis.

  Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 20010601

• Essential requirement of antigen presentation by monocyte lineage cells for the activation of primary human gamma delta T cells by aminobisphosphonate antigen.

  Journal of immunology (Baltimore, Md. : 1950) 20010501

• Visualization of bisphosphonate-induced caspase-3 activity in apoptotic osteoclasts in vitro.

  Bone 20010501

• Systemic treatment of metastatic breast cancer.

  Hospital medicine (London, England : 1998) 20010501

• Efficacy of low dose schedule pamidronate infusion in children with osteogenesis imperfecta.

  Journal of pediatric endocrinology & metabolism : JPEM 20010501

• Clinical, endocrinological and radiography features in a child with McCune-Albright syndrome and pituitary adenoma.

  Journal of pediatric endocrinology & metabolism : JPEM 20010501

• The impact of pamidronate on inpatient and outpatient services among metastatic breast cancer patients.

  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20010501

• Pamidronate increases markers of bone formation in patients with multiple myeloma in plateau phase under interferon-alpha treatment.

  Calcified tissue international 20010501

• Bisphosphonate inhibits alveolar bone resorption in experimentally-induced peri-implantitis in dogs.

  Clinical oral implants research 20010401

• Effect of intravenous pamidronate on bone mineral density in adults with cystic fibrosis.

  Thorax 20010401

• Analgesic effect of bisphosphonates in mice.

  Pain 20010401

• Zoledronic acid reduces skeletal-related events in patients with osteolytic metastases.

  Cancer 20010401

• Bisphosphonates regulate cell growth and gene expression in the UMR 106-01 clonal rat osteosarcoma cell line.

  British journal of cancer 20010401

• New advances in the biology and treatment of myeloma bone disease.

  Seminars in hematology 20010401

• Intravenous bisphosphonate for hypercalcemia accompanying subcutaneous fat necrosis: a novel treatment approach.

  Clinical pediatrics 20010401

• Chemical and biological prerequisites for novel bisphosphonate molecules: results of comparative preclinical studies.

  Seminars in oncology 20010401

• The role of zoledronic acid in cancer: clinical studies in the treatment and prevention of bone metastases.

  Seminars in oncology 20010401

• Zoledronic acid in the treatment of hypercalcemia of malignancy: results of the international clinical development program.

  Seminars in oncology 20010401

• Zoledronic acid in cancer patients with bone metastases: results of Phase I and II trials.

  Seminars in oncology 20010401

• Consensus statement on the modern therapy of Paget's disease of bone from a Western Osteoporosis Alliance symposium. Biannual Foothills Meeting on Osteoporosis, Calgary, Alberta, Canada, September 9-10, 2000.

  Clinical therapeutics 20010401

• [Bone scintigraphy in the control of bone metastasis of breast cancer during pamidronate and tamoxifen combination therapy].

  Nuklearmedizin. Nuclear medicine 20010401

• Osteogenesis imperfecta: care and management.

  Paediatric nursing 20010401

• Bisphosphonate treatment inhibits the growth of prostate cancer cells.

  Cancer research 20010315

• Bisphosphonates inhibit the growth of Trypanosoma brucei, Trypanosoma cruzi, Leishmania donovani, Toxoplasma gondii, and Plasmodium falciparum: a potential route to chemotherapy.

  Journal of medicinal chemistry 20010315

• Effect of pamidronate in preventing local bone loss after total hip arthroplasty: a randomized, double-blind, controlled trial.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20010301

• Use of bisphosphonates for the treatment of metastatic bone pain. A survey of palliative physicians in the UK.

  Palliative medicine 20010301

• Osteogenesis imperfecta: lifelong management is imperative and feasible.

  Joint, bone, spine : revue du rhumatisme 20010301

• Prolonged, symptomatic hypocalcemia with pamidronate administration and subclinical hypoparathyroidism.

  Endocrine 20010301

• The diabetic foot: a major problem for the new millennium.

  The West Indian medical journal 20010301

• Effects of gonadal steroid suppression on skeletal sensitivity to parathyroid hormone in men.

  The Journal of clinical endocrinology and metabolism 20010201

• Structure-activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates.

  The Journal of pharmacology and experimental therapeutics 20010201

• [Osteogenesis imperfecta: a new, early therapeutic approach with biphosphonates. A case report].

  Archives de pediatrie : organe officiel de la Societe francaise de pediatrie 20010201

• Treatment of osteoporosis with bisphosphonates.

  Rheumatic diseases clinics of North America 20010201

• Zoledronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy: a pooled analysis of two randomized, controlled clinical trials.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010115

• Therapeutic advances in ankylosing spondylitis.

  Expert opinion on investigational drugs 20010101

• A newly developed bisphosphonate, YM529, is a potent apoptosis inducer of human myeloma cells.

  Leukemia research 20010101

• Primary prevention of glucocorticoid-induced osteoporosis with intravenous pamidronate and calcium: a prospective controlled 1-year study comparing a single infusion, an infusion given once every 3 months, and calcium alone.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20010101

• Bisphosphonate therapy in fibrous dysplasia.

  Clinical orthopaedics and related research 20010101

• Metal-ion speciation in blood plasma incorporating the tetraphosphonate, N,N-dimethylenephosphonate-1-hydroxy-4-aminopropilydenediphosphonate (APDDMP), in therapeutic radiopharmaceuticals.

  Journal of inorganic biochemistry 20010101

• Treatment of Langerhans cell histiocytosis with pamidronate.

  Journal of pediatric hematology/oncology 20010101

• Clinical and radiological amelioration of refractory peripheral spondyloarthritis by pulse intravenous pamidronate therapy.

  The Journal of rheumatology 20010101

• Pamidronate and calcitonin as therapy of acute cancer-related hypercalcemia in children.

  Klinische Padiatrie 20010101

• Tumor 'flare' hypercalcemia--an additional indication for bisphosphonates?

  Oncology 20010101

• Influence of cyclic intravenous pamidronate on proinflammatory monocytic cytokine profiles and bone density in rheumatoid arthritis treated with low dose prednisolone and methotrexate.

  Clinical and experimental rheumatology 20010101

• Intravenous pamidronate as treatment for osteoporosis after heart transplantation: a prospective study.

  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20010101

• Pamidronate increases trabecular bone mineral density in immobilization osteopenia in male rats.

  Annales chirurgiae et gynaecologiae 20010101

• Inhibition of cholesteatomatous bone resorption with pamidronate disodium.

  Acta oto-laryngologica 20010101

• Zoledronic acid.

  Drugs 20010101

• Bone loss. Therapeutic approaches for preventing bone loss in inflammatory arthritis.

  Arthritis research 20010101

• [Vertebral osteoporosis induced by corticoids and cyclosporine ina a patient with Still disease].

  Medicina 20010101

• Bone mineral density response to long-term bisphosphonate therapy in fibrous dysplasia.

  Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 20010101

• The clinical and cost considerations of bisphosphonates in preventing bone complications in patients with metastatic breast cancer or multiple myeloma.

  Drugs 20010101

• [Paget disease or fibrous dysplasia of the radius?--A case report].

  Wiener medizinische Wochenschrift (1946) 20010101

• Incremental cost analysis of ambulatory clinic and home-based intravenous therapy for patients with multiple myeloma.

  PharmacoEconomics 20010101

• Bisphosphonates for osteoporosis in people with cystic fibrosis.

  The Cochrane database of systematic reviews 20010101

• Bisphosphonates in multiple myeloma.

  The Cochrane database of systematic reviews 20010101

• Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: a phase III, double-blind, comparative trial.

  Cancer journal (Sudbury, Mass.) 20010101

• Intravenously administered pamidronate in the treatment of Paget's disease of bone.

  Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20010101

• Hypercalcemia associated with squamous cell carcinoma of tongue.

  Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20010101

• Preventive therapy for Paget's disease of bone.

  Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 20010101

• Recovery from severe glucocorticoid-induced osteoporosis in an adolescent boy.

  Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 20010101

• Phase II trial of clarithromycin and pamidronate therapy in myeloma.

  Medical oncology (Northwood, London, England) 20010101

• Fragility fractures in dialysis and transplant patients. Is it osteoporosis, and how should it be treated?

  Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis 20010101

• Combined calcitriol-pamidronate therapy for bone hyperresorption in spinal cord injury.

  The journal of spinal cord medicine 20010101

• Bisphosphonates induce breast cancer cell death in vitro.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20001101

• [A case of effective bisphosphonate therapy of sequential pamidronate and incadronate for bone metastases from breast cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20000801

• Bisphosphonates induce apoptosis in human breast cancer cell lines.

  British journal of cancer 20000401

• Alendronate is a specific, nanomolar inhibitor of farnesyl diphosphate synthase.

  Archives of biochemistry and biophysics 20000101

• Use of pamidronate to reverse vitamin D3-induced toxicosis in dogs.

  American journal of veterinary research 19990901

• An in vitro and in vivo study of cytokines in the acute-phase response associated with bisphosphonates.

  Calcified tissue international 19971101

• Retrobulbar optic neuritis after pamidronate administration in a patient with a history of cutaneous porphyria.

  Clinical rheumatology 19970101

• Cauda equina syndrome with pagetic vertebral fusion. Clinical recovery under calcium-vitamin D supplementation plus clodronate after apparent failure of pamidronate and acquired resistance to etidronate.

  Revue du rhumatisme (English ed.) 19970101

• Characteristics of clodronate-induced apoptosis in osteoclasts and macrophages.

  Molecular pharmacology 19961101

• Milk-alkali syndrome induced by 1,25(OH)2D in a patient with hypoparathyroidism.

  Journal of the National Medical Association 19960501

• Pamidronate in patients with painful bone metastases, who failed initial treatment with hormones and/or chemotherapy.

  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 19960101

• Preclinical pharmacology of CGP 42'446, a new, potent, heterocyclic bisphosphonate compound.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 19940501

• Pamidronate associated hallucinations.

  Annals of the rheumatic diseases 19920701

• Effect of pamidronate in a rat hypercalcemia model induced by cholecalciferol.

  Arzneimittel-Forschung 19920401

• 1,25-Dihydroxyvitamin D-related hypercalcemia in lymphoma: two case reports.

  Clinical rheumatology 19900901